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SUMMARY 
 
Obesity has become a global health problem for both children and adults. White 
adipose tissue (WAT) displays unique plasticity upon excessive feeding by expanding its 
mass through proliferation and differentiation of resident adipocyte progenitor cells (AP). 
Studies have shown that excessive accumulation of WAT is pre-determined during early 
childhood. However, mechanisms of the body weight programming and effect of WAT 
expansion during childhood on metabolic disease risk later in life are still elusive. In order to 
investigate regulation of AP expansion by obesogenic diet, we established a diet-induced 
obesity model. We observed a rapid gain in body weight and increased accumulation of WAT 
already one week after high-fat diet (HFD) feeding in young, sexually immature female mice, 
but not adult mice. Moreover, HFD induced WAT growth via proliferation of APs and partially 
through mature adipocyte hypertrophy. Employing an isocaloric, pair feeding approach, we 
found that dietary fat content is able to induce proliferation of APs, while the amount of 
consumed calories seems to promote inflammation. Moreover we demonstrated that AP 
proliferation could occur without initial hypertrophy of mature adipocytes. Although we 
demonstrated that the concentration of insulin-like growth factor 1 (IGF-1) was regulated by 
calorie load as little as 2 days of HFD, it was not changed upon isocaloric HFD thus could not 
fully explain the proliferation we observed in APs. Additionally, we found lipids transiently 
increased after feeding and could be potentially involved in AP activation. In order to identify 
genes involved in regulating AP responses in the niche upon excessive feeding during 
childhood, we performed gene expression profiling from whole tissue and specific cellular 
subpopulations of WAT. A large portion of the differentially expressed genes from WAT 
profiles were associated with key events in tissue remodeling and cell-to-cell communication, 
such as inflammation, cytokine production, and extracellular matrix proteins/remodeling 
enzymes. In order to functionally validate candidate genes, a novel co-culture system with 
APs and feeder niche-like cells was established to mimic WAT physiological conditions. This 
system was used for siRNA screening by high-content microscopy to identify alterations in 
cell proliferation and differentiation. Several gene targets related to increased proliferation of 
APs in response to HFD feeding have been validated including epithelial membrane protein 1 
(EMP1), which known to play a role in cell junctions. EMP1 modulation in feeder cells (siRNA 
mediated knockdown or overexpression) altered AP-derived colony growth. Our results 
suggested that high fat feeding induces activation of the network of cell-cycle related genes 
triggering AP proliferation in early development. 
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ZUSAMMENFASSUNG 
 
Fettleibigkeit ist ein globales Gesundheitsproblem für Kinder und Erwachsene 
geworden. Weißes Fettgewebe (WF) zeigt eine einzigartige Plastizität bei übermäßiger 
Kalorienaufnahme durch Expansion seiner Masse durch Proliferation und Differenzierung 
von residenten Adipozyten-Vorläuferzellen (AV). Studien haben gezeigt, dass eine 
übermäßige Akkumulation von WF in der frühen Kindheit vorausbestimmt wird. Allerdings 
sind die Mechanismen der Körpergewichts-Programmierung und Wirkung der WF-Expansion 
während der Kindheit auf das metabolische Krankheitsrisiko später im Leben noch schwer 
fassbar. Um die Regulation der AV-Expansion durch obesogene Ernährung zu untersuchen, 
haben wir ein Diät-induziertes Fettleibigkeitsmodell etabliert. Wir beobachteten einen 
raschen Anstieg des Körpergewichts und eine erhöhte Akkumulation von WF bereits eine 
Woche nach Beginn der Hochfettdiät (HFD) bei jungen, aber nicht bei erwachsenen Mäusen. 
Darüber hinaus induzierte Hochfettdiät das WF-Wachstum durch die frühe Zellproliferation 
und auch teilweise durch Adipozytenhypertrophie. Mittels eines isokalorischen 
Fütterungsansatz es haben wir festgestellt, dass hoher Fettgehalt in der Nahrung die 
Proliferation von AVs induzieren kann, während die Menge der verbrauchten Kalorien die 
Entzündung zu fördern scheint. Darüber hinaus haben wir gezeigt, dass AV-Proliferation 
ohne anfängliche Hypertrophie von reifen Adipozyten auftreten konnte. Obwohl wir gezeigt 
haben, dass die Konzentration von IGF-1 durch Kalorienbelastung bereits nach 2 Tagen 
HFD reguliert wurde, wurde sie bei isokalorischer HFD nicht verändert, was die in AVs 
beobachtete Proliferation nicht vollständig erklären konnte. Darüber hinaus fanden wir 
vorübergehend erhöhte Lipide nach der Fütterung, welche möglicherweise an der AV-
Aktivierung beteiligt sein könnten. Um Gene, die an der Regulation der AV-Antwort bei 
übermäßiger Fütterung während der Kindheit beteiligt sind, zu identifizieren, führten wir eine 
Transkriptomanalyse aus dem gesamten WF und aus spezifischen zellulären 
Subpopulationen durch. Ein großer Teil der differentiell exprimierten Gene aus WF-Profilen 
wurde mit wichtigen Ereignissen in der Geweberegenerierung und der Zell-Zell-
Kommunikation, wie Entzündung, Zytokinproduktion und extrazelluläre Matrixproteine/ 
Remodelingenzyme, in Verbindung gebracht. Um die funktionelle Validierung von 
Kandidatengenen durchzuführen, wurde ein Kokultursystem von AV und Feeder-Zellten 
entwickelt, um die physiologischen Bedingungen der WF-Nische nachzuahmen. Dieses 
System wurde für das siRNA-Screening verwendet, mittels High-Content Mikroskopie, um 
Veränderungen in der Zellproliferation/ -differenzierung zu identifizieren. Mehrere Gen-
Targets, die im Zusammenhang mit AVs Reaktion auf fettreiche Fütterung stehen wurden im 
Co-Kultur-System validiert, einschließlich epithelial membrane protein 1 (EMP1), von dem 
bekannt ist, dass es eine Rolle im Zellkontakt spielt. EMP1-Manipulation in Feeder-Zellen 
(siRNA-vermittelter Knockdown oder Überexpression) veränderte AV-abgeleitetes 
Kolonienwachstum. Unsere Ergebnisse deuten darauf hin, dass eine fettreiche Fütterung die 
Aktivierung des Netzwerks von zellzyklusbezogenen Genen induziert, die die AV-
Proliferation in der frühen Entwicklung auslösen. 
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1. INTRODUCTION 
1.1 Adipose tissue  
Adipose or fat tissue (AT) is a complex organ with metabolic and endocrine functions 
in the body. AT can be classified into two main types: white adipose tissue (WAT) and brown 
adipose tissue (BAT) (Peirce et al. 2014). WAT consists of unilocular adipocytes (fat cells) 
with one big lipid droplet, specialized for storage of calories. BAT is composed of multilocular 
cells with many small lipid droplets enriched with mitochondria for dissipating energy by heat 
production. Another distinct type of adipocyte is the “beige” or “bright”, a brown-like adipocyte 
found within WAT upon special stimuli, e.g. cold exposure (Cinti 2012). Recently, the “pink” 
adipocyte was observed during lactation deriving from mammary gland alveolar epithelial 
cells (Giordano et al. 2014). The main focus of this work is the WAT, as it is the main source 
for storage of calories.  
1.1.1 Location of different types of white adipose tissue in human and mouse 
Although WAT is found throughout the body, there are some specialization, with 
distinct characteristics and functions, depending on the location. WAT is subdivided as 
subcutaneous (sc), which is the fat located under the skin, and visceral (v), which is the fat 
positioned inside of peritoneum; scWAT in humans can be further divided into abdominal, 
gluteal and femoral (Fig. 1.1 - A). In mice, scWAT is classified by anterior and posterior 
position in the body. The anterior scWAT is subdivided into deep cervical, superficial cervical, 
interscapular, subscapular, and axillo-thoracic depots, whereas the posterior, into dorso-
lumbar, inguinal and gluteal (Fig. 1.1 - B). Visceral fat in humans is divided into periental, 
retroperitoneal, omental and mesenteric (Fig. 1.1 - A). In mice there are several vWAT 
depots as peritoneal, retroperitoneal, mesenteric, and perigonadal (epididymal) (Fig. 1.1 - B). 
Taking into consideration the differences between mouse and human physiology, the mouse 
perigonadal WAT (gWAT) is used as a model for the human vWAT. The mouse counterpart 
of human scWAT is the inguinal WAT (ingWAT).  
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Figure 1.1 Location of different types of WAT in human and mouse. 
1.1.2 Main functions of white adipose tissue  
 Among other vital functions, the key function of WAT is to be the main source of 
energy for the organism, storing calories during food availability and releasing them in time of 
need. By buffering energy, adipose tissue plays a pivotal role in organism homeostasis 
(Rosen & Spiegelman 2014), (Rutkowski et al. 2015). Mature adipocytes are the main cell 
type within the adipose tissue and responsible for sustaining this function. These specialized 
cells can store triglycerides in the form of lipid droplets. After feeding, energy is transported 
in the form of fatty acids into the adipocytes directly from food or through de novo lipogenesis 
in hepatocytes/adipocytes. Non-esterified fatty acids (NEFAs or free fatty acids – FFAs) are 
taken up from the circulation by fatty acids binding and transporting proteins like CD36 and 
FATPs, which are highly expressed on adipocytes (Rutkowski et al. 2015). Then FFA are 
esterified into triglycerides and stored in the lipid droplets leading to an increase of adipocyte 
size. Another source of energy from food are carbohydrates. Glucose is transported into 
mature adipocyte in the presence of insulin by the Glut4 transporter (Stry & Renold 1965). 
12 
 
During glycolysis, dihydroxyacetone phosphate is produced from glucose and converted to 
glycerol-3-phosphate going for triglyceride synthesis. Around 25% of glucose taken by 
mature adipocyte is used for triglyceride synthesis (Frayn & Humphreys 2012). Alternatively, 
glucose can enter the tricarboxylic acid (TCA) cycle leading to the production of citrate, which 
is used for fatty acids synthesis. During fasting, adipose tissue has a central role in body 
homeostasis by providing fatty acids via lipolysis, which are released to the circulation. Fatty 
acids can be used as source of energy in different tissues, sparing glucose for the brain and 
red blood cells (Rosen & Spiegelman 2014). 
1.1.2.1 Lipodystrophy 
To understand the importance of adipose tissue functions, transgenic mice A-ZIP/F-1 
lacking fat were generated in 1998 by the group of Dr. Charles Vinson. Lipodystrophic mice 
have no WAT and reduced BAT, which leads to a severe metabolic phenotype with enlarged 
liver filled with lipids, elevated serum glucose (3-fold), insulin (50-400 fold), FFA (2-fold), 
triglycerides (3-5 fold) (Moitra et al. 1998). Recently the first model of an inducible 
lipoatrophic mouse was created, FAT-ATTAC (fat apoptosis through targeted activation of 
caspase 8). Within 2 weeks of induction of adipocytes apoptosis FAT-ATTAC mice had 
reduced adipose tissue and became glucose intolerant with reduced glucose-stimulated 
insulin secretion (Pajvani et al. 2005). Lipodystrophy is known in humans as partial or 
complete loss of adipose tissue, which is often associated with other symptoms as ectopic fat 
accumulation, metabolic disorders as insulin resistance, diabetes mellitus, 
hypertriglyceridemia and hepatic steatosis (Endocrinology et al. 2012). Another example of 
atrophy of adipose tissue is a part of complex disorder called cancer-associated cachexia 
(CAC) (Petruzzelli & Wagner 2016). Provided examples of lipodystrophic phenotype 
underlined that AT plays a key role in “save” storing of toxic lipids which can cause ectopic 
fat accumulation in other organs, e.g. liver. 
1.1.2.2 Obesity  
Obesity is a result of a positive energy balance, when energy intake is higher than 
energy expenditure involving the combination of resting metabolic rate, energy spend for 
absorption and metabolism of dietary macronutrients, and during physical activity (Hill et al. 
2012), (Spiegelman & Flier 2001), (Gesta et al. 2007). Although adipose tissue serves as a 
reservoir for excess calories, increased abdominal fat mass, the so–called central obesity, is 
strongly associated with increased risk of developing cardiometabolic diseases and 
increased mortality (Coutinho et al. 2011), (J. J. Lee et al. 2014). Dysfunction of AT 
expansion is one of the key factors in development of insulin resistance due to impaired lipid 
storage. Accumulating of vWAT during obesity is associated with chronic inflammation and 
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insulin resistance induced by tissue macrophages producing proinflammatory cytokines 
(tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6)) (Girard & Lafontan 2008). 
According to the World Health Organization, the number of people suffering from obesity has 
doubled since 1980 and totaling over 1.9 billion adults (18 years and older). Obesity leads to 
life threatening conditions as cardiovascular diseases (CVD) (mainly heart disease and 
stroke), diabetes, musculoskeletal disorders like osteoarthritis, and some cancers (including 
endometrial, breast, ovarian, prostate, liver, gallbladder, kidney, and colon) (WHO, 2016).  
Nevertheless, not all obese individuals are metabolically unhealthy. It has been 
shown that some overweight/obese individuals have no association with CVD. These 
“metabolically healthy obese” (MHO) individuals, despite excess body fat, have no 
hypertension and display normal metabolic parameters as high insulin sensitivity, normal 
level of lipids, liver enzymes, hormones and immune profile (Denis & Obin 2013), (Primeau 
et al. 2011), (Sims 2001). Intriguingly, population studies have shown that moderate obesity 
can be beneficial effect for health (Andres 1980). More recently some molecular details of 
healthy expansion of adipose tissue were shown. Type II transmembrane protein 
tenomodulin (TNMD) is upregulated in AT of individuals with insulin resistance compared 
with insulin sensitive ones from body mass index (BMI) - matched group. Mice 
overexpressing Tnmd under an adipose tissue-specific promoter, despite having increased 
gWAT upon high-fat diet, exhibit improved systemic insulin sensitivity, decreased fibrogenic 
collagen production and inflammation of AT (Senol-Cosar et al. 2016). Another example is 
using thiazolidinediones (TZD) for treating patients with diabetes mellitus type 2 (T2DM). 
TZD are known as agonists of PPARs (peroxisome proliferator-activated receptors), 
increasing storage of fatty acids in adipocytes, thus decreasing amount of fatty acids in the 
circulation. TZD increases amount of triglyceride (TG) in WAT and decreasing in liver, which 
leads to improved insulin sensitivity (Yamauchi et al. 2001). Additionally, TZD induces 
adipogenesis in vivo as rosiglitazone (Tang et al. 2011). Although patients under TZD 
treatment have improved hepatic and peripheral insulin sensitivity, it leads to weight gain as 
a side effect (Fonseca 2003). Weight gain was observed to be directly proportional to the 
level of metabolic improvement (Wilding 2006). It is becoming clear that the functional quality 
of adipose tissue contributes to metabolic complications during obesity. Comparison studies 
on the quality and components of extracellular matrix (ECM) in health obese and 
metabolically compromised women demonstrated that some types of collagen (COL6A3) and 
enzymes involved in tissue remodeling could discriminate these two groups of obese people 
(Lackey et al. 2014). Interestingly, MHO individuals have smaller adipocyte size and less 
macrophage infiltration (Klöting et al. 2010). 
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1.1.3 Early adipose tissue growth 
1.1.3.1 Epidemiology of childhood obesity 
Childhood obesity has become a serious public health problem of modern society 
(Nishtar et al. 2016). Accordingly to the WHO, in 2013 42 million children were overweight or 
obese (31 million are leaving in developing countries) and this trend predicted continues to 
grow (Fig. 1.2). 
 
Figure 1.2 Global increase in number of overweight and obese children (WHO, 2016). 
1.1.3.2 Chronic problems related to childhood obesity 
Obesity is harmful to many organ systems as cardiovascular, endocrine, renal, and 
can cause physiological and psychological damage for a child as illustrated on Figure 1.3 
(Garver et al. 2013). Obese children have a higher risk to remain obese during adult life. It 
was reported that although obese children before age of 3 years without obese parents have 
low risk, 80% of children being obese in age 10-15 became obese adults in age of 25 years 
regardless parental status (Whitaker et al. 1997). In 2014 longitude study was conducted 
with 7738 participants demonstrating that overweight children in age of 5 have 4 times higher 
risk to become obese at age fourteen (31.8% vs. 7.9%) (Cunningham et al. 2014).  
15 
 
 
Figure 1.3 Health consequences of childhood obesity. Adapted from (Garver et al. 2013). 
1.1.3.3 Risk factors and etiology 
While the most common form of childhood obesity is polygenic, studies support that rare 
monogenic forms are not contributing to the current epidemic of obesity in children (Garver et 
al. 2013). Having obese parents increases more than 2 times the risk of obesity in adulthood 
among obese and non-obese children below age of 10 years (Whitaker et al. 1997). The 
National Health and Nutrition Examination Survey (2005–2006, USA) investigated pre-
diabetic status among adolescents (12–19 years) from different ethnic and gender groups; 
they measured fasting blood glucose and performed glucose tolerance tests (GTT). They 
showed that Caucasian (white) and Latino- children have the highest prevalence when 
African-American children have the lowest (Alderete et al. 2014). Accordingly, the same 
study showed a higher prevalence in boys than girls (Alderete et al. 2014). Although 
regulation of body weight is considered highly heritable (Kannel et al. 1977), genetic factors 
interact with environmental ones as adaptation to nutritional/behavior changes (Garver et al. 
2013). One obesogenic environmental factor is consuming a diet high in fat and sweet 
beverages. Studies and surveys in the USA from 1989 till 2008 measuring the intake of 
sugar from sweetened beverages e.g. fruit drinks, soda, high fat, high sugar milk, and sports 
drinks have reported increased consumption among children 6-11 years old (Lasater et al. 
2011). High- fat diet enriched with saturated fatty acids has a strong association with 
increased adiposity in obese children (Aeberli et al. 2008). Recently, associations between 
different food composition as saturated fat on body weight increase in adults were found (Lin 
et al. 2012). Correlations have been found between sleeping quality/duration and obesity in 
adolescents. From 1586 individuals aged 11–14 years 24% were overweight/obese. Self-
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reported short sleep duration and poor sleep, according to the questionnaires, were 
associated with increased BMI, fat mass and consuming more unhealthy food (Ferranti et al. 
2016). Many studies have investigated the effects of maternal feeding effects on metabolic 
health of offspring. Increased maternal fructose consumption was associated with obesity of 
children in humans (Goran et al. 2013). In mice, sucrose feeding during pregnancy leads to 
obesity in female offspring (Samuelsson et al. 2013). One of the mechanisms proposed is 
that maternal obesity leads to mitochondrial dysfunction within the oocyte. After 
transplantation to recipient mothers fertilized oocytes from obese mice gave rise to heavier 
fetuses (Wu et al. 2015).  
1.1.3.4 Models to study early adipose tissue growth 
To study early adipose tissue growth, a model of early postnatal overfeeding (PNOF) 
was developed. In this rodent model, investigators achieved increased body and fat 
accumulation by reducing litter size (reduced number of offspring). Sprague-Dawley rats, 
raised in a smaller litter size (4 vs. 22 siblings) from birth till weaning (21 day later) and later 
had free access to food, had increased body weigh already during weaning and heavier 
gWAT 10 weeks after weening (Knittle & Hirsch 1968). A more recent study demonstrated 
that PNOF leads to increased vWAT, lipogenic activity and inflammatory status, while 
pancreatic and hepatic responsiveness, BAT thermogenic activity were reduced 
(Consequences et al. 2013). Moreover, PNOF mice are more susceptible to ischemia-
reperfusion injury of the heart potentially due to changes in extracellular matrix genes 
(Habbout et al. 2013). A porcine model of restricted feeding during suckling was also utilized 
to study early adipose tissue growth and feeding behavioral (Houpt et al. 1979). There are 
many different methods and model organisms that have been used to study early adipose 
tissue growth. Each presents its own challenge to study this dynamic tissue, which is 
becoming a global target for therapy. 
1.1.3.5 Global perspective and treatments 
Several initiatives have been taken around the world to combat the growing childhood 
obesity epidemic. An association was found between childhood obesity and low levels of 
growth hormone (GH). Through inhibition of FFA, a pilot study was conducted with 
administration of Niacin and results are coming (Galescu et al. 2016). Sleep- lengthening 
programs for infants with combination of teaching techniques for mothers gave significant 
results toward preventing obesity during the first year after birth (Paul et al. 2011), (Yanovski 
2011). In 2016 WHO published „Report of the commission on ending childhood obesity”, in 
which prevention of childhood obesity was highlighted as crucial for health of future 
generations (WHO 2016). 
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1.2 Adipose tissue expansion  
WAT has a unique capacity of adapting to changes in nutrient environment. Tissue 
expansion is one of the features of WAT presented upon excess feeding. As it was 
mentioned before, mature adipocytes are the main units of adipose tissue. However, adipose 
tissue consists of many cell types as adipose tissue progenitor cells, endothelial cells in 
vessels, fibroblasts, many types of immune cells, nerves and extracellular matrix, building 
together a adipose tissue niche (Fig. 1.4). Moreover physiological turnover of adipose tissue 
is possible due to proliferation and differentiation immature stromal cells called adipose 
tissue progenitor cells resisting in the low number in adipose tissue.  
 
 
Figure 1.4 Adipose tissue niche components. Adipose tissue consists of many cell types and 
extracellular structures as extracellular matrix (ECM).  
1.2.1 Adipose tissue progenitor cells  
For long time it was common to use adherent cells of stroma vascular fraction (SVF) 
from adipose tissue after digestion to culture so-called mesenchymal stem cells. The surface 
markers of the heterogeneous population were defined after several passages (Baer 2014). 
However, very little was known about specific progenitor subpopulations inside of adipose 
tissue. Recently several groups have contributed substantially to our understanding what 
adipose tissue progenitors (APs) are. In 2008 Rodeheffer et al. described subpopulations of 
APs with high adipogenic capacity as Lin-CD29+CD34+Sca-1+CD24+ cells. These cells 
could differentiate towards mature adipocytes in vitro and in vivo after transplantation to 
lipodystrophic mice reversing the diabetic complications of this model by giving rise new 
adipocytes (Rodeheffer et al. 2008). In a follow up study the same group demonstrated a 
hierarchy of APs, that Lin-CD29+CD34+Sca-1+CD24+ cells lose the CD24 marker during 
differentiation and leave the early progenitor pool (Berry & Rodeheffer 2013). The 
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Granneman group has identified platelet- derived growth factor receptor alpha positive cells 
(PDGFRα+ cells) as a population of cells with high in vivo adipogenic potential. PDGFRα+ 
cells have unique morphology characterized by cytoplasm with long lamellipodias. They were 
located in between of mature adipocytes and very often close to blood capillaries. PDGFRα+ 
cells are CD34+ and Sca-1+, but negative for endothelial marker (IB4), or B-cell marker 
(CD24), or other family member PDGFRβ, for SMA and PPARγ. PDGFRα+ cells can give 
rise to white adipocytes after high-fat diet (HFD) feeding or after transplantation into Matrigel 
in mice (Lee et al. 2012). Resent reporter-linage studies demonstrated that adipose 
progenitor cells (PDGFRβ+) expressing the zinc-finger transcription factor Zfp423 are 
contributing to de novo adipogenesis in vivo (Vishvanath et al. 2016). 
1.2.2 Hypertrophy and hyperplasia 
AT expansion can be mainly achieved by two mechanisms: increasing size of 
preexisting adipocytes (hypertrophy) by filling lipid droplets or through proliferation and 
differentiation of resident APs (hyperplasia). A combination of both hyperplasia and 
hypertrophy can also occur. The currently accepted model of AT expansion upon calorie 
excess can be divided on 3 steps: mature adipocyte hypertrophy, death of mature adipocytes 
and then recruitment of new ones from APs pool (Choe et al. 2016) is shown on Fig. 1.5.  
 
 
Figure 1.5 Cellular mechanism of adipose tissue growth. Upon calorie excess adipose tissue 
grows via hypertrophy (increased cell size) of exciting adipocytes and by recruitment of adipose 
progenitors - hyperplasia (increased cell number). 
1.2.2.1 Adipocyte hypertrophy  
Upon excess of calories, adipocytes increase their size up to a pre-determined limit, 
which is estimated as maximum fat cell weight equivalent to 0.7- 0.8 μg/cell (Krotkiewski et 
al. 1983). Many studies suggested that hypertrophic fat cell has different functions showing a 
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necrotic phenotype attracting macrophages and secreting pro-inflammatory cytokines (Cinti 
et al. 2005), (Strissel et al. 2007). Frequency of such necrotic-like adipocytes is higher in 
diet-induced obesity rodent models and during development of obesity in humans (Cinti et al. 
2005). Apparently mice vWAT has greater rate of adipocyte death upon HFD, reaching up to 
80% after 4 months of HFD compared with first indication of adipocyte death in scWAT after 
3 months of HFD (Strissel et al. 2007). There are many studies showing how hypertrophy 
and death of adipocytes leads to insulin resistance, but also it is one of the mechanisms to 
recruit adipose progenitors to proliferate and differentiate.  
1.2.2.2 Adipogenesis 
The process of AP differentiation towards mature adipocytes (adipogenesis) is very 
complex and regulated by multiple transcription factors, co-activators and miRNAs (Peirce et 
al. 2014). The key regulators of adipogenesis are peroxisome proliferator-activated receptor 
γ (PPARγ) (Spiegelman et al. 1997) and CCAAT/enhancer binding protein family (C/EBP-α, 
C/EBP-β and C/ EBP-δ) (Rosen et al. 2000), (Hansen & Kristiansen 2006) responsible for 
triggering and maintenance of the process. Another transcriptional factor that drives 
expression of genes involved in lipogenesis is sterol regulatory element binding transcription 
factor 1c (SREBP1c). Additionally, activation of SREBP1c leads to through secretion of lipid 
ligands directly activating PPARγ (Kim et al. 1998). Some other pathways are playing role in 
fate determination of APs as bone morphogenetic proteins (BMPs) (Schulz & Tseng 2016), 
insulin and insulin-like growth factors (IGFs) (Smith et al. 1988), Wnt/β-catenin signaling 
(Jeon et al. 2016). However most of molecular studies of adipogenesis were performed in 
cell lines or primary APs and not much known about in vivo adipogenesis. The latest study 
shown contribution of APs in in vivo adipogenesis will be discussed in 1.2.3 section. 
 
 
Figure 1.6 Transcriptional regulation of adipocyte differentiation. Adapted from (Peirce et al. 
2014). 
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1.2.2.3 Adipose tissue plasticity decline in adulthood 
According to the currently accepted paradigm (Rosen & Spiegelman 2014), (Choe et al. 
2016), the number of adipocytes is set during childhood and remains stable through the life. 
scWAT arise in humans from 12-24 weeks till 28 weeks of embryonic development via 
increasing number of cells (Poissonnet et al. 1984). In rats, it was shown that primary after 
birth scWAT fat pad was grown via increased number of cell and then by combination of both 
hyperplasia and hypertrophy (Knittle & Hirsch 1968). Another independent study showed that 
adipocyte number is determined (288 individuals from 4th month till 19 years). This study 
revealed the dynamic process of increasing cell number from birth till 8 years then a 3 times 
elevation in cell number until 19 years of age on Fig. 1.7 (Knittle et al. 1979). Interestingly, 
obese children had an increased number of cells already one year after birth.  
 
Figure 1.7 Dynamic of scWAT adipocyte number after birth in lean and obese children. Adapted 
from (Knittle et al. 1979). Obese individuals shown as open circles, lean as black squares. n= number 
of individuals. Data represented as mean ± SEM, *, pV < 0.05; **, pV < 0.01; ***, pV < 0.001; obese 
vs. lean Student’s t test. 
 
Due to difficulties to access vWAT, little is known about cellular dynamic of this fat depot 
in humans in early age. Several studies were performed on 6 to 18 - year-old children using 
magnetic resonance (MR) imaging or ultrasound revealed strong correlation between total fat 
volume/vWAT thickness and obesity (Fox et al. 1993), (Siegel et al. 2007), (Jung et al. 2016). 
Contribution of hypertrophy vs. hyperplasia during early development of vWAT is still elusive.  
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Number of adipocytes was not increased upon experimental over/restricted feeding in 
adult humans (Salans et al. 1971). In this study, metabolically healthy male volunteers were 
overfed for 3-4 months to gain weight, later they had restricted feeding to lose weight (Salans 
et al. 1971). Three subcutaneous depots (gluteal, anterior abdominal wall and from triceps) 
were analyzed to determine adipose tissue cellularity dynamic upon excess/restricted 
feeding. During the experiment volunteers gained around 10 kg of fat mass, but the number 
of adipocytes did not change rather only the size of adipocytes was increased. This process 
was reversible and adipocyte size decreased upon dietary restriction (Salans et al. 1971). A 
more recent study showed that scWAT from upper-body (abdominal part) increased mass 
upon overfeeding through hypertrophy, but scWAT from lower-body (femoral part) grow via 
hyperplasia (Tchoukalova et al. 2010). Both these studies were limited to scWAT depots. 
The same effect was observed in pigs, in which growth of adipose tissue was achieved by 
increased size of existing adipocytes, but no changes in cell number per gram of tissue was 
observed (Mersminn et al. 1975). Stable isotope labeling studies confirmed that the number 
of adipocytes is set early in life and remain stable during life in mice (Kim et al. 2014) and 
humans (Spalding et al. 2008). Kim et al. showed adipocyte and SVF cell turnover in adult 
mice. vWAT had greater rate of adipogenesis comparing to scWAT (1.05% vs. 21.57%). The 
key point of this study is the age-dependent comparison of adipogenic potential in which the 
authors came to the conclusion that diet-induced hyperplasia acures only in young mice (4-
week old), but not in the adult mice. In this study, 4 or 10-week old male C57Bl/6 mice were 
fed with high-fat diet for 5 weeks in combination of 15N-thymidine- labeling. An increased % of 
labeled adipocytes in both vWAT and scWAT was observed only in young mice (Kim et al. 
2014). Similar conclusions were achieved in another independent study using isotopes that 
number of adipocites is set during childhood and early adolescence and remain the same in 
lean and obese individuals. Even after bariatric surgery and substantial weight loss number 
of adipocytes remain the same, but size was decreased (Spalding et al. 2008). Interestingly, 
another group showed that proliferation of APs has time and depot specific dynamics (Jeffery 
et al. 2015). Employing bromodeoxyuridine (BrdU) to label proliferating cells, it was 
demonstrated that APs proliferate in response to high-fat diet only during first week and only 
in vWAT. The human study has shown as well that vWAT growth more dependent on 
increased cell number, than cell size in mails (Arner et al. 2013). The potential of APs to give 
rise to mature adipocytes declines with age due to multiple reasons, including the expression 
of the tumor suppressor as p16Ink4a (Nishino et al. 2008). Since adipose tissue plasticity 
declines with age, it is important to study molecular mechanism of early adipose tissue 
growth. 
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1.2.3 Molecular mechanisms of adipose tissue expansion (systemic and local factors) 
1.2.3.1 Overnutrition and rapid fat expansion 
Molecular mechanisms of adipose tissue expansion have been long a challenge to be 
uncovered. In 2015, Rodeheffer at al. (Jeffery et al. 2015) proposed that phosphoinositide 3-
kinase (PI3K) - AKT2 pathway is a required element for diet-induced explanation of WAT. In 
this study, it was shown that APs proliferate upon HFD, with the highest proliferation rate on 
the 3rd day. They demonstrated that proliferating APs differentiate to mature adipocytes 
contributing to in vivo adipogenesis. To reveal molecular mechanism of APs proliferation they 
analyzed well known nutrient sensing pathway PI3K-AKT and found that AKT2, but not 
AKT1, is phosphorylated in response to 3 days of HFD in vWAT APs. Using conditional 
knockout of Akt2 crossed with the PdgfRα promoter lacking Akt2 only in specific population 
of APs and pharmacological inhibitor of PI3K, they showed that AKT2- pathway is required 
for vWAT AP activation during HFD feeding. Specifically, mice lacking Akt2 in specific 
population of APs - PdgfRα+ cells (PdgfRα-cre; Akt2fl/fl) has no increase in percentage of 
BrdU labeled (proliferating) cells after one week of high fat diet (HFD) vs. SD (standard diet) 
when Akt2fl/fl line is showing a similar to wild type phenotype with increased labeling of APs 
after HFD feeding (Jeffery et al. 2015). This study demonstrates that one particular pathway 
can influence AP activation upon nutritional challenges and it would be expected that our 
knowledge about other contributors will grow next years. 
1.2.3.2 Role of local inflammation 
vWAT contributes to systemic inflammation during obesity via production of pro-
inflammatory cytokines affecting liver and inducing insulin resistance (Girard & Lafontan 
2008). However, until recently, little was known about local molecular events leading to AP 
recruitment and differentiation in vivo. In 2013, Granneman et al. (Lee et al. 2013) 
demonstrated the importance of immune cells creating a special signaling environment for 
APs to proliferate and differentiate. The chain of cellular and molecular events was elegantly 
untangled: b3-adrenergic receptor stimulation or HFD feeding or physical injury involves the 
death of mature adipocytes that are cleared by immune cells as M2-polarized macrophages. 
Proliferating EdU-labeled APs are located in places with are clusters of immune cells (F4/80+ 
macrophages) so-called crown-like structures (CLS). Macrophages expressing osteopontin, 
receptors to which are present on PDGFRa+ progenitors, which in turn are recruited to side 
of clearance of dying mature adipocyte (Lee et al. 2013). Other research groups also 
demonstrated contribution of local inflammation to adipose tissue remodeling. Adipogenesis 
in vivo can be induced by local injection of lipopolysaccharides (LPS) into fat pad 
(Wernstedt Asterholm et al. 2014). In the same study, it was shown that knocking out of 
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some pro-inflammatory cytokines, specifically in adipose tissue, leads to adipose tissue 
dysfunction and metabolic disorders (Wernstedt Asterholm et al. 2014). It was also reported 
that activation of type 2 innate lymphoid cells (ILC2s) is sufficient to induce proliferation and 
differentiation of bipotential APs, which can give rise to beige fat in vivo (M.-W. Lee et al. 
2014). This data indicates that immune signals can affect expansion and functional property 
of adipose tissue. 
1.2.3.3 Role of sympathetic nervous system innervation 
Sympathetic nervous system (SNS) is involved into regulation of blood flow and fatty 
acids metabolism in WAT (Y.-H. Lee et al. 2014). It was shown that sympathetic denervation 
leads to increased number of fat cells (Bowers et al. 2004), (Foster & Bartness 2006). It was 
proposed that increased sympathetic innervation leading to increased norepinephrine (NE) 
release and that could inhibit proliferation of cell in fat pat in depot specific manure (Foster & 
Bartness 2006). This data in line with in vitro work when it was shown that NE can inhibit 
proliferation of progenitors (Lin & Scott 2012). 
1.2.3.4 Gut microbiota 
Luck has shown that altered due to high-fat diet feeding immunity in the intestine 
causes increased gut permeability. Followed by leaking bacterial and dietary components 
increased systemic inflammation leads to insulin resistance (Luck et al. 2015). Recently 
another mechanism was proposed by Perry and colleagues. They found that altered gut 
microbiota produce increased amount of acetate which activates parasympathetic nerve 
system promoting glucose-stimulated insulin secretion, hyperphagia and obesity (Perry et al. 
2016). Resent progress in sequencing allowed to identify specific bacterial spices which were 
driven by HFD feeding and associated with obesity (Heo et al. 2016). 
1.2.3.5 Role of insulin-like growth factor 1 
Recently it was postulated in several reviews that insulin-like growth factor 1 (IGF-1) 
is a crucial factor in pre-adipocyte proliferation, differentiation and survival (Garten et al. 
2012) and it contributes to development of obesity (Berryman et al. 2013), (Kreitschmann-
Andermahr et al. 2010). Also it was reported that IGF-1 stimulates proliferation of cancer cell 
lines (Davison et al. 2011), proliferation and adipogenic differentiation of human MSCs 
(Scavo et al. 2004). IGF-1 seems to play important role in adipocyte differentiation of 3T3-L1 
(Smith et al. 1988). Recently importance of AKT2-signaling pathway in induction of AP 
proliferation were shown (Jeffery et al. 2015) which can be mediated through IGF-1. 
However direct prove of contribution of IGF-1 in in vivo adipogenesis was not available.  
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1.3 Aims of the project 
This project aimed to understand how systemic and local factors can affect the fate of 
adipose tissue progenitors and contribute to adipose tissue growth. Since it has been shown 
that the number of adipocytes is set during childhood and plasticity of adipose tissue 
progenitors decline with age, we focused our efforts on investigating dietary models of early 
childhood obesity. The specific objectives were: 
1 To develop and characterize a diet-induced model of childhood obesity; 
2 To demonstrate mechanisms by with adipose tissue growth achieved in the developed 
model; 
3 To study contributions of adipose tissue progenitors to adipose tissue growth; 
4 To evaluate systemic factors potentially involved in adipose tissue growth; 
5 To identify novel genes that could play a role in adipose tissue remodeling; 
6 To describe gene networks regulating adipose tissue remodeling upon dietary 
challenges; 
7 To develop an in vitro system for functional investigation of candidate factors that 
control the fate and activation of the APs using high content automated microscopy 
screening; 
8 To validate several candidate factors involved to adipose tissue remodeling using the in 
vitro system; 
 
 
Figure 1.8 Aim of the study. Adipose progenitors (APs) are known to contribute to in vivo 
adipogenesis. However little is known about systemic and local factors regulating behavior and fate of 
APs inside of adipose tissue niche.  
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2. RESULTS 
2.1 Diets high in fat lead to rapid growth of adipose tissue  
2.1.1 The long-term effects of high-fat diet feeding in a model of early onset 
obesity 
In order to investigate cellular and molecular mechanisms that lead to white adipose 
tissue (WAT) remodeling, a diet-induced obesity model in mice before sexual maturation had to 
be established. Although high-fat diet (HFD) feeding is a well-established model of diet-induced 
obesity in rodents (Buettner et al. 2006), there was lack of information on the effect of HFD 
feeding in early age on WAT growth and developing of childhood obesity. Most of the studies 
conducted to date have used male mice shortly after sexual maturation (5-6 week-old) (Jeffery 
et al. 2015), (Rabot et al. 2016). Additionally, the intake of sugar-sweetened beverages has 
increased dramatically among school-aged children over the past years and became the top 
calorie source (Lasater et al. 2011), which could be one of the main factors contributing to the 
increased incidence of obesity amongst teenagers. It was demonstrated that diet-induced 
proliferation occurs in both fat depots, inguinal and perigonadal WAT (ingWAT and gWAT, 
respectively) in young male mice (Kim et al. 2014), but it was not investigated in sexually 
immature female mice. In order to find a combination of diet and sugary drink, which would 
efficiently stimulate obesity in early age, 40 female 3-week-old pups were weaned and 
randomized between 4 groups with different diets: control diet (CD) with water vs. high-fat diet 
with water (HFD, 60% of fat), CD with sucrose/fructose solution (S/F) vs. HFD with S/F. Diets 
were applied for 15 weeks. For the first 5 weeks, low concentration of S/F was applied to 
acclimatize mice to sweet drinks and, for the remaining 10 weeks, concentration was increased 
(see methods section 4.1.2). Body weight dynamic, body composition and food/drink intake 
were measured weekly as shown in Figure 2.1 – A. Food intake was measured during the first 8 
weeks and, as expected, HFD groups consumed significantly more calories than CD groups 
(Appendix Fig. 1 – A, B). Mice drinking S/F in combination with HFD consumed more calories as 
compared with HFD group drinking water. Interestingly, there was no significant difference 
between the groups drinking water and S/F under CD (Appendix Fig. 1 – A, B). As expected, 
mice under HFD had higher body weight and accumulated fat mass more rapidly compared with 
CD (Fig. 2.1 – B, C, and D). However, S/F had no additional effect on body and fat mass growth 
in any time point measured in this experiment (Fig. 2.1 – B, C, and D). Nevertheless, S/F 
seemed to trigger an increase of lean mass after week 11, when compared in CD group 
(Appendix Fig. 1 – C). Blood glucose level is well-regulated by hormone systems. Insulin 
decreases level of glucose whereas another hormones as glucagon, cortisol and 
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catecholamines increase blood glucose. There are several methods to challenge endocrine 
system which allow to reveal altered metabolic condition as hyperglycemia/ hypoglycemia. The 
most commonly used is analysis of glucose level after long fasting (16h). To analyze diet-
dependent effects on blood glucose regulation, fasting blood glucose level was measured after 
12 weeks of diet. HFD leads to increased fasting glucose levels, whereas S/F solution intake 
had no effect (Fig. 2.1 – E). Another method is to observe time-course clearance of glucose 
after injection of glucose solution - glucose tolerance tests (GTT). Insulin tolerance test (ITT) is 
time course analysis of blood glucose level after injection of insulin. Glucose tolerance test 
(GTT) and insulin tolerance test (ITT) also revealed increased levels of glucose in both HFD 
groups independently of S/F solution (Appendix Fig. 1– D, E). All mice were euthanized after 15 
weeks of diet, organs were weighed, and collected for gene expression and histological 
analysis. Significant increase was observed in tissue weight from 3 different adipose depots 
after HFD compared with CD (Fig. 2.1 – E and Appendix Fig. 2). The gWAT was 6-fold heavier 
after HFD as compared with CD (2.97 +/- 0.1g vs. 0.53 +/- 0.04 g) (Fig. 2.1 – E). Similarly, a 4-
fold increase in the weight of ingWAT was observed (1.82 +/- 0.21g vs. 0.4 +/- 0.01g; Appendix 
Fig. 2 – A). Interscapular brown adipose tissue (isBAT) was 2 times heavier after HFD 
compared to CD (0.163 +/- 0.013 g vs. 0.08 +/- 0.0008 g) (Appendix Fig. 2 – B). S/F showed no 
additive effect for all three adipose tissue depots. In contrast, liver weight was affected by S/F 
treatment in CD group (1.236 +/- 0.16 g vs. 1.594 +/- 0.4 g), which can contribute to changed 
lean mass (Appendix Fig. 2 – C). Gastrocnemius (Gc) muscles were not affected by neither diet 
nor S/F treatment (Appendix Fig. 2 – D). 
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Figure 2.1: Long-term effects of high-fat diet and sucrose/fructose in early onset obesity. A) 
Scheme of animal experiment; 40 two-week old female C57BL/6NCrl mice were acclimatized on control 
diet (CD) for one week and then fed with 4 different diets: CD with water, high-fat diet with water (HFD, 
60% of fat), CD with sucrose/fructose solution (S/F) and HFD with S/F. Diets were applied for 15 weeks. 
For the first 5 weeks, low concentration of S/F (18.9/23.1 g/l) was applied to acclimatize mice to sweet 
drinks and for the remaining 10 weeks concentration was increased (94.5/115.5 g/l). During the course of 
experiment food/drink intake, body weight and body composition were measured weekly. Fasting blood 
glucose (FB), glucose tolerance test (GTT), insulin tolerance test (ITT) were measured in different time 
points indicated by arrows. B) Weekly body weight dynamic, data represented as mean ± SEM. Area in 
orange, one week (7 days) is the first time point for significant weight gain in HFD in comparison to CD. 
C) Weekly whole body fat mass (by EchoMRI), data represented as mean ± SEM. D) Delta of whole body 
fat mass in the end of experiment. E) Fasting blood glucose (after 16 hours of fasting) on 12 week after 
start of diets. F) Perigonadal WAT (gWAT) weight at the end of experiment. For D, E and F each dot 
represented individual mouse, line is mean of the group, two-way Anova with Bonferroni post-hoc test 
was used to assess significance, ns, no statistically significant difference. 
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In conclusion, long-term HFD caused severe obesity with elevated fasting glucose level 
and impaired glucose clearances occurring during development of type 2 diabetes mellitus 
(T2DM). S/F treatment did not affect fat mass accumulation during the course of experiment and 
thus it will not be part of this model for WAT accumulation. The main observation contributing to 
the next step of the project was the significant increase in body weight upon HFD, which was 
achieved already after one week of treatment (Figure 2. 2). This indicated rapid early growth 
upon HFD in young age and determined the one week as the shortest period of treatment 
leading to a significant body weight increased. Successfully established model of HFD-induced 
obesity directly after weaning provided us a model for studying WAT remodeling during 
development of childhood obesity. 
 
 
 
Figure 2.2: Body weight comparison after one-week diet. Each dot represents individual mouse, line 
is mean of the group, two-way Anova with Bonferroni post-hoc test was used to assess significance, *, 
pV< 0.05.  
 
2.1.2 Acute high-fat diet leads to adipose tissue growth via increased number 
of adipose tissue progenitor cells in sexually immature mice 
The data in section 2.1.1 showed that HFD feeding leads to a significant increase in 
body weight of sexually immature female mice after one week. The next question was to 
discriminate which cell types are contributing to this increase in fat mass. In order to study early 
adipose tissue accumulation and remodeling, 42 three-week old female C57BL/6NCrl mice were 
fed with HFD or CD for one week as shown on Fig. 2.3 – A. Mice from the HFD-fed group were 
consuming significantly more calories every day (Fig. 2.3 – B). After 2 and 7 days upon diet, 
mice were euthanized, organs weighted and tissues collected for RNA and histological analysis. 
We found significant increases in body weight (Fig. 2.3 – C, D), gWAT (Fig. 2.3 – E) and 
ingWAT (Fig. 2.3 – F) after 7 days of HFD, but not after 2 days (Appendix Fig. 3 – A, B, C). This 
confirmed that one week of HFD feeding leads to significant increased body weight in sexually 
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immature female mice. Furthermore, this increase was due to acute fat mass accumulation in 
both gWAT and ingWAT (Fig. 2.3 – E, F). This rapid accumulation of WAT served as an 
experimental model to investigate mechanisms of WAT remodeling. 
 
 
Figure 2.3: Fat accumulation and adipose tissue growth on one week of high-fat diet. A) Scheme of 
animal experiment; 42 two-week old female C57BL/6NCrl mice were acclimatized on control diet (CD) for 
one week and then fed with high-fat (HFD) or CD for one week. B) Daily food intake (kcal/mouse) was 
measured from 4 cages per group (n= 5-6 mice per cage), data represented as mean ± SEM, two-way 
Anova for repeated measurements was used to assess significance, *, pV< 0.05. C) Daily body weight 
dynamic, data represented as mean ± SEM. D) Body mass gain between day 0 and day 7 (delta). E) 
Perigonadal WAT (gWAT) weight in day 7. F) inguinal WAT (IngWAT) weight in day 7. For D, E and F 
each dot represents individual mouse, line is mean of the group, Mann-Whitney t- test was used to 
assess significance, *, pV< 0.05. 
 
To investigate cellular mechanisms contributing to rapid WAT growth, the main constituents 
of WAT were analyzed: mature adipocytes by microscopic sections (gWAT) and the stroma 
vascular fraction (SVF) by cell counting (Fig. 2.4 – A-H). A shift in the frequency distribution of 
lipid droplets area was observed in gWAT after 7 days of HFD (Fig. 2.4 – B). Bigger lipid 
droplets were more frequent in HFD samples compared to CD, indicating adipocyte 
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hypertrophy. Adipocyte diameter (Fig. 2.4 – D) and volume (Fig. 2.4 – E) were increased 
following HFD; however the total number of adipocytes in the whole depot remained the same 
between diets (Fig. 2.4 – F). These data showed that, upon one week of HFD feeding, mature 
adipocytes increased their size by lipid filling, rather than by cell proliferation. To investigate the 
effect of HFD on the stromal component of adipose tissue, the number of cells from the gWAT 
SVF was counted. After one week of HFD, an increased number of SVF cells per gram of gWAT 
(Fig. 2.4 – G) and per mouse (Fig. 2.4 – H) was observed, indicating tissue hyperplasia. These 
data suggested that one week of HFD feeding leads to rapid WAT growth via 2 independent 
mechanisms: increased number of SVF cells and hypertrophy of existing mature adipocytes. 
 
 
Figure 2.4: Mechanisms of early adipose tissue growth: contribution of hyperplasia and 
hypertrophy. A) Histological analysis of perigonadal WAT (gWAT) of sexually immature female mice 
after one week of CD and HFD, scale bar, 100 μm. B) Relative frequency distribution of lipid droplets area 
(μm
2
) based on histological slides from A. C) Adipocyte diameter (μm). D) Adipocyte volume (x10 μm
3
). 
E) Absolute number of mature adipocytes in gWAT. For B, C, D and E 5 mice per group were used, 3 
pictures per mouse were acquired, each dot represents individual mouse. F) Stroma vascular fraction 
(SVF) cell count obtained after one week of CD vs. HFD normalized per gram of gWAT. G) SVF cell 
count obtained after one week of CD vs. HFD calculated per one mouse. For F and G each dot 
represents pooled sample from 3-6 mice. For C-G line is mean of the group, Mann Whitney t-test was 
used to assess significance, *, pV< 0.05; ns, no statistically significant difference. 
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The SVF is non-homogeneous, consisting of many different cell types such as 
endothelial cells (CD31+), immune cells (CD45+) and adipose tissue progenitor cells (Sca-1+). 
To investigate the contribution of different cell subpopulations to the proliferation of SVF cells 
upon HFD, after 1-week of HFD gWAT was digested and cells were sorted. To estimate number 
of cells per gram of tissue and absolute number per mouse, gWAT was weighted and number of 
SVF cells was counted after digestion. An increased number of Sca-1+ cells per gram of gWAT 
(Fig. 2.5 – A) and per mouse (Fig. 2.5 – B) was observed. The number of CD31+ cells per gram 
of gWAT was not different between diets (Fig. 2.5 – C). However, when calculated per mouse, 
the number of CD31+ cells was higher upon HFD (Fig. 2.5 – D). The number of CD45+ cells 
was increased per gram of gWAT (Fig. 2.5 – E) and per mouse upon HFD (Fig. 2.5 – F). 
Additionally, no changes in the number of CD34low cells (potentially an important cell type for 
adipose tissue fibrosis) per gram of gWAT were observed (Fig. 2.5 – G). Nevertheless, there is 
an increase in the total number per mouse upon HFD (Fig. 2.5 – H). These data indicated that 
number of Sca-1+ APs and CD45+ cells per gram of gWAT/ per mouse has increased, which 
contributes to increase WAT mass during growth. Additionally, we observed increased total 
number of potentially profibrotic CD34 low and endothelial cells, which are also contributing to the 
WAT remodeling. 
 
Figure 2.5: Contribution of different cell subpopulations to perigonadal WAT (gWAT) increased 
cell number upon one week of HFD. First replicate with 25 and second with 60 two-week old female 
C57BL/6NCrl mice were acclimatized on control diet (CD) for one week and then fed with high-fat (HFD) 
or CD for one week. FACS was performed on SVF cells from gWAT. A) Number of Sca-1+ cell per gram 
of gWAT. B) Absolut number of Sca-1+ cell per mouse. C) Number of CD31+ endothelial cell per gram of 
gWAT. D) Absolut number of CD31+ endothelial cell per mouse. E) Number of CD45+ hematopoietic cell 
per gram of gWAT. F) Absolut number of CD45+ hematopoietic cell per mouse. G) Number of CD34
low
 
cell per gram of gWAT. H) Absolut number of CD34
low
 cell per mouse. For A-H each dot represents 
pooled sample from 3-6 mice, line is mean of the group, Mann Whitney t-test was used to assess 
significance, *, pV< 0.05, ns, no statistically significant difference. 
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To compare adipose tissue plasticity in early age and adulthood, 27-week old mice were 
fed with CD and HFD as previously described for young mice (Fig. 2.6 – A). The HFD group 
consumed daily more calories and gained significantly more weight compared with CD (Fig. 2.6 
– B, C, and D). However the weight of two WAT depots did not change between feeding groups 
(Fig. 2.6 – E, F). 
 
 
 
Figure 2.6: Absence of rapid adipose tissue gain in adult mice. A) Scheme of animal experiment: 20 
female 26-week-old female C57BL/6NCrl mice were acclimatized on control diet (CD) for one week and 
then fed with high-fat (HFD) or CD for one week. B) Daily food intake (kcal/mouse) from 2 cages per 
group (5 mice per cage); t-test inside of each time point was used. C) Daily delta of body weight, data 
represented as mean ± SEM. D) Delta body weight in the end of experiment. E) Weight of perigonadal 
WAT (gWAT). F) Weight of inguinal WAT (ingWAT). For D, E and F every dot represents individual 
mouse, line is mean of the group, Mann Whitney t-test was used to assess significance, *, pV< 0.05, ns, 
no statistically significant difference. 
 
To investigate cellular mechanisms contributing to adipose tissue growth in adult mice in 
our dietary setup, we used histological analysis of gWAT sections (Fig. 2.7 – A). We did not 
observe changes in lipid droplet area frequency distribution after one week of HFD (Fig. 2.7 – 
B). Additionally, the number of SVF was not increased upon one week of HFD in adult mice 
(Fig. 2.7 – C). There is a trend for decrease number of SVF cells per gram of gWAT (Fig. 2.7 – 
C), but not per mouse (Fig. 2.7 – D). Decreased numbers of SVF cells suggested to us that APs 
may be leaving the progenitor pool and differentiating into mature adipocytes. 
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Figure 2.7: Absence of adipocyte hypertrophy or hyperplasia upon one week of HFD in adult mice. 
Female 26-week-old C57BL/6NCrl mice were acclimatized on control diet (CD) for one week and then fed 
with high-fat (HFD) or CD for one week. A) Histological analysis of perigonadal WAT (gWAT) after one 
week of CD and HFD in adult mice, scale bar, 100 μm. B) Relative frequency distribution of lipid droplets 
area (μm
2
) based on histological slides from A, 6 mice were used per group (3 images per mouse). C) 
Stroma vascular fraction (SVF) cell count obtained from gWAT of adult mice after one week of CD vs. 
HFD normalized per gram of gWAT. D) Absolute number of SVF cells per mouse. For C and D each dot 
represents pooled sample from 3-5 mice, line is mean of the group, Mann Whitney t-test was used to 
assess significance, ns, no statistically significant difference. 
 
To further analyze the effect of HFD in cell populations we performed FACS for adult mice 
fed with HFD for one week. There were no significant difference between feeding groups for the 
number of Sca-1+ cell per gram of gWAT (Fig. 2.8 – A) or per mouse (Fig. 2.8 – B). The number 
of CD31+ endothelial cells per gram of gWAT was significantly decreased (Fig. 2.8 – C), but not 
per mouse (Fig. 2.8 – D). Number of CD45+ cells per gram of gWAT was not affected by diets 
(Fig. 2.8 – E, F). There was significantly less CD34low cells per gram of gWAT (Fig. 2.8 – G), but 
not per mouse (Fig. 2.8 – H). 
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Figure 2.8: Contribution of different cell subpopulations to perigonadal WAT (gWAT) cell number 
upon one week of HFD in adult mice. Female 28-week-old C57BL/6NCrl mice were acclimatized on 
control diet (CD) for one week and then fed with high-fat (HFD) or CD for one week. FACS was 
performed on SVF cells from gWAT. A) Number of Sca-1+ cell per gram of gWAT. B) Absolut number of 
Sca-1+ cell per mouse. C) Number of CD31+ endothelial cell per gram of gWAT. D) Absolut number of 
CD31+ endothelial cell per mouse. E) Number of CD45+ hematopoietic cell per gram of gWAT. F) 
Absolut number of CD45+ hematopoietic cell per mouse. G) Number of CD34
low
 cell per gram of gWAT. 
H) Absolut number of CD34
low
 cell per mouse. For A-H each dot represents pooled sample from 3-5 mice, 
line is mean of the group, one-way Anova with Tukey’s post-hoc test was used to assess significance, *, 
pV< 0.05, ns, no statistically significant difference. 
 
Our data demonstrated that HFD increases body weight and fat mass via an increase in 
the number of Sca-1+ APs after one week of feeding in sexually immature female mice, but not 
adult female mice. These data open questions for a following study about the exact mechanism 
driving AP proliferation and the early remodeling of WAT. 
2.1.3 Fat content in the food induces adipose tissue progenitor cell proliferation 
In this work, we have shown that one week of HFD feeding of sexually immature female 
mice leads to gWAT accumulation and increased number of Sca-1+ APs. However, since CD 
and HFD have a different composition of macronutrients and animals were fed ad libitum, there 
were two factors that could play a role in our observations: the delta in calorie consumption 
among the groups and/or different food composition. To investigate the independent effect of 
these two factors, 40 three-week old female mice were fed either with CD, high protein diet 
(HPD), HFD ad libitum and one group was fed with restricted HFD (HFD-R) for 7 days. HFD-R 
and HPD groups received the same number of calories as CD, but the macronutrient 
composition was different (see methods section 4.1.2). Using this approach, we had 3 groups 
enriched with different macronutrients (CD with carbohydrates, HPD with proteins and HFD-R 
with fat) and the same energy intake from them. The comparison between HFD with HFD-R 
would allow us to observe the role of higher calorie consumption on adipose tissue growth but 
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under the same diet. Previous works have reported that the CD used is actually enriched in 
simple carbohydrates (sucrose) and can have an effect on experiments/gene expression at 
least in intestine and liver (Wang et al. 2009). Therefore, HPD served as an additional control, 
since it has the same amount of fat as CD but enriched proteins instead of carbohydrates. 
Scheme of animal experiment is shown in Fig. 2.9 – A. Energy intake was elevated in HFD 
compared to CD, HPD and HFD-R (Fig. 2.9 – B). During 1 week upon HFD, mice gained 
significantly more body weight (Fig. 2.9 – C, D), gWAT (Fig. 2.9 – E) and ingWAT (Fig. 2.9 – F) 
weight than all other groups. These data suggested that new dietary scheme worked 
accordingly our experimental design and allowed using well-controlled feeding groups for 
investigation WAT remodeling process. 
 
 
Figure 2.9: Contribution of diet composition to weight gain. Excess calories but not food 
composition, induces body and adipose tissue weight gain in sexually immature mice. A) Scheme of 
animal experiment: 40 two-week old female C57BL/6NCrl mice were acclimatized on control diet (CD) for 
one week and then fed with CD or high-protein diet (HPD), high-fat diet (HFD) or restricted HFD (HFD-R) 
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for one week. CD, HPD and HFD-R received equal calorie amounts, while HFD consumed significantly 
more calories. B) Daily food intake from 2 cages per group (5 mice per cage), data represented as mean 
± SD, two-way Anova for repeated measurements was used to assess significance, *, pV< 0.05. C) Daily 
body weight increase during one week of different diets, data represented as mean ± SEM. D) Delta of 
body mass after 7 days of diets. E) Weight of perigonadal WAT (gWAT). F) Weight of inguinal WAT 
(ingWAT). For D, E and F every dot represents individual mouse, line is mean of the group, one-way 
Anova with Tukey’s post-hoc test was used to assess significance, *, pV< 0.05. 
 
First we investigated histology of gWAT (Fig. 2.10 – A) to estimate mature adipocyte size 
by measuring area of lipid droplets. In accordance with the previous experiment (see section 
2.1.2), bigger lipid droplets were observed upon HFD, when compared to all other groups (Fig. 
2.10 – B). These data indicated that, on the tissue level, only HFD ad libitum leads to 
hypertrophy of mature adipocytes.  
 
.  
Figure 2.10: One week of high-fat diet (HFD) leads to mature adipocyte hypertrophy but not in 
isocaloric to control diet amount (HFD-R). Two-week old female C57BL/6NCrl mice were acclimatized 
on control diet (CD) for one week and then fed with CD or high-protein diet (HPD), high-fat diet (HFD) or 
restricted HFD (HFD-R) for one week. Then histological analysis of perigonadal WAT (gWAT) was 
performed. A) Histological analysis of gWAT after one week of CD, HPD, HFD and HFD-R, 6 mice were 
used per group (3 images per mouse), scale bar, 100 μm. B) Relative frequency distribution of lipid 
droplets area (μm
2
) based on histological cuts. 
 
The next question was how different macronutrients directly affect proliferation of SVF 
cells. To investigate this, 3-week old female mice were fed with CD and HFD ad libitum and 
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HFD-R. To identify the proliferating subpopulations, 5-ethynyl-2'-deoxyuridine (EdU) was 
applied in drinking water for one week during the diet challenges as on Fig. 2.11 – A. After one 
week, mice were euthanized; gWAT and ingWAT were dissected, weighted and digested. 
Erythrocytes were depleted and SVF cells were counted, stained and FACS was performed. 
HFD ad libitum increased percentage and amount of Sca-1+ EdU+ APs per gram of tissue in 
both fat pats, when compared to CD (Fig. 2.11 – B, C, D, and E). Although mice from HFD-R 
group received the same number of calories as CD group, there was significantly higher 
percentage of Sca-1+ EdU+ APs for both fat depots (Fig. 2.11 – B, D). In gWAT, the number of 
Sca-1+ EdU+ APs per gram of tissue was increased upon HFD-R in comparison to CD (Fig. 
2.11 – C). In ingWAT, no significant changes were observed (Fig. 2.11 – E). Additionally, when 
HFD compared with HFD-R we observed an increased percentage of Sca-1+ EdU+ APs in 
gWAT, but not in ingWAT (Fig. 2.11 – B, D). The number of Sca-1+ EdU+ APs per gram of 
tissue was not changed upon HFD when compared with HFD-R in both fat depots (Fig. 2.11 – 
C, E). This data indicated that dietary fat content can stimulate proliferation of APs independent 
of calorie load.  
Although there was no significant effect of diets on the percentage of parent of CD31+ 
EdU+ cells in gWAT and ingWAT (Fig. 2.12 – A, C), we noticed a trend toward decreases 
numbers of CD31+ cells per gram of tissue upon HFD. In gWAT only in comparison of HFD-R 
with CD was significant (Fig. 2.12 – B), but in ingWAT both HFD and HFD-R lead to a significant 
decrease in the number of CD31+ EdU+ cells compared to CD group (Fig. 2.12 – D). These 
data indicated that fat content in the food is capable to negatively regulate endothelial cell 
proliferation. There were no significant differences between dietary groups on the amount of 
CD45+ EdU+ cells in both fat pats (Fig. 2.12 – E, G). We noticed significant increases in the 
number of CD45+ EdU+ cells per gram of tissue upon HFD compared to CD in gWAT (Fig. 
2.12– F), but not in ingWAT (Fig. 2.12– H). Although previously we observed an increased 
number of CD45+ cells in gWAT upon HFD, it is not due to proliferation of these cells (section 
2.1.2, Fig. 2.5 – E and F). We also investigated CD34low cells with fibroblastic surface marker 
phenotype. No dietary effects were observed in this subpopulation in gWAT (Fig. 2.12 – I, J). 
However, in ingWAT there were significantly increased percentages of parent and total number 
of CD34 CD34low EdU+ cells per gram of tissue upon HFD when compared to CD (Fig. 2.12 – K, 
L). This observation may indicate that different fat depots have distinct cellular response to HFD 
suggesting that ingWAT is more proud to fibrosis upon HFD. 
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Figure 2.11: High-fat diet induces Sca-1+ AP proliferation in both fat depots in female sexually 
immature mice. A) Scheme of animal experiment: 30 two-week old female C57BL/6NCrl mice were 
acclimatized on control diet (CD) for one week and then fed with CD, high-fat diet (HFD) or restricted HFD 
(HFD-R) for one week in combination with 5-ethynyl-2'-deoxyuridine (EdU) administered in drinking water. 
Then FACS was performed on SVF cells from perigonadal WAT (gWAT) and inguinal WAT (IngWAT). B) 
Frequency of parent (%) of Sca-1+ EdU+ APs from gWAT. C) Number of Sca-1+ EdU+ APs per gram of 
gWAT. D) Frequency of parent (%) of Sca-1+ EdU+ APs from ingWAT. E) Number of Sca-1+ EdU+ APs 
per gram of ingWAT. For B-E each dot represents pooled sample from 2.5 mice, line is mean of the 
group, one-way Anova with Tukey’s post-hoc test was used to assess significance, *, comparison with 
CD, #, comparison between indicated groups, pV< 0.05, ns, no statistically significant difference.  
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Figure 2.12: High-fat diet does not induce proliferation of other cell subpopulations. 
A) Frequency of parent (%) of CD31+ EdU+ endothelial cells (ECs) from gWAT. B) Number of CD31+ 
EdU+ ECs per gram of gWAT. C) Frequency of parent (%) of CD31+ EdU+ ECs from ingWAT. D) 
Number of CD31+ EdU+ ECs per gram of ingWAT. E) Frequency of parent (%) of CD45+ EdU+ 
hematopoietic cells (HCs) from gWAT. F) Number of CD45+ EdU+ HCs per gram of gWAT. G) Frequency 
of parent (%) of CD45+ EdU+ HCs from ingWAT. H) Number of CD45+ EdU+ HCs per gram of ingWAT. 
I) Frequency of parent (%) of CD34
low
 EdU+ cells from gWAT. J) Number of CD34
low
 EdU+ cells per gram 
of gWAT. K) Frequency of parent (%) of CD34
low
 EdU+ cells from ingWAT. L) Number of CD34
low
 EdU+ 
cells per gram of ingWAT. For A-L each dot represents pooled sample from 2.5 mice, line is mean of the 
group, one-way Anova with Tukey’s post-hoc test was used to assess significance, *, comparison with 
CD, pV< 0.05, ns, no statistically significant difference. 
 
In summary, HFD induces Sca-1+ AP proliferation in both fat depots in sexually 
immature, female mice independently from the amount of consumed calories. This raises the 
question as which systemic factors can regulate proliferation of APs in response to dietary 
stimulus, furthermore what regulatory networks are contributing to the WAT remodeling. 
Established one-week HFD model allow us to investigate dietary regulation of AP proliferation, 
since we have the short time between stimulus (nutrient) and response of adipose tissue via AP 
proliferation. 
2.2 Systemic factors in the regulation of adipose tissue growth 
2.2.1 Dynamic of systemic factors in blood serum upon high-fat diet feeding 
Systemic factors, nutrients, metabolites circulate in the blood and communicate 
direct/indirect metabolic signals to WAT. To investigate systemic factors regulated tissue growth 
upon HFD in young mice, we measured metabolic factors in blood serum as glucose, insulin 
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and insulin-like growth factor 1 (IGF-1). Insulin system directly affects adipocyte hypertrophy by 
regulating glucose uptake. We measured blood glucose and insulin after 2 and 7 days of HFD 
feeding. Random fed blood glucose was not changed between groups after 2 days (Fig. 2.13 – 
A). However, it was increased at day 7 in both groups being significantly higher upon HFD (Fig. 
2.13 – A). Insulin level was higher in CD-fed group after 2 days and stayed on the same level at 
day 7 (Fig. 2.13 – B). In HFD-fed group, insulin was lower as compared with CD-fed group at 2 
days, but increased after 7 days of diet (Fig. 2.13 – B). Playing an important role in cell growth, 
IGF-1 was also interesting for us. IGF-1 levels were higher upon HFD at both time points, when 
compared with CD-fed group (Fig. 2.13 – C). To investigate lipid species involved in energy 
homeostasis and contributing to WAT growth, we measured triglycerides (TG), non-esterified 
fatty acids (NEFA) and cholesterol in blood serum. TG was on the same level between HFD and 
CD on day two (Fig. 2.13 – D). However, level of TG elevated upon HFD after 7 days and 
decreased upon CD as compared with two days (Fig. 2.13 – D). As for true TG, NEFA levels 
were the same after 2 days of diet (Fig. 2.13 – E). Interestingly, NEFA levels slightly decreased 
upon HFD and slightly increased upon CD after 7 days when compared to levels at day 2 (Fig. 
2.13 – E). This data indicates that upon HFD mice accumulate excess amount of TG in the 
blood. The level of cholesterol was significantly higher upon HFD after 2 days of diet when 
compared to CD-fed group and remained unchanged after 7 days of diet (Fig. 2.13 – F). 
Cholesterol in CD-fed group increased from day 2 to day 7, reaching the level of HFD-fed group 
at day 7 (Fig. 2.13 – E). 
 
 
Figure 2.13: Dynamic of systemic factors in blood serum upon high-fat diet feeding. 
Forty two 2-week old female C57BL/6NCrl mice were acclimatized on control diet (CD) for one week and 
then fed with high-fat (HFD) or CD for one week. After euthanizing blood was collected after 2 and 7 days 
of diets and blood serum factors were measured. Mice were in random fed state. A) Blood glucose. B) 
Insulin. C) Insulin-like growth factor 1 (IGF-1). D) Triglycerides (TG). E) Non-esterified fatty  
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acids (NEFA). F) Cholesterol. For A-F each dot represents individual mouse, line is mean of the group, 
two-way Anova with Bonferroni post-hoc test was used to assess significance, *, comparison with CD of 
each time point, pV< 0.05, orange arrows indicate dynamic inside of one group from day 2 to day 7, black 
arrows indicate consistent level on both time points. 
 
We found several systemic factors altered upon HFD feeding, which potentially can 
contribute to adipose tissue growth by directly affecting APs such as IGF-1 or indirectly through 
lipid metabolism as TG and NEFA. The next question was the calorie and nutritional regulation 
of systemic factor which we answered in following section. 
2.2.2 Nutritional regulation of systemic factors in blood serum 
To understand the influence of diet composition on systemic factors, we used a similar 
approach as described in section 2.1.3, with CD, HPD, HFD and HFD-R. There was no 
difference in random fed glucose and insulin level between all groups after 7 days of diets (Fig. 
2.14 – A, B). IGF-1 was elevated upon HFD after 7 days as compare with CD, HPD, and HFD-R 
(Fig. 2.14 – C), indicating that amount of consumed calories affecting level of IFG-1 rather than 
food composition. TG was elevated upon HFD as compared with CD and upon HPD as 
compared with CD and HFD-R group (Fig. 2.14 – D). We found significant decrease in NEFA 
level upon HFD, HFD-R and HPD as compared with CD after 7 days (Fig. 2.14 – E), which 
correlates with abundance of carbohydrates in CD. There was no difference in the level of 
cholesterol upon HFD as compared with CD and HFD-R (Fig. 2.14 – F), which is in line with our 
previous observation for 7 day time point. Decrease of cholesterol level was detected upon HPD 
as compared with HFD (Fig. 2.14 – F). Also increased amount of ketone bodies was observed, 
which can indicate active gluconeogenesis upon carbohydrate restriction. The level of ketone 
bodies was higher in HFD-R as compared with all diets (Fig. 2.14 – G), which possibly indicates 
that mice were fasted before blood collection in HFD-R group due to limited amount of food. 
Summary of nutritional regulation of systemic factors in blood 7 days after different diets is 
represented in Table 1. 
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Figure 2.14: Nutritional regulation of systemic factors in blood serum in sexually immature mice 
after one week of diet. Forty two-week old female C57BL/6NCrl mice were acclimatized on control diet 
(CD) for one week and then fed with CD or high-protein diet (HPD), high-fat diet (HFD) or restricted HFD 
(HFD-R) for one week. After euthanizing blood was collected and blood serum factors were measured. 
Mice were in random fed state. A) Blood glucose. B) Insulin. C) Insulin-like growth factor 1 (IGF-1). D) 
Triglycerides (TG). E) Non-esterified fatty acids (NEFA). F) Cholesterol. G) Ketone bodies. For A-G each 
dot represents individual mouse, line is mean of the group, one-way Anova with Tukey’s post-hoc test 
was used to assess significance, *, comparison with CD, #, comparison between indicated groups, pV< 
0.05.  
Table 1: Nutritional regulation of systemic factors in blood serum one week after of diet, 
noΔ – was not significantly changed, Δ↑ significantly increased, Δ↓ significantly decreased.  
Serum factor HFD ad libitum vs. CD  HFD-R vs. CD HPD vs. CD 
Random fed glucose noΔ noΔ noΔ 
Insulin noΔ noΔ noΔ 
IGF-1 Δ↑ noΔ Δ↓ 
TG Δ↑ noΔ Δ↑ 
NEFA Δ↓ Δ↓ Δ↓ 
Cholesterol  noΔ noΔ noΔ 
Ketone bodies  noΔ Δ↑ noΔ 
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To evaluate the same parameters in adult mice, we have performed similar experiment 
with 26-week old female mice. No difference was observed on the levels of random glucose 
(Fig. 2.15 – A), insulin (Fig. 2.15 – B), IGF-1 (Fig. 2.15 – C), TG (Fig. 2.15 – D), NEFA (Fig. 2.15 
– E) and cholesterol (Fig. 2.15 – F). The level of ketone bodies was elevated in HFD-R as 
compared with all diets (Fig. 2.15 – G). 
 
Figure 2.15: Nutritional regulation of systemic factors in blood serum in adult mice after one week 
of diet. Thirty female 26-week-old female C57BL/6NCrl mice were acclimatized on control diet (CD) for 
one week and then fed with CD, high-fat (HFD) or restricted HFD (HFD-R) for one week. After 
euthanizing blood was collected and blood serum factors were measured. Mice were in random fed state. 
A) Blood glucose. B) Insulin. C) Insulin-like growth factor 1 (IGF-1). D) Triglycerides (TG). E) Non-
esterified fatty acids (NEFA). F) Cholesterol. G) Ketone bodies. For A-G each dot represents individual 
mouse, line is mean of the group, one-way Anova with Tukey’s post-hoc test was used to assess 
significance, *, comparison with CD, #, comparison between indicated groups, pV< 0.05. 
 
We demonstrated that regulation of IGF-1 depends on calorie load, but not on food 
composition in young mice. Some lipids, e.g. NEFA, were regulated by food composition and 
were decreased upon HFD and HFD-R in young, but not adult mice. TG had combined 
regulation since they were elevated upon HPD as compared with groups with same calorie load 
and also by HFD with excess calories.  
44 
 
Many circulated serum factors have dynamic regulation due to fasting/refeeding or 
day/night phases. To understand which factors can be transiently increased upon feeding, 30 
female, sexually immature mice were fed with CD, HFD and HFD-R diets for 3 days. To achieve 
maximal nutrient load and anabolic response mice were euthanized in their active phase (dark 
phase), 3 hours after receiving diet. Blood glucose was increased in both HFD and HFD-R 
groups (Fig. 2.16 – A), but levels of insulin did not change (Fig. 2.16 – B). IGF-1 was higher 
upon HFD, but no differences were observed between HFD-R and CD (Fig. 2.16 – C). These 
data indicated that increased on IGF-1 levels depend on overall calorie load and this was not 
observed in the HFD-R group at least 3 hours after meal. No difference in TG could be 
observed (Fig. 2.16 – D). NEFA was higher in both HFD-R and HFD groups as compared with 
CD (Fig. 2.16 – E and F). Additionally cholesterol was significantly higher in HFD group 
compared to HFD-R (Fig. 2.16 – F). Ketone bodies were higher in both HFD and HFD-R groups 
(Fig. 2.16 – G). Summary of nutritional regulation of systemic factors 3 hours after feeding is 
represented in Table 2. 
 
 
Figure 2.16: Level of systemic factors 3 hours after feeding in sexually immature mice. Thirty two-
week old female C57BL/6NCrl mice were acclimatized on control diet (CD) for one week and then fed 
with CD, high-fat diet (HFD) or restricted HFD (HFD-R) for one week. Food was applied only during 
dark/active phase and removed during light/resting phase. Blood was collected 3 hours after beginning of 
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feeding and blood serum factors were measured. A) Blood glucose. B) Insulin. C) Insulin-like growth 
factor 1 (IGF-1). D) Triglycerides (TG). E) Non-esterified fatty acids (NEFA). F) Cholesterol. G) Ketone 
bodies. For A-G each dot represents individual mouse, line is mean of the group, one-way Anova with 
Tukey’s post-hoc test was used to assess significance, *, comparison with CD, #, comparison between 
indicated groups, pV< 0.05. 
 
Table 2: Nutritional regulation of systemic factors in blood 3 hours after feeding, noΔ – was 
not significantly changed, Δ↑ significantly increased, Δ↓ significantly decreased. 
Serum factor HFD ad libitum vs. CD  HFD restricted vs. CD 
Glucose Δ↑ Δ↑ 
Insulin noΔ noΔ 
IGF-1 Δ↑ noΔ 
TG noΔ noΔ 
NEFA noΔ Δ↑ 
Cholesterol  Δ↑ Δ↑ 
Ketone bodies  Δ↑ Δ↑ 
 
These data showed that regulation of blood glucose was affected by HFD 3 hours after 
beginning of food consumption. Increase on IGF-1 levels 3 hours post cibum was dependent 
only on the amount of calories consumed, but not on the food composition. Interestingly, 
cholesterol is affected by both food composition and amount of calories. These observations 
provide important information for future investigation of systemic factors contributing to the WAT 
remodeling. 
2.2.4 Mouse serum does not affect adipose progenitor proliferation in vitro 
To investigate direct effects of blood serum factors on proliferation of APs, we stimulated 
APs from gWAT in vitro with mouse serum collected after 2 and 7 days of CD and HFD feeding. 
After 21 hours of stimulation and EdU labeling, automated images were acquired and analyzed 
(Fig. 2.17 – A). We found that there was no significant difference in percentage of labeled cells 
between dietary conditions in both time points (Fig. 2.17 – B). This experiment indicated that 
direct short-term treatment of APs with serum form mice fed with HFD and CD cannot stimulate 
proliferation of APs. 
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Figure 2.17: Proliferation rate of adipose progenitors after treatment with serum collected from CD 
and HFD-fed mice. Forty two 3-week old female C57BL/6NCrl mice were fed with control diet (CD) or 
high-fat (HFD) for one week. After 2 and 7 days of diets blood serum was collected. gWAT Sca-1+ APs 
were isolated from 3-week old female C57BL/6NCrl mice and seeded in monoculture. Serums from CD-
fed and HFD-fed mice were applied on gWAT Sca-1+ APs for 21 hour following with EdU pulse. A) 
Representative image of nuclei stained with DAPI (blue) /EdU (red). B) Percentage of EdU+ nuclei based 
on automated analysis, each dot represents individual mouse serum (25 images per mouse), line is mean 
of the group, two-way Anova with Bonferroni post-hoc test was used to assess significance. 
2.3 Local molecular networks of adipose tissue remodeling and 
growth in response to high-fat diet 
2.3.1 High-fat diet feeding induces acute adipose tissue remodeling  
To identify the regulatory networks leading to adipose tissue remodeling upon HFD, we 
performed microarray hybridizations using RNA isolated from gWAT after 2 and 7 days of diet. 
Analysis via gene set enrichment analysis (GSEA) showed 69 and 126 gene sets enriched after 
2 and 7 days of HFD as compared with CD, respectively, with false discovery rate (FDR) of less 
than 0.1. We selected 116 gene sets, out of the total 195, from representative pathways related 
to tissue remodeling process. A complete list of pathways with an enrichment scores and false 
discovery values is displayed in the Appendix table 1. There are 31 unique pathways 
characterizing early process in tissue remodeling identified 2 days upon HFD (Fig. 2.18 - A). 
Among these, there were genes involved in key processes such as angiogenesis, inflammation, 
leukocyte migration, T-cell activation and differentiation, and cell-cell communication, including 
receptor signaling protein activity and transmembrane receptor protein kinase activity (Fig. 2.18 
– B and Appendix table 1). There are 38 gene sets overlapping between the 2 time points (Fig. 
2.18 – A). Among the common pathways, the most relevant to tissue remodeling are: 1) 
inflammation as immune responses; 2) cytokine and chemokine regulation; 3) neurogenesis 
(Fig. 2.18 – B and Appendix table 1). After 7 days of HFD, there are 88 pathways enriched (Fig. 
2.18 – A). These pathways are involved in extracellular matrix (ECM) remodeling as collagen 
and cell signaling and in the Jak/STAT and cAMP cascades. Additionally, regulation and 
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progression of cell cycle pathways were enriched further supporting our data indicating cell 
proliferation upon HFD (Fig. 2.18 – B and Appendix table 1). 
 
Figure 2.18: Enriched gene sets upon HFD. Three-week old mice were fed with high-fat diet (HFD) vs. 
control diet (CD) for 2 and 7 days followed by perigonadal WAT (gWAT) dissection, RNA isolation and 
microarray hybridizations for gene expression profiling. Gene set enrichment analysis was performed for 
each time point using Gene Ontology database A) Enriched upon HFD gene sets represents as Venn 
diagram with false discovery rate (FDR) <10%. B) Enriched upon HFD gene sets related to adipose 
tissue remodeling represented as bar plot for day 2 (blue) and day 7 (orange) with indicated enrichment 
score.  
 
We found 68 and 69 gene sets enriched after 2 and 7 days of CD respectively with a 
false discovery rate of less than 0.1 (Fig. 2.19 – A). Interestingly, 80 from 137 pathways were 
related to metabolic process. A complete list of pathways with enrichment scores and false 
discovery values is displayed in Appendix table 2. After 2 days of CD we found 28 pathways 
related to carbohydrates catabolism and cellular respiration (Fig. 2.19 – B) which continued after 
7 days of CD as well. Another prevalent metabolic process was lipid biosynthesis which is 
largely represented in the 40 common pathways (Fig. 2.19 – B). After 7 days of CD we 
observed 29 unique gene sets related to secondary metabolic processes and intracellular 
transport (Appendix table 2). We noticed that proteasome related gene sets were enriched upon 
CD after 2 and 7 days (Fig. 2.19 – B), which is in line with fact that upon HFD gene set 
responsible for positive regulation of cellular protein metabolism was enriched (Appendix table 
2). 
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Figure 2.19: Enriched gene sets upon CD. Three-week old mice were fed with high-fat diet (HFD) vs. 
control diet (CD) for 2 and 7 days followed by perigonadal WAT (gWAT) dissection, RNA isolation and 
microarray hybridizations for gene expression profiling. Gene set enrichment analysis was performed for 
each time point using Gene Ontology database A) Number of enriched gene sets upon 2 and 7 days of 
CD in comparison with HFD represents as Venn diagram with false discovery rate (FDR) <10%. B) 
Enriched upon CD gene sets related increased carbohydrate catabolism and lipid biosynthesis 
represented as bar plot for day 2 (blue) and day 7 (orange) with indicated enrichment score. 
 
These data indicated that activation of gene network related to adipose tissue 
remodeling was already observed 2 days upon high-fat diet and many processes continue to be 
driven by HFD until 7 days. We identified dynamic in pathway enrichment as inflammation, 
cytokine-receptor interaction, cell-cell communication and angiogenesis start early following by 
extracellular matrix remodeling and activation of proliferation. Additionally, many metabolic 
related gene sets were upregulated upon CD meaning downregulated upon high-fat diet as 
carbohydrates catabolism and lipid biosynthesis. 
2.3.2 Fat content, but not calorie, induces cell proliferation in adipose tissue 
As the diets used have different content of macronutrients (see section 2.1.3), it would 
be possible that the results of the first expression profile could have been influenced by these 
differences. To identify which gene sets are induced by excess calorie versus the macronutrient 
content, we performed a new profile with HFD, HFD-R, CD and HPD and compared the 
enriched gene sets. We included the HPD in order to compare with our previous observations 
by manipulating dietary content. The HFD group had excess calories compared with CD and 
HPD (Fig. 2.20 – A). We found 32 pathways exclusively enriched in HFD vs. CD with a false 
discovery rate of less than 0.1 (Fig. 2.20 – B). Interestingly, some of the gene sets are related to 
regulation of immune process (Appendix table 3). Most of the 38 common pathways were 
related to cell cycle and to immune- related processes, confirmed our previous observations 
(see section 2.3.1). HFD vs. HPD gave rise to 17 pathways exclusively enriched, mostly related 
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to ECM as collagen. The complete comparison of pathways with enrichment scores and false 
discovery values are displayed in the Appendix table 3. Also we looked into downregulated 
gene sets upon HFD with a false discovery rate of less than 0.1. We found 63 gene sets 
downregulate upon HFD mostly related to metabolism as carbohydrate catabolism and lipid 
biosynthesis, corroborating our previous result (see section 2.3.1). Surprisingly, no gene set 
was downregulated comparing HFD with HPD (Fig. 2.20 – C). 
 
Figure 2.20: Scheme of analysis of enriched genes using excess calorie model. 
A) In this type of experiment 2 factors are present: excess calories from high-fat diet (HFD) ad libitum 
feeding and different composition of food of comparison as control diet (CD) or high-protein diet (HPD). 
B) Number of enriched gene sets upon HFD in comparison with CD (blue) or HPD (orange) represents as 
Venn diagram with false discovery rate (FDR) <10%. C) Number of enriched gene sets upon CD (blue) or 
HPD (orange) in comparison with HFD represents as Venn diagram with FDR <10%. 
 
To identify pathways enriched depending on different food components, but not calorie 
excess, the following pairs were compared: HFD-R vs. CD and HFD-R vs. HPD (Fig. 2.21 – A). 
There were 18 pathways enriched exclusively between HFD-R and CD and 19 between HFD-R 
and HPD and 44 common gene sets (Fig. 2.21 – B and Appendix table 4). Proliferation-related 
pathways were enriched in both comparisons as well as cell cycle phase (Appendix table 4). 
These data suggested HFD leads to adipose tissue cell proliferation independently of the calorie 
load. These data was confirmed by the increased number of EdU-labeled APs seen in section 
2.1.3. To understand the effects of high-fat content in the diet we performed additional 
comparisons of HFD and HFD-R to CD (Fig. 2.21 – D). There were 30 pathways exclusively 
enriched in HFD mostly with immune-related functions (Fig. 2.21 – E), indicating that activation 
of immune-related processes depends on excess calorie load. Most of common enriched gene 
sets belong to cell-cycle progress (Fig. 2.20 – E), confirming again that fat content was able to 
activate cell proliferation in adipose tissue independent on calorie load. We found 22 gene sets 
enriched in response to food restriction mostly muscle-related (Fig. 2.21 – E). 
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Figure 2.21: Scheme of analysis of enriched genes using isocaloric model. A) In this type of 
experiment using pair feeding approach mice received the same amount of calories from high-fat diet 
(HFD-R) as control groups: control diet (CD) and high-protein diet (HPD). B) Number of enriched gene 
sets upon HFD-R in comparison with CD (blue) or HPD (orange) represents as Venn diagram with false 
discovery rate (FDR) <10%. C) Number of enriched gene sets upon CD (blue) or HPD (orange) in 
comparison with HFD-R represents as Venn diagram with false discovery rate (FDR) <10%. D) Number 
of enriched gene sets upon HFD in comparison with CD (blue) and HFD-R in comparison with CD 
(orange) represents as Venn diagram with false discovery rate (FDR) <10%. E) Enriched upon HFD gene 
sets related to adipose tissue remodeling represented as bar plot for ad libitum (blue) and restricted 
(orange) with indicated enrichment score. 
 
To investigate the effect of the amount of consumed calories on gene regulation, a 
comparison between HFD and HFD-R was performed, as these groups received the same type 
of diet but in different amounts, reflecting different calorie load (Fig. 2.22 – A). Surprisingly, only 
one gene set was found to be enriched upon HFD in this comparison – Carboxylesterase 
activity. This pathway is important for hydrolyze of esters and also long-chain fatty acid esters 
and thioesters. We also found 14 pathways downregulated upon HFD related to muscle as 
regulation of muscle cell differentiation and muscle constriction.  
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Figure 2.22: Scheme of analysis of enriched genes using same composition of the food. 
In this type of experiment mice were fed with HFD only either ad libitum or in restricted form. No cell cycle 
related gene sets were enriched.  
 
We demonstrated that cell cycle gene sets enriched in HFD ad libitum and HFD-R when 
compared with CD, but not in comparison HFD ad libitum vs. HFD-R. These data indicated that 
fat content can alone trigger AP proliferation which can contribute to WAT remodeling during 
development of childhood obesity. Additionally we demonstrated that inflammation-related gene 
sets were not significantly different in HFD-R vs. CD that indirectly indicated independence of 
inflammation from induction of AP proliferation in response to high-fat diet. 
2.3.3 Cell population response to high-fat diet 
To investigate response of different cell subpopulations in AT remodeling upon HFD 
feeding, we performed 2 independent mouse experiments followed by cell sorting. Female 
sexually immature mice were fed with HFD and CD for 7 days, then gWAT was dissected, 
digested and SVF cells were stained (as described in methods section 4.2.5), 5 different cell 
subpopulations were collected: mature adipocytes, CD45+ cells, CD31+ endothelial cells, Sca-
1+ APs and CD34low cells. We performed microarray hybridizations using RNA isolated from 
Sca-1+ APs, CD31+ and CD34low cells (Fig. 2.23 – A). Specificity of cell populations was 
confirmed by identifying the expression of markers that characterize these cells CD45 antigen 
(Ptprc) for hematopoietic lineage, CD31 (Pecam1) for endothelial cells, Pdgfrα for Sca-1+ APs 
and Acta2 for CD34low cells (Fig. 2.23 – B). CD45 antigen was not expressed on any of cell 
subpopulations. CD31 was expressed only in sorted CD31+ cells samples, Pdgfrα was 
expressed on Sca-1+APs, and Acta2 was present only on CD34low cells (Fig. 2.23 – B). These 
data indicated that cell subpopulation was correctly sorted. 
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Figure 2.23: Validation of cell population-specific expression of sorted cells. A) Scheme of 
experiment: 3-week old female C57BL/6NCrl mice were fed with HFD or CD for one week, perigonadal 
WAT (gWAT) was dissected, digested and stroma vascular fraction cell were stained followed by FACS. 
Two independent animal experiments were conducted (n=25 and n=60), each sample was pooled from 3-
12 mice. RNA was isolated from 3 subpopulations: Lin-CD29+CD34+Sca-1+ adipose progenitors (APs), 
Lin-CD29+CD34
low 
cells and from CD45-CD31+ endothelial cells (ECs) and microarray hybridizations for 
gene expression profiling was performed. B) Surface markers from gene expression profiling conforming 
purity of sorted subpopulations as all samples are negative for Ptprc (CD45), only ECs samples are 
positive for Pecam1 (CD31), only APs expressed Pdgfrα, only CD34
low 
cells expressed Acta2.  
 
We investigated the effects of HFD feeding on specific cell subpopulations from gWAT 
using GSEA with a false discovery rate of less than 0.1. We found only 8 gene sets enriched 
upon HFD in Sca-1+ APs (Fig. 2.24 – A, B). Coagulation, wound healing, cytokine biosynthetic 
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processes, and peptide receptor activity indicate active cell-cell communicating upon HFD. 
There were no gene sets enriched upon CD in Sca-1+ APs. We found 34 enriched sets upon 
HFD in CD31+ cells. Most gene sets were related to ECM remodeling such as 
glycosaminoglycan binding and collagen (Fig. 2.24 – A, B). Also 14 gene sets were enriched 
upon CD in CD31+ cells related to cell adhesion as intercellular junction assembly (Fig. 2.24 – 
A, B). There were 35 gene sets enriched upon HFD in CD34low cells. The majority of them were 
related to ECM regulation, T cell activation, negative regulation of angiogenesis and M-phase of 
cell cycle (Fig. 2.24 – A, B). There were no gene sets enriched upon CD diet. There was no 
overlap between the enriched gene sets among all different subpopulations, except for Sca-1+ 
cells, sharing 6 enriched gene sets with CD34low cells including coagulation and wound healing 
(Fig. 2.24 – A, B). CD34low cells shared 4 enriched gene sets with CD31+ endothelial cells 
related to extracellular region (Fig. 2.24 – A, B). 
 
 
Figure 2.24: Cell specific enrichment of gene sets upon high-fat diet. A) Enriched upon high-fat diet 
(HFD) gene sets represented as bar plot for Sca-1+ adipose progenitors (APs) (blue), CD34l
ow
 cells 
(orange) and CD31+ endothelial cells (ECs) (grey) with indicated enrichment score with false discovery 
rate (FDR) <10%, each group was enriched in compared with CD. B) Number of enriched upon HFD 
gene sets represents as Venn diagram with FDR <10%.  
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These data indicate that different cell subpopulation in WAT had distinct cell response on 
HFD feeding and the understanding of cell-cell interactions could inform us about role of specific 
cell population in WAT remodeling. 
2.3.4 Novel gene search – differentially expressed genes during early adipose 
tissue remodeling 
In order to identify candidate targets for further functional screening, we investigated 
differentially expressed genes potentially involved in WAT remodeling and AP activation upon 
short term high-fat feeding. For that we performed microarray hybridizations using RNA isolated 
from gWAT after 2 and 7 days of HFD as described in section 2.3.1. We were interested in cell-
cell crosstalk mediators such as secreted proteins, receptors, enzymes, extracellular matrix 
proteins/remodeling enzymes which could be manipulated by overexpression/siRNA silencing, 
or application of soluble factors. First, using linear modeling, we discriminated genes with 
interaction between two factors: time of diet and effect of diet. Although, we did not find genes 
with interaction satisfying filtering criteria (pV <0.05 and at least 1.5 -fold change in linear or 
0.58 in log scale), there were 2 genes close with pV=0.06 (Appendix table 5, marked orange). 
We identified 230 genes with pV <0.05 for effect of diet (main effect- diet), but only 129 had at 
least 1.5-fold change in their expression level (Appendix table 5, marked blue). Two groups 
tests were used for HFD vs. CD comparison inside each time point (for 2 days and for 7 days 
separately). There were 72 genes which were significant for day 2 of diet with more than 1.5-
fold change. However, 71 of them were already in the main effect list and only one was 
additional (Appendix table 5, marked green). When tested for day 7 of diet, 181 genes were 
significant with at least 1.5-fold change. Again 109 genes were already selected by main effect 
and 72 were added to the list (Appendix table 5, marked yellow). Insulin is a potent hormone for 
adipose tissue function. Genes upregulated upon CD were involved in glucose homeostasis and 
regulated by insulin were found as Slc2a5 and Slc2a4 (solute carrier family 2 (facilitated glucose 
transporter), member 5 and member 4 respectively, also known as GLUT5 and GLUT4), Insig1 
(insulin induced gene 1) (Fig. 2.25 – A). We found genes involved in cell-cell communication 
such as ECM and adhesion proteins e.g. epithelial membrane protein 1 (Emp1), leucine-rich 
alpha-2-glycoprotein 1 (Lrg1), versican (Vcan), thrombospondin 2 (Thbs2) (Fig. 2.25 – B). Also 
genes involved in cytokine- receptor interaction were found such as BMP-binding endothelial 
regulator (Bmper), interleukin 4 receptor, alpha (Il4ra), bone morphogenetic protein 3 (Bmp3), 
TNF receptor associated factor 4 (Traf4) (Fig. 2.25 – C). Additionally we found genes with 
unknown function in adipose tissue and not related to the categories above as neuronatin 
(Nnat), fragile X mental retardation syndrome 1 (Fmr1), prostate transmembrane protein, 
androgen induced 1 (Pmepa1), procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (Plod2), 
lipase, endothelial (Lipg) (Fig. 2.25 – D). 
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Figure 2.25: Change in expression pattern of representative candidate genes upon 2 and 7 days of 
HFD. RNA expression levels from microarray data. A-D – different gene category and the main 
representatives in each category. Data represented as mean ± SEM from 5 measurements. 
 
2.3.5 Novel gene search – impact of fat content on gene expression 
In order to investigate molecular signals leading to AP activation upon different 
dietary components we performed microarray hybridizations using RNA isolated from gWAT 
as described in section 2.3.2. Applying 2 filtering parameters with p value < 0.05 and at least 
1.5-fold change, 65 genes were differentially expressed between HFD vs. CD (Appendix 
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table 6). There were 43 genes overlapping between this experiment and the one in described 
above (section 2.3.4). (Appendix table 6, marked orange). Genes of interest involved in cell-
cell communication have the same pattern as in first profiling (Fig. 2.26). As in the first 
profiling insulin-regulated genes, Slc2a5, Slc2a4 and Insig1 were upregulated upon CD 
compared with HFD and HFD-R, but not when compared with HPD (Fig. 2.26 – A). Genes 
involved to ECM and cell adhesion exhibited a similar pattern as in first profiling: Emp1, Lrg1, 
and Vcan were upregulated in HFD compared with CD and HPD. However Thbs2 did not 
show significant differences (Fig. 2.26 – B). Cytokines and receptors were upregulated upon 
HFD and HFD-R such as Bmper, Il4ra, Bmp3, while Traf4 was downregulated with HFD and 
HFD-R (Fig. 2.26 – C). Nnat and Pmepa1 were upregulated upon HFD and HFD-R diet 
compared with CD and HPD (Fig. 2.26 – D). Fmr1 was upregulated only upon HFD 
compared with all other diets (Fig. 2.26 – D). However, Plod2 did not show significant 
difference. Lipg was downregulated upon HFD and HFD-R (Fig. 2.26 – D). There were 22 
genes that appeared elusively in the second profiling with a p value < 0.05 and at least 1.5-
fold change (Appendix table 6, no color). One of these genes was particulary interesting so 
we followed it for further analysis. Lumican (Lum) as an ECM protein, was upregulated upon 
HFD and HFD-R (Fig. 2.26 – B). In order to find genes which were differentially expressed 
only in response to excess calories we compered HFD vs. HFD-R and found 83 genes with p 
value < 0.05 and at least 1.5-fold change (Appendix table 7). Interestingly when we 
compared HFD vs. CD and HFD vs. HFD-R we identified 4 overlapping genes: Fmr1, Emp1, 
oxytocin receptor (Oxtr) and solute carrier family 27 (fatty acid transporter), member 1 
(Slc27a1). These genes were potentially acting independently of food composition but were 
sensitive to calorie load. 
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Figure 2.26: Change in expression pattern of representative candidate genes upon different diets. 
RNA expression levels from microarray data. A-D – different gene category and the main representatives 
in each category. Data represented as mean ± SEM from 5 measurements. 
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2.3.6 Novel gene search – different cell subpopulations response 
In order to identify cell population specific genes altered in response to HFD, we 
performed microarray hybridizations using RNA isolated from 3 different cell subpopulations as 
described in section 2.3.3 and two groups analysis as it was described above. Appling 2 filtering 
parameters with p value < 0.05 and at least 1.5-fold change, 19 genes were differentially 
expressed in comparison HFD vs. CD in Sca-1+ APs (Fig. 2.27 – A). We found new targets 
which were not differentially expressed on whole tissue level, e.g. transforming growth factor, 
beta-induced (Tgfbi) specifically downregulated in Sca-1+ APs upon HFD (Fig. 2.27 – B). There 
were 109 genes differentially expressed in CD31+ ECs upon HFD (Fig. 2.27 – A, C). 
Interestingly as we have observed extracellular matrix related genes altered upon HFD in this 
subpopulation, e.g. Vcan was upregulated and collagen, type VIII, alpha 1 (Col8a1) was 
downregulated (Fig. 2.27 – C). In CD34low cells 108 were differentially expressed upon HFD, 
e.g. reelin (Reln) and calsequestrin 2 (Casq2) (Fig. 2.27 – D). 
 
Figure 2.27: Change in expression pattern of representative candidate genes upon different diets 
in different cell subpopulation from gWAT. RNA expression levels from microarray data. A) Number of 
differentially expressed genes represented as Venn diagram for Sca-1+ adipose progenitors (APs) (blue), 
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CD34l
ow
 cells (orange) and CD31+ endothelial cells (ECs) (grey) B-D) Different gene category and the 
main representatives in each category. Data represented as mean ± SEM from 5 measurements. 
 
We identified genes differentially expressed upon dietary challenges and selected 
several targets for futher validation. 
2.3.7 Validation and function of candidate genes 
We selected several genes described in sections 2.3.4 – 2.3.6 by following criteria: 
potentially involved in cell-cell communication, could be modified by siRNA/ overexpressin, 
function were not described in context of in vivo adipogenesis or/and AP 
proliferation/differentiation. First in order to validate target genes, we analyzed gene expression 
after 7 days of CD, HFD, HPD and HFD-R in young and adult female mice via qPCR. Summary 
of validation represented in table 3 and Appendix Fig. 4. 
Table 3: Validation of selected from expression profiles genes by qPCR. Significance 
between groups were tested by one-way Anova with Tukey’s post-hoc test, *, comparison between 
indicated conditions, pV< 0.05, ns, no statistically significant difference.  
  Young mice Adult mice 
Gene 
name CD vs HFD 
CD vs 
HFD-R 
HFD vs 
HFD-R 
CD vs 
HFD 
CD vs 
HFD-R 
HFD vs 
HFD-R 
Emp1 * * * * * * 
Fmr1 * * * ns ns * 
Bmper * * ns ns ns ns 
Fap * ns * ns * * 
Plod2 ns ns ns ns ns ns 
Ngfr * ns * ns ns ns 
Traf4 ns * ns ns ns * 
Vcan * ns ns ns ns * 
Emb ns ns ns ns ns * 
Pkp2 * ns * ns ns ns 
Lum * ns * ns * * 
2.4 Functional characterization of genes related to adipose tissue 
remodeling and responding to high-fat diet using co-culture system in 
a niche-like setting 
 
2.4.1 Establishment of co-culture system for modeling AP regulation 
To investigate the functional role of identified genes, we established a co-culture system, 
in which Sca-1+ APs were seeded on top of feeders. One of the main advantages of this system 
is the single cell density of APs, which was not possible in classical monoculture because of 
high seeding density. This system allowed us to follow individual cells and the colonies 
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developing from them, which is important taking in consideration heterogeneity of AP 
population. Second, feeder cell layer provided a niche-like environment partially mimicking cell-
cell interaction in the tissue in vivo, influencing gene expression and cell behaver by slowing 
proliferation of APs (Fig. 2.28). 
 
Figure 2.28: Scheme of co-culture system. Not-labeled feeders can be modified in order to mediate 
knockdown or overexpression for gene of interest. After isolation from adipose tissue GFP-labeled 
adipose progenitors (GFP+ Sca-1+ APs) are seeded on top of modified/unmodified feeders in the single 
cell density. In this moment different soluble factors can be added to the system. After co-culturing GFP+ 
APs form colonies with adipogenic and fibroblastic fate. To distinguish different colonies LipidTox staining 
can be utilized for natural lipids staining. Finally, colonies can be recognized and counted to asses 
function of the gene of interested in niche-like setting.  
 
 
2.4.1.1 Testing GFP+ mice strains 
In order to track and distinguish adipose progenitors from other cell types in a co-culture 
system, cells expressing detectable levels of GFP were introduced to the system. Two mice 
strains expressing enhanced GFP ubiquitously were tested: C57BL/6-Tg(UBC-GFP)30Scha/J 
and STOCK Tg(CAG-EGFP)D4Nagy/J. Lin-Sca-1+ progenitor cells (APs) were isolated from 
gWAT, ingWAT, isBAT and tested for their ability to sustain GFP signal during proliferation and 
differentiation in monoculture in vitro. Progenitor cells from mice without GFP served as 
negative control. Only cells derived from C57BL/6-Tg(UBC-GFP)30Scha/J mice strain 
expressed GFP on a detectable level with standard microscopy (Fig. 2.29 – A). To promote 
differentiation in vitro, we used common inducers of adipogenesis such as insulin, 
dexamethasone, 3,3'5'-triiodothyronine (T3), isobutylmethylxanthine (IBMX), prostacyclin (PGI2) 
and rosiglitazone (Rosi) (see materials and methods 4.2.1). Adipose progenitor cells from UBC-
GFP mice differentiated with the same efficiency as cells derived  
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from control mice in depot- specific manner while sustaining high GFP signal (Fig. 2.29 – B). 
Therefore, these cells were further used in experiments. 
 
Figure 2.29: Comparison of GFP-signal intensity of cells isolated from two different mice strains. 
Sca-1+ adipose progenitors (APs) were isolated from three different fat depots: perigonadal WAT 
(gWAT), inguinal WAT (IngWAT) and interscapular brown adipose tissue (isBAT) of two mice strains 
expressing enhanced GFP ubiquitously: C57BL/6-Tg(UBC-GFP)30Scha/J (UBC-GFP) and STOCK 
Tg(CAG-EGFP)D4Nagy/J (CAG-GFP). A) Florescent microscopy of APs monoculture, scale bar, 100 µm. 
B) IngWAT APs from UBC-GFP were differentiated in a presence of isobutylmethylxanthine (IBMX) and 
rosiglitazone (Rosi) for 8 days. Phase contrast (Ph.C) and florescent (in GFP channel) images with 
differentiated adipocytes are represented, scale bar, 100 µm. 
2.4.1.2 Feeder types and growing conditions for co-culture system 
Several feeder systems were tested to address different questions. To mimic the 
physiological niche, differentiated to mature adipocytes pre-adipocyte cell lines (derived from 
mouse embryo fibroblasts) C3H10T1/2 were used. The C3H10T1/2 line can be terminally 
differentiated to adipocytes by presence of rosiglitazone (Rosi). Using this feature of the cell 
line, it is possible to obtain completely differentiated feeders with Rosi or just arrest the cells 
before accumulating lipid (Appendix Fig. 5). In the first experiment, C3H10T1/2 cells, which 
were induced to differentiate with or without Rosi (dif-C3H/ undif-C3H, respectively), were used 
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as feeders. ingWAT GFP+ APs were seeded on top of feeders with or without the potent growth 
factor - basic fibroblast growth factor (bFGF), promoting proliferation and survival of APs. 
Growth factors in the serum play an important role in AP proliferation/differentiation and were 
used to determine potential sensitivity of the system to growth factors. After 4 days of co-
culturing, we observed first forming colonies (Fig. 2.30 – A). Colonies were counted manually 
and a significant interaction between stage of feeder differentiation and presence of bFGF was 
witnessed by two-way ANOVA. There were two times more colonies in the presence of bFGF 
on undif-C3H, but no effect of bFGF was observed when used differentiated feeders (Fig. 2.30 – 
B). After 10 days, GFP+ cells had spontaneously differentiated into adipocytes without any 
differentiating stimulus, which has not been yet achieved in standard monoculture (Fig. 2.30 – 
C). This result showed that a co-culture system is suitable to mimic the in vivo 
microenvironment and promotes natural cell fate. Additionally, functional heterogeneity inside of 
Lin-Sca-1+ progenitor population was observed. Some colonies differentiated into adipocytes, 
whereas others exhibited fibroblastic morphology (Fig. 2.30 – D). We concluded that co-culture 
system with feeder layer provided differentiation signals for progenitor cells and can be used for 
functional validation of target genes. 
 
Figure 2.30: Colony formation in co-culture system. A) IngWAT APs gave rise to GFP+ colonies 
several days after seeding. Phase contrast (Ph.C) and florescent (in GFP channel) images of 
representative colony 4 days after seeding on top of undifferentiated C3H10T1/2 cells (undiff-C3H), scale 
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bar, 50 µm. B) Number of GFP+ colonies per well formed on undiff-C3H or differentiated C3H10T1/2 (diff-
C3H) in presence bFGF (+bFGF) or absence (-bFGF) 4 days after seeding, each dot represents count 
per well, line is mean of the group, two-way Anova with Bonferroni post-hoc test was used to assess 
significance, *, pV< 0.05. C) Phase contrast (Ph.C) and florescent (in GFP channel) images of IngWAT 
GFP+ adipogenic and D) fibroblast-like colony formed on top of undiff-C3H 8 days after seeding, scale 
bar, 50 µm. bFGF - basic fibroblast growth factor. 
2.4.1.3 Assessment of differentiation of APs in co-culture system 
To test the ability of the co-culture system to provide a better environment to detect AP 
proliferation and differentiation upon gene expression manipulation, C3H10T1/2 cells were used 
as feeders, this time treated with Mitomycin C to prevent overgrowth (Appendix Fig. 5). We 
seeded GFP+ Sca-1+ progenitor cells from ingWAT on top of feeders in different growth 
conditions (Fig. 2.31 – A). In first 3 conditions, initial 2 days cells were cultured with bFGF or 
IGF-1 or control cells had no additional growth factors, after that growth factors were replaced 
with insulin until the end of experiment (Fig. 2.31 – A). In condition 4, 5 and 6, cells were grown 
ether without any additional factors or with insulin or with insulin + IGF1 for whole time of 
experiment (Fig. 2.31 – A). After 10 days, cells were fixed and stained with LipidTox to visualize 
lipid droplets (Fig. 2.31 – B). LipidTox positive colonies were manually counted and significantly 
more colonies with differentiated APs upon initial bFGF treatment were observed (Fig. 2.31 – 
C). Interestingly, the initial two-day treatment with IGF-1 did not lead to a higher number of 
colonies. The number of adipocytes inside of the colony was also manually counted (Fig. 2.31 – 
D). There was a shift in the frequency distribution upon bFGF treatment towards higher number 
of differentiated APs (Fig. 2.31 – D, E). Insulin or insulin combined with IGF-1 had no effect on 
number of colonies or number of cells inside of colony compared with control condition for whole 
course of experiment (Fig. 2.31 – F, G). These data indicated that using co-culture system 
allows us to identify factors influencing AP differentiation, e.g. IGF-1 and insulin had no effect on 
AP proliferation/differentiation. However bFGF seems to be important growth factor promoting 
AP proliferation and was included in following screening experiments.  
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Figure 2.31: Assessment of adipogenesis in co-culture system. A) Experimental design: ingWAT 
GFP+ Sca-1+ APs were seeded on top of mitomycin C-treated C3H10T1/2 feeders in 6 different growing 
conditions: for initial days media was supplemented with bFGF (2) or IGF-1 (3) vs. control without any 
additives (1). After 2 days all cell were cultured in presence of insulin. Alternatively cells were cultured 
with insulin (5) or insulin and IGF-1 (6) vs. control without any additives (4) for whole course of 
experiment. Co-cultures were fixed after 10 days, stained with DAPI/LipidTox. B) Representative image of 
adipogenic LipidTox positive colony, scale bar, 100 μm. C) Number of LipidTox+ colonies per well upon 
control, IGF-1 and bFGF treatment for 2 initial days. D) Number of LipidTox+ cells per colony upon 
control, IGF-1 and bFGF treatment for 2 initial days. E) Relative frequency distribution (%) of cells per 
colony from D, bin center = 6 cells. F) Number of LipidTox+ colonies per well upon control, insulin (Ins) 
and insulin combined with IGF-1 treatment (Ins+IGF-1) for whole course of co-culture. G) Number of 
LipidTox+ cells per colony upon control, Ins and Ins+IGF-1 treatment for whole course of co-culture. For 
C, F each dot represents count per well, for D, G each dot represents count per colony, line is mean of 
the group, one-way Anova with Tukey’s post-hoc test was used to assess significance, *, comparison with 
Control, pV< 0.05, ns, no statistically significant difference. bFGF- basic fibroblast growth factor, IGF-1 - 
insulin-like growth factor 1. 
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2.4.1.4 Developing an automated system for colony recognition and count 
To increase and automate the data acquisition, an automated high content microscopy 
assay protocol was developed. Images were automatically acquired in 3 channels (100 pictures 
per channel - 30% of one 24- well) and analyzed. It is possible to observe difference between 
conditions in colony size, numbers, ratio GFP+ colonies/LipidTox+ colonies. For instance, GFP+ 
progenitors proliferated faster and had bigger area of colonies after prostacyclin treatment 
(cPGI2) that known as a specific effector of adipogenesis (Fig. 2.32).  
 
Figure 2.32: Developing of automated system for colony recognition and count. Upper panel 
represents GFP+ colonies, lower panel – LipidTox+ colonies on top of feeders with presence/ absence of 
prostacyclin (PGI2) treatment (etanol, EtOH serves as control). Stitched images from one well for 
GFP/LipidTox channels. Manual colony recognition was performed. 
 
Further algorithms for image data analysis (GFP+/LipidTox colony recognition and 
count) were established. Automatic algorithms using KNIME Analytics Platform were created for 
colony recognition and count. A virtual stitching algorithm was created to analyze multiple 
images from one well. Analysis included assessment of proliferation by number (N) of GFP+ 
cells and differentiation capacity by N of double positive GFP+ LipidTox+ cells. First all nuclei 
were segmented based on DAPI staining and had individual labels, then each nucleus was 
crosschecked in the GFP channel based on the maximum intensity measurement around the 
nucleus. If the nucleus was assigned as GFP+, then it was checked in the LipidTox channel. 
Analysis was classified in two levels: cellular level (N of GFP+ cells per well/ per colony, N of 
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GFP+ LipidTox+ cells per well/ per colony) and colony level (N of GFP+ colonies per well, area 
of GFP+ colonies, N of GFP+ LipidTox+ colonies). This algorithm was further used for 
automated screening. 
2.4.1.5 Development of an automated screening for characterization of candidate genes 
To test established protocols for automated screening for distinct growth conditions, ingWAT 
GFP+ APs were seeded on top of two types of feeders, Mit-C treated C3H10T1/2 and 3T3-L1 
(Appendix Fig. 5), in 4 different growing conditions (Fig. 2.33 – A). Co-culturing cells were fixed 
and stained with LipidTox/DAPI. Microscopy and image data analysis were performed according 
to the protocol developed in this project. When C3H10T1/2 was used as feeder, there were 
more colonies and we could discriminate differences between growing conditions (Fig. 2.33 – B, 
C.). It was same trend of increased number of colonies upon bFGF treatment as during manual 
count in section 2.4.1.2. Also we could confirm previous observation from section 2.4.1.3 that 
upon bFGF treatment during 2 initial days of co-culture number of LipidTox+ colonies was 
higher compared with control (Fig. 2.33 – E.). Only on C3H10T1/2 feeders this phenotype was 
exhibited, but not on 3T3-L1 (Fig. 2.33 – D). For further investigations we used only C3H10T1/2 
feeders. 
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Figure 2.33: Automated screening for validation on example of different growing conditions. A) 
Experimental design: GFP+ APs were seeded on top of MitC-treated C3H10T1/2 and 3T3-L1, in 4 
different growing conditions: for initial days media was supplemented with bFGF or insulin or combination 
of bFGF and insulin vs. control without any additives. After 2 days all cell were cultured in presence of 
insulin. On 6
th
 day and 10
th
 day of co-culturing on top of 3T3-L1 and C3H10T1/2, respectively, co-cultures 
were fixed. After staining an automated imaging was performed and algorithm for colony recognition was 
tested. B) Number of ingWAT GFP+ colonies per well after co-culturing on top of 3T3-L1 feeders. C) 
Number of ingWAT GFP+ colonies per well after co-culturing on top C3H10T1/2 feeders. D) Number of 
ingWAT GFP+ LipidTox+ colonies per well after co-culturing on top of 3T3-L1 feeders. E) Number of 
ingWAT GFP+ LipidTox+ colonies per well after co-culturing on top of C3H10T1/2 feeders. For B-D data 
represented as mean ± SEM, 8-16 wells per condition were used for analysis, one-way Anova with 
Tukey’s post-hoc test was used to assess significance, *, comparison with Control, pV< 0.05, #, 
comparison between indicated conditions, pV< 0.05. bFGF - basic fibroblast growth factor. 
2.4.1.6 Optimizing siRNA treatment in feeder cells 
Ultimately, the co-culture system should be used for functional characterization of candidate 
genes. To test the efficiency of siRNA transfection in feeder cells, 3T3-L1 and C3H10T1/2 were 
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transfected with siRNA against Cited2 gene, which is highly expressed in both cell lines (Fig. 
2.34 – A). Two different concentrations of siRNA were tested (5 and 20nM). Cells were 
harvested 3 and 10 days after transfection for testing silencing efficiency via qPCR. One of the 
concentrations (5nM) showed 85-90% and 72-78% 3 and 10 days after transfection, 
respectively in both cell lines (Fig. 2.34 – B, C). These data indicated that using optimized 
siRNA treatment protocol allows us to sustain knockdown during prolonged co-culture.  
 
Figure 2.34: Measurement of siRNA knockdown efficiency in feeder cells. A) Experimental design: 
3T3-L1 and C3H10T1/2 were transfected with siRNA against Cited2 (C2) and negative control (NC) using 
2 different concentrations 5 and 20nM, 2 days after cells were treated with Mitomycin C, RNA was 
isolated 2 and 10 days after transfection followed by cDNA synthesis and qPCR. B) Relative expression 
of C2 gene in C3H10T1/2. C) Relative expression of C2 gene in 3T3-L1. Data represented as mean ± 
SEM, efficiency of transfection was calculated in comparison with NC for each time point for each 
concentration, two-way Anova with Bonferroni post-hoc test was used to assess significance, *, pV< 0.05. 
 
To conclude, a co-culture system was established with image analysis algorithms for 
automated assessment of proliferation and differentiation of adipose tissue progenitor cells. 
Automated algorithms were able to discriminate differences between growing conditions and 
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confirmed manual count observations indicating that the protocol developed for automated 
screening is sensitive to study candidate genes. 
2.4.2 Functional validation of target genes in co-culture system 
In order to characterize candidate genes found in our screening (section 2.3.4 – 2.37) 
we approached two different systems for each target: 1) in the co-culture system, gene 
knockdown in feeder cells for investigating niche-mediated effect on AP proliferation/ 
differentiation 2) in monoculture, AP knockdown for investigating direct effect on AP 
proliferation via EdU-labeling. We performed functional screening with several targets and 
two examples presented to illustrate abilities of functional screening via co-culture system. 
2.4.2.1 Lumican as an example of gene with no co-culture phenotype 
Lumican (Lum) is an extracellular matrix protein that involved in collagen fibrogenesis 
and suspected to be involved in cell proliferation (Nikitovic et al. 2008). Lumican upregulated 
in response to HFD (section 2.3.5) and highly expressed in Sca1+ APs. We hypothesize that 
this gene can be potentially involved in mediating APs proliferative response. Accordingly to 
biogps data Lum in not expressed in feeder cells and our first line strategy was to knock it 
down in APs monoculture. gWAT APs were seeded in monoculture with bFGF to induce 
growth of the cell, then cells were transfected with siRNA against Lum (2 different siRNAs) in 
comparison with negative control siRNA. Using EdU pulse 24 h after transfection to label 
proliferating cells and the automated algorithm to count the number of EdU-labeled nuclei 
and total number of nuclei, we demonstrated that Lum knockdown negatively regulated 
proliferation of APs (Fig. 2.35 – A). Additionally we used this gene as a negative control in 
co-culture screening, in which only feeder cells were transfected with siRNA against Lum. 
For co-culture experiment, GFP+ APs isolated from gWAT and ingWAT were seeded on top 
of feeders previously transfected with siRNA against Lum (Lum_1 and Lum_2). Afterward co-
cultured cells were fixed and stained with LipidTox/DAPI (Fig. 2.35 – B). Following that, 96-
well plates were screened and analyzed using the automated protocol described in section 
2.4.1.4. The algorithm accessed cell proliferation by counting the number of GFP+ cells per 
well and per colony, GFP+ colonies per well and differentiation by the number of LipidTox+ 
cell/colonies inside GFP+ population. We did not observe consistently significant changes in 
the number of GFP+ cells (Fig. 2.35 – C) or colonies (Fig. 2.35 – D) as well as in LipidTox+ 
GFP+ cells (Fig. 2.35 – E) or colonies (Fig. 2.35 – F) from both fat depots.  
70 
 
 
Figure 2.35: Effect of Lumican knockdown on AP proliferation and differentiation in monoculture 
and co-culture systems. A) Sca-1+APs isolated from perigonadal WAT (gWAT) were transfected with 
Lum siRNA (Lum_1 and Lum_2) vs. negative control siRNA (NC), after 2 days rate of proliferation was 
measured via Edu-labeling, data represented as mean ± SEM, one-way Anova with Tukey’s post-hoc test 
was used to assess significance, *, comparison with NC. B) Experimental design: not-labeled C3H10T1/2 
feeders were seeded, transfected with siRNA against Lum and with NC following by mitomycin C (MitC) 
treatment. GFP+ Sca-1+ APs isolated from gWAT and inguinal WAT (ingWAT) of 4-week old female mice 
were seeded on top of feeders with knockdown of Lum, co-cultured without (control) or with bFGF 
(+bFGF) for initial days, then after one week fixed, stained with DAPI/LipidTox and imaged. C) Number of 
gWAT and ingWAT GFP+ cells per well after co-culturing on top of feeders transfected with negative NC, 
Lum_1, Lum_2 without (control) or with bFGF (+bFGF). D) Number of gWAT and ingWAT GFP+ colonies 
per well after co-culturing on top of feeders transfected with negative NC, Lum_1, Lum_2 without (control) 
or with bFGF (+bFGF). E) Number of gWAT and ingWAT LipidTox+ GFP+ cells per well after co-culturing 
on top of feeders transfected with negative NC, Lum_1, Lum_2 without (control) or with bFGF (+bFGF). 
F) Number of gWAT and ingWAT LipidTox+ GFP+ colonies per well after co-culturing on top of feeders 
transfected with negative NC, Lum_1, Lum_2 without (control) or with bFGF (+bFGF). For C-F data 
represented as mean ± SEM, 8-16 wells were used for analysis, two-way Anova with Bonferroni post-hoc 
test was used to assess significance, *, comparison with NC of each condition, pV< 0.05, dashed line is 
level of background based on GFP-feeders. bFGF -basic fibroblast growth factor. 
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These data indicated that although knockdown of Lum had direct effect on AP 
proliferation in monoculture, we did not observe niche mediated effect, which served us a 
control of specificity in co-culture screening. 
2.4.2.1 EMP gene family modulate AP response through the niche 
Two genes from the EMP family (EMP1 and EMP3) were selected from our candidate gene 
list. EMP-1 is involved in tight-junctions formation (Durgan et al. 2015), thus cell remodeling. 
Emp1 and Emp3 was upregulated upon HFD, when compared with CD (Fig. 2.24 – B and Fig. 
2.25 – B). Both genes were expressed in feeders and their role in adipose cell biology was still 
unknown. For co-culture experiment, GFP+ APs isolated from gWAT and ingWAT were seeded 
on top of feeders previously transfected with siRNA against Emp1 and Emp3. After co-culture 
cells were fixed and stained with LipidTox/DAPI (Fig. 2.36 – A). Following, 10 96-well plates 
were screened and analyzed using the automated protocol described in section 2.4.1.4. First 
controls were analyzed. No effect of transfection was observed when compered negative control 
siRNA (NC) and non-treated cells (NT, only transfection reagents) for both fat depots gWAT and 
ingWAT (Fig. 2.36 – B, C). Also level of background was set accordingly GFP-feeder cells (Fig. 
2.36 – B, C). Treatment with bFGF for 2 initial days of co-culture served us as positive control 
and as it was observed previously addition of bFGF increases cell count (Fig. 2.36 – B, C). 
When we mediated knockdown either Emp1 or Emp3 in feeder cells, a decrease in the number 
of GFP+ cells compared with NC was observed for both growing conditions (control and +bFGF) 
in ingWAT (Fig. 2.36 – E). However, in gWAT the decrease was significant only in combination 
with bFGF (Fig. 2.36 – D). The same results for colony count with all described above controls 
(Fig. 2.36 – F, G, H, I). These data suggested that mediated in feeders knockdown of Emp1 and 
Emp3 played a role in AP proliferation. 
72 
 
 
Figure 2.36: Effect of Emp1 and Emp3 knockdown in the feeder cells on proliferation of adipose 
progenitors. A) Experimental design: not-labeled C3H10T1/2 feeders were seeded, transfected  
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with siRNA against EMP1 (EMP1_1 and EMP1_2), EMP3 (EMP3_1 and EMP3_2) and with negative 
control siRNA following by mitomycin C (MitC) treatment. GFP+ Sca-1+ APs isolated from perigonadal 
WAT (gWAT) and inguinal WAT (ingWAT) of 4-week old female mice were seeded on top of feeders with 
knockdown of Emp1 and Emp3, co-cultured without (control) or with bFGF (+bFGF) for initial days, then 
after one week fixed, stained with DAPI/LipidTox and imaged. B) Number of gWAT GFP+ cells per well 
after co-culturing on top of negative control (NC) and NC with bFGF (NC+bFGF), not treated feeders 
(NT). C) The same as B for ingWAT. D) Number of gWAT GFP+ cells per well after co-culturing on top of 
feeders transfected with negative control (NC), EMP1_1, EMP1_2, EMP3_1, EMP3_2 siRNAs without 
(control) or with bFGF (+bFGF). E) The same as D for ingWAT. F) Number of gWAT GFP+ colonies per 
well after co-culturing on top of NC and NC+bFGF, NT. G) The same as F for ingWAT. H) Number of 
gWAT GFP+ colonies per well after co-culturing on top of feeders transfected with NC, EMP1_1, 
EMP1_2, EMP3_1, EMP3_2 siRNAs in control or +bFGF. I) The same as H for ingWAT. For B, C, F, G 
each dot represents count per one well, line is mean of the group, one-way Anova with Tukey’s post-hoc 
test was used to assess significance, *, comparison with NC, pV< 0.05, dashed line is level of background 
based on GFP-feeders. For D, E, H, I data represented as mean ± SEM, 8-16 wells were used for 
analysis, two-way Anova with Bonferroni post-hoc test was used to assess significance, *, comparison 
with NC of each condition, pV< 0.05. bFGF -basic fibroblast growth factor. 
 
The second part of analysis was assessment of differentiation of co-cultured cells. Increased 
number of LipidTox+ colonies and cells were observed before (section 2.4.1.3) upon bFGF 
treatment using ingWAT APs, when counted manually. In this experiment we could confirm the 
same trend for ingWAT cells (Fig. 2.37 – B). Interestingly, APs from gWAT had the opposite 
phenotype and the number of LipidTox+ cells were reduced upon bFGF treatment (Fig. 2.37 – 
A). There was no significant difference between siRNA treatment in number of LipidTox+ cells in 
both gWAT and ingWAT (Fig. 2.37 – C, D). These data indicated that mediated in feeders 
knockdown of Emp1 and Emp3 had no effect on AP differentiation.  
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Figure 2.37: Effect of Emp1 and Emp3 knockdown in the feeder cells on differentiation of adipose 
progenitors. A) Number of gWAT GFP+ LipidTox+ cells per well after co-culturing on top of negative 
control (NC) and NC with bFGF (NC+bFGF), not treated feeders (NT). B) The same as A for ingWAT. C) 
Number of gWAT GFP+ LipidTox+ cells per well after co-culturing on top of feeders transfected with NC, 
EMP1_1, EMP1_2, EMP3_1, EMP3_2 siRNAs without (control) or with bFGF (+bFGF). D) The same as 
C for ingWAT. For A, B each dot represents count per one well, line is mean of the group, one-way Anova 
with Tukey’s post-hoc test was used to assess significance, *, comparison with NC, pV< 0.05, dashed line 
is level of background based on level of spontaneous differentiation of feeder cells. For C, D data 
represented as mean ± SEM, 8-16 wells were used for analysis, two-way Anova with Bonferroni post-hoc 
test was used to assess significance. bFGF - basic fibroblast growth factor. 
 
To investigate the direct effect of Emp1 and Emp3 knockdown on AP proliferation in 
monoculture we employed cell count and EdU-labeling. gWAT APs were seeded in monoculture 
with bFGF to induce growth of the cell, then cells were transfected with siRNA against Emp1 
and Emp3 (3 different siRNAs per target) in comparison with negative control siRNA. Cells were 
manually counted daily up to 3 days after transfection. There was no effect of siRNA treatment 
on growth of gWAT APs (Fig. 2.38 – A). To confirm these data we used EdU pulse 24 h after 
transfection to label proliferating cells and used the automated algorithm (method section 4.5.2) 
to count the number of EdU-labeled nuclei and total number of nuclei. No direct effect of Emp1 
and Emp3 transfection on ration of proliferating cells was observed, in agreement with our 
previous results (Fig. 2.38 – B).  
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Figure 2.38: Effect of Emp1 and Emp3 knockdown on proliferation of adipose progenitors in 
monoculture. Isolated from perigonadal WAT (gWAT) Sca-1+ APs were seeded and transfected with 
siRNA agents Emp1 (EMP1_1, EMP1_2 and EMP1_3), Emp3 (EMP3_1, EMP3_2 and EMP3_3), and 
negative control (NC) A) Number of cell per well 1, 2 and 3 days after transfection with siRNAs. Data 
represented as mean ± SEM, 3 wells per condition were used, two-way Anova with Bonferroni post-hoc 
test was used to assess significance. B) Present (%) of EdU+ nuclei 2 days after transfection with 
siRNAs, data represented as mean ± SEM from 3 wells (5 images per well), one-way Anova with Tukey’s 
post-hoc test was used to assess significance. 
 
To confirm and further investigate effect of Emp1 knockdown in feeders on proliferation of 
APs another co-culture experiment was performed by master student Wujun Hong 
supervised by me. In this experiment GFP+ APs were seeded on top of feeders transfected 
with empty vector pcDNA3.1 or overexpression construct pCMV-EMP1 and siRNA again 
Emp1 vs. negative control siRNA. After 4 days of co-culture, EdU pulse were applied to label 
proliferating cells, then cells were fixed and analyzed by FACS. We demonstrated that upon 
overexpression in feeders % of GFP+ cells were increased and upon siRNA treatment 
decreased (Fig. 2.39 – A). However % GFP+ EdU+ cells were not changed among 
conditions, indicating that feeder-mediated changes in % of GFP+ cells were not due to 
proliferation. The next steps are measure feeder-mediated adhesion and apoptosis of APs. 
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Figure 2.39: Effect of Emp1 overexpression and knockdown on proliferation of adipose 
progenitors in co-culture. Experiment performed by Wujun Hong. GFP+ APs were seeded on top of 
feeders transfected with: empty vector pcDNA3.1 or with overexpression vector pCMV-EMP1, siRNA 
against Emp1 (EMP1_1 and EMP1_2). After 4 days of co-culturing EdU pulse were performed and 
cells were fixed and analyzed by FACS. A) % of GFP+ cells B) % of GFP+ EdU+ cells. Data 
represented as mean ± SEM from 3 samples, each sample contained 2 pooled wells, one-way Anova 
with Tukey’s post-hoc test was used to assess significance, *, comparison with NC of the group, pV< 
0.05. 
 
These data underlined that Emp1 had no direct effect on AP proliferation but acted through 
another type of cells via cell-cell communication and affected number of APs. 
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3. DISCUSSION 
3.1 Long-term impact of HFD feeding on young mice: WAT remodeling 
We demonstrated that adipose tissue of young sexually immature mice grew rapidly in 
response to excess calories. In fact, HFD increased body weight, fat mass due to increased 
number of Sca-1+APs after one week of feeding of sexually immature female mice, but not 
adult female mice. These data were in line with other studies showing age-dependent decline 
of adipose tissue plasticity in mice (Kim et al. 2014) and human (Spalding et al. 2008). These 
data indicated that early remodeling of WAT is the set point for future metabolic outcome of 
adult tissue. Moreover, we have observed that the determination of AP cell fate occurs 
rapidly upon HFD, leading to visible phenotype upon 7 days of diet. It is interesting to notice 
that there seems to be a short window in time that can lead to significant consequences for 
the WAT constitution throughout the whole lifespan of a mouse. Although obesity is tightly 
associated with development of cardiovascular diseases and mortality, little is known about 
long-term impact of increased number of cells in adipose tissue during childhood. We can 
hypnotize that increased number of adipose progenitors in response to dietary challenges 
can be beneficial to future metabolic condition, since these cells can give rise to mature 
adipocytes and store more lipids preventing lipotoxicity of other tissues. Based on our 
experiments so far, we are still not able to have a clear picture of long-term impact, but we 
had a hint. During the experiment with the addition of sweetened beverage, we observed 
increased liver size upon sucrose/fructose treatment only in control diet, but not in high-fat 
diet. Potentially after hyperplastic response on high-fat diet, adipose tissue can store more 
energy preventing from ectopic accumulation in other organs, e.g. liver. Further experiments, 
considering initial HFD challenge, followed by CD (wash out effect) and re-challenge with 
HFD, are planned and could give more information on tissue memory upon diet stimuli. We 
still need to demonstrated direct prove that APs do not proliferate in adult mice upon one 
week of HFD employing EdU-labeling approach. Moreover, we have found target genes, e.g. 
Fmr1, Bmper, Traf4, Vcan which were exclusively differentially expressed in young mice 
upon HFD, but not in adults. As some of these genes could be involved in early adipose 
tissue remodeling, they could be used to potentially restore loss of plasticity in adults.  
3.2 Sex-dependent proliferation of APs 
There are some studies on adipose tissue proliferation in young male mice (Kim et al. 
2014), but not female. To us, it was important not only to better define the window of time 
where HFD would lead to cell proliferation, but also to identify possible sex-specific 
differences. Two studies in male mice have shown slightly discrepant results. In the first, 
young male mice have proliferation in both fat depots (scWAT and vWAT) upon HFD (Kim et 
al. 2014). However, in the second, only APs from vWAT proliferated in response to HFD in 
78 
 
male adolescent mice (Jeffery et al. 2015). It is important to notice that there was a 
difference between the age of mice used in these studies (4 weeks and 6-8 weeks, 
respectively), which can explain that younger mice had diet-induced proliferation in both 
depots. Therefore, determining the earliest time point when phenotypical difference upon 
HFD could be observed had an importance. We demonstrated that APs from both fat depots 
proliferate in response to HFD in young female mice. Our data is consistent with recent study 
demonstrating sex- and depot-specific differences in response to HFD showing that 
adipogenesis occurs in both depots in female and only in vWAT in male (Jeffery et al. 2016). 
The limitation of this study was an adult age of used mice 6-8 weeks, so they still cannot 
conclude was sex-specific response determined by age. To address this question, we plan to 
conduct short-term HFD study with EdU- labeling using young sexually immature male mice. 
3.3 Dietary fat content triggers expansion of adipose tissue in early development via 
hyperplasia 
Most of obesity related conclusions were done based on diet-induced rodent models, 
in which animals consuming excess amount of calories upon HFD ad libitum compared with 
CD matched by protein content, but enriched with carbohydrates. However limitation of this 
model was that there were 2 factors interacting and contributing to results: mice upon HFD 
consuming more calories and two diets have different composition. To overcome this 
limitation and investigate the impact of food components to WAT growth we used isocaloric 
pair feeding approach, in which mice received restricted HFD equal to consumed calories 
from CD group. We demonstrated that dietary fat triggered proliferation of APs, but did not 
lead to WAT gain. We do not know about impact of this initial proliferation induced by dietary 
fat content and further experiments are required to address this point. Nevertheless, as lipids 
are the main component stored in adipocytes, we could hypothesize that an excess of fat 
content of the diet could trigger a signaling cascade, leading to a higher number of APs, 
which could give rise to adipocytes and allowing more efficient storage of the excess of 
calorie intake. 
3.4 High sugar content does not induce additional adipose tissue weight gain 
Another important observation regarding food composition was that the supplying of 
sweetened beverage, meaning additional calories, had no effect on WAT gain on both CD an 
HFD diet. Although we did not observe significant changes in glucose homeostasis, we still 
are not able to claim, that quality of adipocytes and functional property of WAT was not 
changed due to lack of functional studies. However we observed that upon CD many insulin 
responding genes were upregulated, level of insulin was higher after 2 days and level of 
EdU-labeling of AP was quit high (30-40%) compared with other studies in which it was less 
than 10% in both male in female adolescent mice (Jeffery et al. 2015), (Jeffery et al. 2016). 
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These observations gave us an idea that because of enriched sucrose content in CD no 
additive effect could be achieved with sucrose/fructose in drinking water. The effect of 
sweetened beverage on acute AP proliferation and long-term consciences plan to be tested, 
since now new matched CD with lower sucrose content is commercially available. We can 
conclude that nutrient content is very important for experiment design and type of diet can 
have a major impact in the outcome of experiments. 
3.5 Contributions of adipocyte hypertrophy to AP proliferation 
According to current paradigm, mature adipocytes grow via hypertrophy till their size limit 
upon calorie excess (Rosen & Spiegelman 2014). After that, hypertrophic mature adipocytes 
die and macrophages are recruited to sites of adipocyte death to remove the dead cells. This 
macrophages one of the factors recruiting APs (Lee et al. 2013). However we demonstrated 
that fat content in the food induces Sca-1+ AP proliferation without hypertrophy of mature 
adipocytes in gWAT of sexually immature female mice. These data suggested that nutritional 
stimulus can activate AP proliferation before mature adipocyte hypertrophy occurs and 
potentially prepare adipose tissue to following dietary challenges at least in young age. 
3.6 Contributions of inflammation to AP proliferation 
It was postulated that local inflammation in adipose tissue triggers in vivo angiogenesis 
(Wernstedt Asterholm et al. 2014), (Brestoff et al. 2014). Accordingly to our data immune-
related gene sets were enriched in response to excess calorie load, but not in isocaloric 
groups. Taking in consideration our result that fat content in the food in isocaloric amount as 
in CD group leaded to AP proliferation, we could not conclude that inflammation was 
necessary to induce AP proliferation at least in sexually immature female mice. 
3.7 Contributions of IGF-1 to AP proliferation 
Although there is no consistency in observations of serum level of insulin-like growth 
factor 1 (IGF-1) in obese adults and children, IGF-1 is believed to play an important role in 
AP proliferation, differentiation and contributing to development of obesity (Garten et al. 
2012), (Berryman et al. 2013), (Kreitschmann-Andermahr et al. 2010). In this project, we 
demonstrated that although IGF-1 was increased 2 days after HFD feeding, it was not 
increased upon isocaloric high fat diet (restricted HFD) and cannot fully explain AP 
proliferation. Additionally in vitro IGF-1 treatment of ingWAT APs showed no effect on 
number of differentiated colonies in co-culture system.  
3.8 Contributions of insulin to AP proliferation 
  Insulin is one of the major players in sustaining glucose homeostasis by inducing 
glucose intake by mature adipocytes, liver and muscle cells (Rutkowski et al. 2015). We have 
observed increased insulin in serum 2 days upon CD, after 7 days there was no difference in 
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serum insulin level among diets. However we noticed upregulation of insulin-regulated genes 
in gene expression profiling upon CD in both time points. Taking into consideration data that 
peak of AP proliferation occurred on 3rd day of HFD (Jeffery et al. 2015) we could hypnotize 
that insulin could serve as an inhibitory factor for AP proliferation. This hypothesis has 
counter argument, since insulin level is increased during obesity. However it can play 
regulatory role just in short developmental window. We plan to address acute effect of insulin 
treatment on AP proliferation upon HFD. We observed decrease in ingWAT GFP+ colonies 
upon insulin treatment, but not in number of differentiated colonies. This data could indicate 
that insulin supported differentiation of committed APs from heterogenic progenitor pool, but 
not proliferation of immature progenitors. Additionally, since we have observed increased 
insulin already on days 2 of CD we planned to generate samples with time point 0 during 
switch from mother milk enriched in fat to high carbohydrate control diet. It would allow us to 
conclude about early dynamic of insulin. 
3.9 Contributions of lipids to AP proliferation 
It became clear form this project that dietary fat is able to promote proliferation of 
APs. However it is not clear through which systemic factor it can be communicated to 
adipose tissue niche. Since we know that initial burst of AP proliferation accrues 3 days after 
start of HFD feeding (Jeffery et al. 2015), we studied serum lipid dynamic in the random-fed 
state 2 and 7 days upon HFD. We observed no changes in triglycerides (TG) and non-
esterified fatty acid (NEFA) 2 days after diet. However cholesterol was increased 2 days after 
HFD, which could indicate potential signaling role of cholesterol. Further NEFA was lower 
upon HFD and isocaloric HFD (HFD-R) 7 days after diets. Since signaling molecules should 
have a quick turnover, we hypothesized that we may not able to detect some differences in 
random-fed state. To overcome this problem, we collected blood 3 hours after feeding, which 
corresponded to highest peak of nutrients in the blood. We found that NEFA and cholesterol 
were increased upon HFD-R 3 hours after feeding which indicated their potential signaling 
role in induction of AP proliferation. TG was higher upon HFD ad libitum and was not 
significantly altered 3 hours after feeding between groups.  
3.10 Gene expression patterns reveal a cascade of events leading to rapid tissue 
remodeling upon HFD 
 In order to identify which genes could play a role in AP expansion upon HFD, gene 
expression profile was performed using microarrays. From the 195 gene sets enriched upon 
HFD, there were 116 that function associated to tissue remodeling. When compared 2 and 7 
days of HFD, it was possible to observe dynamic change in enriched genes. After 2 days of 
HFD we observed pathways, which characterized early process in tissue remodeling. Among 
the pathways, there were some related to inflammation as leukocyte migration, innate 
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immune response, B-cell activation and cell-cell communication as receptor signaling protein 
activity. We detected evidences indicating hypoxic condition and following angiogenesis. 
Common pathways between 2 time points were related 1) to inflammation as immune and 
defense responses, lymphocyte and leukocyte activation; 2) to cytokine and chemokine 
regulation as cytokine production and chemokine activity; 3) to extracellular matrix 
remodeling as collagen and 4) development of new vessels. We found that after 7 days of 
HFD pathways which were involved in a regulation and progression of cell cycle were 
enriched. This data indicates that inflammation, cytokine receptor interaction, cell-cell 
communication and angiogenesis start early following by extracellular matrix remodeling and 
activation of proliferation.  
 Despite being restrictive to the amount of information that is possible to gather, 
microarrays allowed identifying almost 200 differentially expressed genes that could be 
subject to further characterization of their role in AP proliferation and differentiation. Using 
other detection methods, like NGS, would be interesting in order to identify other elements 
that could also play a role here, as miRNAs, differential splicing, among others. 
3.11 Co-culture system for studying AP functions 
In parallel to target identification we established a co-culture system with feeders, on 
top of which we seeded GFP+ APs in a single cell density that allowed us to validate function 
of identified target genes in an adipose tissue niche in a way which close to physiological. 
The most common way of AP in vitro studies is following: isolation of whole SVF or APs by 
specific markers from fat, seeding in monoculture that activates their proliferation. When 
monolayer is completed differentiation can be induce by specific inductors. This approach is 
not physiological because progenitor cells are not sitting close to each other inside adipose 
tissue and proliferate only in response of certain stimulus, which we would like to study. To 
solve this methodological problem we developed new approach of co-culture system of 
feeder cells and progenitor cell in the low density on top of them. Co-culture approach was 
successfully used in other stem cell systems before, as human embryonic stem cells 
(Peerani et al. 2007) or hematopoietic stem cells (Butler et al. 2012), (Raynaud et al. 2013). 
However, to our knowledge it was not developed for APs from adipose tissue. This system 
allowed us to follow individual cells and colonies developing from them and we found that 
already after 4 days in co-culture Sca-1+ APs formed colonies which further had a different 
fate as they differentiated to adipogenic or fibrogenic colonies. It was not possible to observe 
AP heterogeneity before using classical monoculture and co-culture gave as a significant 
adventure over it. Feeder cell layer provided niche-like environment partially mimicking cell-
cell interaction in the tissue in vivo. Thus, co-culture modulated cell behaver of APs and 
prevented AP senescence by slowing down proliferation rate of APs. Additionally this system 
allowed us easy to manipulate gene of interest in feeders by siRNA or overexpression 
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independently from APs and observe stroma-related phenotype. Our readouts were 
proliferation activity by measuring GFP+ cell number/colony size, differentiation capacity by 
ratio adipogenic vs. fibroblastic colonies. Using co-culture system we validated function of 
Emp1, which were deferentially expressed in profiling data. Co-culture system allows to 
measure functional property of APs beyond our target list, many biological questions can be 
addressed with this system, e.g. gender, depot or age- specific properties of APs. 
Additionally we planned to isolate APs from mice fed with different diets and asses 
proliferation/ differential property. 
3.12 Role of EMP1 in adipose tissue remodeling 
Epithelial Membrane Protein 1 (Emp1) is an integral multi-pass (tetra-span) membrane 
glycoprotein consisting of 160 amino acids, which is important in tight junction function, 
assembly and maintenance in lung epithelium (Durgan et al. 2015). EMP1 is expressed in 
micro vessels of the brain and involved in assembly of brain blood barrier tight junctions 
(Bangsow et al. 2008). However role of Emp1 was not described in context of adipose tissue 
growth, function or in vivo adipogenesis. We demonstrated that Emp1 was upregulated in 
gWAT within 2 and 7 days upon high-fat diet in young and adult female mice. Since it was 
reported that EMP1 has lower expression in tumor vs. normal surrounding tissues, e.g. on 
mRNA level in human lung cancer (Durgan et al. 2015), on protein level in human prostate, 
colorectal and breast cancer (G. G. Sun et al. 2014), (G.-G. Sun et al. 2014) and ovary tumor 
on mRNA and protein level (Demirag et al. 2016) we suspected role of EMP1 in cell 
proliferation. We found that in particular Emp1 was highly expressed in Sca-1+ APs, 
endothelial cells and mature adipocytes. Our hypothesis was that Emp1 modulates directly 
(in APs) or indirectly (through mature adipocytes) AP proliferation in WAT growth. To test it 
we modulated knockdown of Emp1 in feeders and seeded APs on top and after co-culturing 
we demonstrated that number of GFP+ cells/colonies was lower than on top of feeders 
transfected with negative control siRNA. To test direct effect of loss of Emp1 in APs, we 
generate knockdown in monoculture of APs and measured rate of cell divisions. No direct 
effect of Emp1 knockdown was observed on AP proliferation. These data indicated that 
Emp1 was playing role in cell-cell communication rather than directly affecting proliferation of 
APs. In order to explain observed decrease in number of GFP+ cells/colonies co-cultured on 
top of feeders with Emp1 knockdown, we hypothesized that it could be decreased 
proliferation, increased apoptosis or impaired adhesion of APs to feeders. Preliminary data 
suggested that Emp1 knockdown in feeders was not affecting proliferation and apoptosis of 
APs in co-culture (data were obtained by master student Wujun Hong supervised by me). In 
the next stet we would like to investigate the role of Emp1 in landing of APs on feeders. 
Since we found that Emp1 was upregulated upon HFD in mature adipocytes and Sca-1+ APs 
we intend to investigate effect of manipulation of Emp1 expression in model of  
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mature adipocytes and its effect on cell-cell contacts between mature adipocytes and APs. 
Another open question is which factors /signals/ligands could modulate expression of Emp1 
in mature adipocytes and is currently being addressed. 
3.13 Key findings at a glance  
Key findings at a glance  
Diets high in fat lead to rapid growth of adipose tissue: 
1. One week of high-fat diet leads to body and adipose tissue gain in sexually immature 
female mice, but not in adult mice. 
2. Adipose tissue gain after one week of high-fat diet occurs through hyperplasia of 
Sca1+ APs and partially via hypertrophy of mature adipocytes. 
3. Enrichment of dietary fat with isocaloric content (HFD-R), when compared control 
diet, does not lead to body weight gain, far mass gain or hypertrophy of mature 
adipocytes, but induces proliferation of Sca1+ APs. 
4. IGF-1 was regulated by calorie load, but not food content, and its levels were highly 
increased upon HFD ad libitum after 2 days of diet.  
5. NEFA was regulated by food content: decreased upon HFD-R after 7 days in and 
transiently increased 3 hours after feeding upon HFD-R. 
6. Cholesterol was transiently increased 3 hours after feeding upon HFD-R vs. CD. 
7. Mouse serum from different feeding groups had no difference in effect on proliferation 
of AP in ex vivo system. 
Molecular mechanisms of adipose tissue remodeling – novel gene search from tissue 
and cell subpopulations: 
8. Activation of gene network related to adipose tissue remodeling was already 
observed 2 days upon HFD. 
9. Fat content even in isocaloric diet (HFD-R) activates cell-cycle related pathways. 
10. Inflammation-related genes were activated in response to excess calories and were 
enriched upon HFD ad libitum vs. CD, but were not the presence in isocaloric diets 
comparison. 
11. 203 genes were differentially expressed upon high-fat feeding in adipose tissue in 
first gene expression profiling (selected by p value <0.05 and 1.5 fold-change. 
12. Age- and subpopulation-specific genes were found, potentially involved in adipose 
tissue remodeling. 
Functional characterization of genes responding to HFD using co-culture system in a 
niche-like setting: 
13. Co-culture system was successfully established. 
14. Adipocyte progenitor cells can form colonies and differentiate in co-culture into 
mature adipocytes without providing classical inductors of differentiation. 
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15. Microscopy screening settings/image data analysis algorithms were established and 
tested. 
16. Emp1 mediated knockdown in feeder cells decreased the number of GFP+ 
cells/colonies formed from APs in co-culture system.  
3.14 Conclusions and future perspectives 
In this project we established and characterized diet-induced model for investigating 
early adipose tissue growth during development of childhood obesity. We found molecular 
network connecting dietary stimulus and response of APs and investigated several genes 
using niche-like setting. 
We opened new questions as:  
1. What are the long-term consequences of AP proliferation on adipose tissue 
function and metabolic health? 
2. Nutritional sensing mechanisms, which cells and how can sense nutrients and 
respond to them. 
3. Which exact component of fat is able to promote AP proliferation? 
4. Age and sex-specific AP response on dietary challenges. 
5. In vitro and in vivo function of identified target genes. 
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4. MATERIALS and METHODS 
4.1 Animal work 
4.1.1 Mouse strains and housing 
For dietary experiments/APs isolations female C57BL/6NCrl mice were obtained from 
Charles River Laboratories (Sulzfeld, Germany). For initial co-culture experiments female 
C57BL/6-Tg (UBC-GFP) 30Scha/J and STOCK Tg (CAG-EGFP) D4Nagy/J mice were 
obtained from The Jackson Laboratory (USA). For all following co-culture experiment female 
C57BL/6-Tg(UBC-GFP) 30Scha/J mice were bred in Unit 6 of University of Heidelberg 
(Germany). Mice were housed in IVC cages on RT in a 12-hour dark and 12-hour dark/light 
condition. All handling and tissue dissection was performed in the light phase of the day 
cycle, if not state differently. 
4.1.2 Dietary regimes 
Diet induced obesity mouse model 
Two-week old pups were acclimatized with mothers on control diet (10% of fat) during 
the first week. After that, 3-week old pups were weaned and randomized equally based on 
their body weight between dietary groups as control diet (CD, 10% kcal from fat), high-fat diet 
(HFD, 60% kcal from fat), high-protein diet (HPD, 10% kcal from fat). Diets were applied for 
the time of experiment ad libitum if not mentioned other. To mimic consumption of sweet 
beverages sucrose/fructose syrup was provided for first 5 weeks in the low concentration = 
18.9/23.1 g/l to acclimatize mice to sweet drinks. Then concentration was increased up to 
94.5/115.5 g/l. Sucrose/fructose solution was filtered after preparation and bottles were 
changed 1-2 per week. 
 
Figure 4.1: Dietary compositions, % of calories from different macronutrient sources as protein, 
carbohydrates and fat. High-fat diet (HFD), control diet (CD) and high-protein diet (HPD). 
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Table 4.1: Diets used in this study. 
Diet Cat. # Distributor 
Control Diet irradiated D12450Bi Research Diets Inc, OpenSource Diets 
High Fat Diet irradiated D12492i Research Diets Inc, OpenSource Diets 
High Protein Diet  
(Special customized composition 
order for Dr. Adam Rose) 
D14032601 Research Diets Inc, OpenSource Diets 
 
Pair feeding approach for equal calorie load 
To equalize amount of consumed calories, control diet (CD) group served as a 
reference group. CD group mice were fed with CD and food was measured before and 24h 
after supplying. Then consumed calories were calculated every day and the same amount of 
calories was applied for high-fat diet restricted group (HFD-R). Since mice at 3 week age 
grow actively, food consumption was increasing every day in CD group. To take this in 
account measurement of food intake of reference CD group was done every 24 h till the end 
of experiment.  
Pair feeding with controlled circadian rhythm 
To measure peak of blood serum factors the scheme of pair feeding experiment was 
modified. CD reference group received food at the beginning of dark/active phase and food 
was taken away in 12 h at the beginning of light/rest phase. Consumed calories were 
calculated and provided for HFD-R group next day at the beginning of dark phase. For all 
groups food was applied at the beginning of dark phase and was removed and measured at 
the beginning of light phase. All mice were euthanized randomly between experimental 
groups 3-5 h after beginning of dark phase when food was just supplied. 
4.1.3 Body composition measurements (EchoMRI) 
Alterations in body composition were measured weekly by NMR quantitation (Echo 
MRI, Echo Medical Systems). The EchoMRI™-100H was calibrated by 32g oil sample. Body 
weight of mice was measured and fat mass, lean mass, free water, total water were 
determined accordingly to the body weight. 
4.1.4 Fasting blood glucose, glucose and insulin tolerance tests 
Fasted blood glucose was collected after overnight fasting (16 h). For that mice were 
transferred into new cages and only water was supplied, in 16 h tail vain blood glucose was 
measured by glucometer Accu-chek Aviva (Roche Diagnostic, Mannheim, Germany). 
Glucose and insulin tolerance tests were performed on overnight fasted mice (16 h and 5h, 
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respectively) with ip injection of glucose (Applichem, Germany) (2 mg/g of lean mass) or 
insulin (Humulin, 1 U/ kg lean mass, USA). Blood glucose from tail blood was measured prior 
to (0 min) and 10, 20, 30, 60 and 120 min after the injection using a glucometer Accu-chek 
Aviva (Roche Diagnostic, Mannheim Germany). 
4.1.5 Tissues dissection  
Mice were euthanized by cervical dislocation by FELASA B licensed investigators. 
Blood was collected from decapitated animal and stored on ice. The mouse peritoneal cavity 
(abdominal coelom) was opened. Abdominal WAT (gWAT) was dissected from area around 
uterus cutting along the uterine tubes. Liver was dissected without glad bladder. IngWAT was 
dissected from the dorsal side close to the lumbar sacrum, and isBAT from the intra scapular 
region. Triceps sureae bundle: gastrocnemius, soleus were dissected from the hind limb. 
Weights of tissues were determined, part was collected for histology and part was frozen in 
liquid nitrogen for RNA extraction. Blood serum was obtained by incubation of blood samples 
at RT for 30 min. and subsequent centrifugation for 30 min. at 5.000 rpm, 4°C. The serum 
(upper phase) was transferred to a new tube and stored at -80°C. 
4.1.6 Edu administration  
5-ethynyl-2-deoxyuridine (EdU, E10187, Thermo Fisher Scientific, Darmstadt, 
Germany) was administered in drinking water (for 1 week) in a final concentration 0.2 mg/ml. 
Water was supplied in the dark bottle and changed every 2 days. Control mice had their 
water supply without EdU (neg. control EdU).  
4.1.7 Histology 
Tissues were kept in histo-cassettes in 4% Histofix (Roth, Germany) at RT for 24 h in 
the fume hood. Histo-cassettes were rinsed with tap water for at least 2 h and transferred to 
70% ethanol and store at 4°C until embedding in paraffin blocks. Embedding of paraffin 
blocks, cutting of the slides and hematoxylin and eosin (H&E) staining were as follows: for 
dehydration Tissue Processing Center (Medite, Germany) was used, to embed samples 
embedding street (Modite) and tissue embedding medium (paraffin) (VO-5-101, Vogel histo-
comp) were used. After that paraffin blocks were cut using RM2245 microtome (Leica, 
Germany). For H&E staining: rehydration: xylene→100% EtOH →95% EtOH →70% EtOH→ 
water; hematoxylin (GHS332-1L, Sigma) for 5 min; water rinse; 0.4% HCl for 20 sec and then 
water rinse; eosin (HT110132-1L, Sigma, Germany) for 30-60 sec and water rinse for 1-2 
min; dehydration: 70% EtOH→95% EtOH→100% EtOH→ xylene; mounting with Eukitt® 
(03989-100ML, Sigma). 
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4.2 Cell biology 
4.2.1 Culture and differentiation of 3T3-L1 and C3H10T1/2 
3T3-L1 and C3H10T1/2 were obtained from ATCC (USA) and from A170 cell bank, 
respectively (Heidelberg, Germany). 3T3-L1 was cultured in DMEM low glucose 1g/l 
(31885049, Thermo Fisher Scientific) supplied with 10% Fetal Bovine Serum (FCS) 
(10270106, Thermo Fisher Scientific) and 1% Penicillin-Streptomycin (P/S) (15140122, 
Thermo Fisher Scientific). Cells were re-fed every 2-3 days and passaged before they reach 
80% confluency, normally 1:10 or 1:15 depending on experiment. To induce differentiation 
following protocol was used: 2 days of induction ->2 days of induction -> 4-6 days of 
maturation ->1 day of culturing media. Induction medium consisted of DMEM glucose 4.5g/l 
(41966052, Thermo Fisher Scientific), 10% FCS, 1% P/S and inductors of differentiation (1 
μg/ml Insulin (I2643-50mg, Sigma), 0.25 μM Dexamethasone (D8893-1MG, Sigma) and 0.5 
mM 3-Isobutyl-1-methylxanthin (IBMX) (I5879-1G, Sigma). Maturation medium consisted of 
DMEM glucose 4.5g/l, 10% FCS, 1% P/S supplied only with 1 μg/ml Insulin. C3H10T1/2 was 
cultured in DMEM glucose 4.5g/l, 10% FCS, and 1% P/S and differentiated similar to 3T3-L1, 
but to achieve differentiation 2μM of rosiglitazone was used during all course of 
differentiation. 
4.2.2 Magnetic isolation of Lin-Sca1+ adipocyte progenitor cells from adipose tissue 
gWAT and ingWAT were dissected, washed with 1x D-PBS stored on ice. Fat pads 
were minced until homogenous mass, transferred to15 ml tubes and digesting solution was 
applied following by warming up in water both on 37°C for 10 min. Than samples were gently 
shacked at 70rpm at 37°C for 20-40 min. Samples were meshed through 300µm nylon mesh 
and centrifuged at 145g at RT for 10 min. After separation into 3 phases: mature adipocyte 
layer were collected or/and removed as well as supernatant. The SVF cells pallet was 
washed with 12ml of BSA buffer (1xPBS, 0.5% BSA, 1mM EDTA). After spinning down at 
300g at RT for 5 min pallet was resuspended in appropriate amount of BSA buffer (0.5 ml of 
buffer for up to 10 4week old mice) and incubated with blocking reagent CD16/32 (2µl/100µl 
BSA-Buffer) on ice for 5-10 min. To deplete erythrocytes (Ter119+), endothelial cells 
(CD31+) and leucocytes (CD45+) - Ter119-, CD31-, CD45-biotin-coupled antibodies were 
applied (1µl of each antibody/100µl BSA-Buffer) to the suspension and were incubated on ice 
for 30 min. After centrifugation at 300g at 4°C for 5 min cell pallet was resuspended in 10 ml 
of pre-cooled BSA buffer and centrifuged again using the same settings. The SVF pellet was 
resuspended in 180µl BSA buffer and 20µl of streptavidin-coupled microbeads were added 
per one magnetic column and incubated on ice for 15 min. Depending on amount of adipose 
tissue/mice 1 or 2 columns were used per sample and accordingly all reagents were 
adjusted. Cell suspension was washed with 4ml of BSA buffer and centrifuged at 300g at 4°C 
89 
 
for 5 min. Cell pellet was resuspended in 1m of BSA buffer and applied on pre-separation 
filter inserted into magnetic column. Flow-through and 3 subsequent washing solutions going 
through column were collected and centrifuged at 300g at 4°C for 5 min. For Sca1-
enrichment cell pellet was resuspended in 80µl of BSA buffer and 20µl of Anti-Sca1-
Microbeads were added and incubated for on ice for 15 min. Cell suspension was washed 
with 4 ml of BSA buffer and centrifuged at 300g at 4°C for 10 min. Cell were resuspended in 
1 ml of BSA buffer, applied on pre-separation filter inserted into magnetic column and 
washed 3 times with 500µl BSA buffer. The columns were removed from the magnet field 
and cells were eluted by applying 1 ml of BSA buffer and pushing piston. After centrifugation 
cells were centrifuged at 300g at RT for 10 min and resuspended in culture medium. Cells 
were count and seeded accordingly to experimental need.  
4.2.3 Co-culture system 
Protocol is divided into 4 steps: 1) Feeder cell preparation; 2) APs seeding on top of 
feeder cells; 3) Co-culturing; 4) Fixing, staining, imaging, image data analysis. 
Step 1: Feeder cell preparation 
C3H10T1/2 or 3T3-L1 were used as a feeder layer in normal culturing. To prevent post 
confluence inhibition of cell division, cells were split at confluence not more than 80%.  
Day 1 C3H10T1/2 cells were seeded on 24- or 96-well plates (7000 cells/well for 24-well 
plate or 1500 cells/well for 96-well plate).  
Day 2: C3H10T1/2 reached 60-70% of confluency when were transfected with siRNA. See 
method section 4.2.4. 
Day 3: 24 h after transfection culturing media was changed with fresh normal culturing 
media. 
Day 4: Feeder cells formed complete monolayer. To privet father divisions, feeder cells we 
treated with 20µg/ml Mitomycin C in the normal culturing media for 2.5h at 37°C. Then, 
Mitomycin C solution was removed and cells were washed with normal culture medium 2 
times. After 2nd wash cells were incubated for 30 min. at 37°C and the medium was changed 
again for fresh one. To test efficiency of transfection some plats were harvested next day 
after Mitomycin C treatment. 
Step 2: Adipose progenitor cells seeding 
Day 5: To isolate Lin-Sca1+ adipocyte progenitor cells from fat pads see section 4.2.2. 
C57BL/6-Tg(UBC-GFP)30Scha/J mice were used to isolate GFP-labelled APs. To achieve 
low density 300 APs per well of 24-well plate were seeded in normal culturing medium. For 
96-well plate 50 APs per well were seeded. To induce APs growth bFGF were added in 
concentration 10ng/ml during first 2-4 days of co-culturing. 
Step 3: Co-culturing 
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Day 7: Media was gently aspirated after 2 days and normal culturing media supplied with 
100nM insulin was added. 
Day 9, 11, 13: Normal culturing media supplied with 100nM insulin was changed every 2 
days. GFP colonies can be detected in 4 days after seeding of APs. GFP colonies 
differentiated into adipocytes can be visualized in 7-10 days after seeding of APs. 
Step 4: Fixing, staining, imaging, image data analysis 
For fixation and LipidTox/DAPI staining see an additional protocol. 
4.2.4 siRNA transfection 
Lipofectamine RNAiMAX Transfection Reagent (Life Technologies, 13778075) and 
5nM or 20nM Silencer® Select siRNA (Applied Biosystems) were used as recommended by 
manufacture (usually 1 µl of RNAiMAX was diluted with 50 µl OptiMEM). Transfection was 
done when cells reached 60-70% confluence. Then after 24 h cells were washed and used 
24 or 48 h after transfection. 
4.2.5 FACS for cell populations study 
gWAT and ingWAT were dissected and processed with digestion as described above 
(section 4.2.2). Mature adipocyte fraction was collected. For erythrocyte depletion SVF cells 
were resuspended in 160 μl BSA buffer with 2% FCS plus 3.2ul FcBlock (CD16/32) (14-
0161-85, e bioscience, Germany) on ice for 5-10 min. This amount for pellet from 3-5 four- 
week old mice was increased accordingly with final concentration 2ul/100ul. Then 
40µl/column of Ter119-microbeads (130-049-901, Miltenyi Biotec, Cologne Germany) were 
added and incubated on ice for 15 min. Sample was washed with 4 ml of BSA buffer and 
centrifuged at 300g on 4 °C for 5 min. Cell pellet was resuspended in 1m of BSA buffer and 
applied on pre-separation filter inserted into magnetic column. Flow through was collected 
into 15 ml tubes. After flow through went completely magnetic column was washed 3 times 
with 500µl BSA buffer and washing solution was collected as well. Then cell number was 
determined for each sample. Cell suspension was centrifuged at 300g on 4 °C for 5 min and 
resuspended in antibody mix. Antibody staining: in order to make FACS gating single stained 
samples for all antibodies were prepared as unstained sample for initiating gating, CD45-
AF700 (56-0451-82 Mouse CD45 Alexa Fluor®700 (30-F11), eBioscience) (1:40), CD31-
APC (17-0311-82, Mouse CD31 APC (390), eBioscience) (1:40), CD34-eFluor450 (48-0341-
82, Mouse CD34 eFluor®450 (RAM34), eBioscience) (1:10) CD29-PE (12-0291-81, 
Mouse/Rat CD29 PE (eBioHMb1-1) (50 ug), eBioscience) (1:40), Sca1-APC-Cy7 (56-0451-
82, Mouse CD45 Alexa Fluor®700 (30-F11), eBioscience) (1:50). Additionally in case of 
EdU-labeling FMO for EdU staining was prepared. FACS gating system used is summarized 
in Figure 4.2. Further analysis was done using FlowJo software (FlowJo, LLC, USA). 
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Figure 4.2: FACS gaiting for cell populations study. Using this analysis we were able to 
discriminate: endothelial cells - CD31+ CD45-; immune cells - CD45+ CD31-, Lin-cells - CD45- CD31-; 
pluripotent cells - Lin-CD29+CD34+ cells; fibrotic cells - Lin-CD29+CD34 CD34
 low 
cells and adipose 
progenitors (APs) - Lin-CD29+CD34+Sca-1+ cells. Additionally in EdU-labeling experiments, we could 
distinguish EdU+ cells inside of subpopulation of interest, e.g. proliferating APs as Lin-
CD29+CD34+Sca-1+EdU+. Gaiting for EdU was done based on fluorescence minus one (FMO) 
control, stained with all other antibodies and without EdU. 
 
4.2.6 Immunofluorescence  
LipidTox/DAPI staining  
Cells were fixed with 4% paraformaldehyde (Fisher Scientific) for 10 min. and washed 
with 1xPBS. To discriminate lipid droplets samples were stained with HSC LipidTOXTM Red 
Neutral Lipid Stain (Life Technologies, Germany) 1:500 in PBS combined with 500ng/ml of 
4,6-diamidino-2-phenylindole (DAPI) to label the cell nuclei for 30 min at RT in the dark. 
EdU pulse and staining 
For cell culture experiments Click-iT® Plus EdU Alexa Fluor® 594 Imaging Kit 
(C10639, Thermo Fisher Scientific) was used accordingly to manufacturer. Cell were pulsed 
with 10 µM EdU for 3 hours (normally 20 µM solution was prepared and only half of the 
culturing media was changed to prevent induction of cell proliferation from fresh media). After 
that cells were fixed with 4% paraformaldehyde (Fischer Scientific) for 15 min. and washed 
with 3%BSA in 1xPBS following by Click-iT protocol. To label nuclei 500ng/ml of 4,6-
diamidino-2-phenylindole (DAPI) was used.  
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4.2.7 Microscopy 
Fluorescence microscopy was performed using a motorized Cell Observer.Z1 
microscope (Zeiss, Jena, Germany) equipped with the HXP 120 burner and with the 
AxioCam MRm CCD camera. The standard excitation/emission filters were used for 
visualizing DAPI (Zeiss filter 49), Alexa Fluor 488 (36HE), LipidTox (Zeiss 43 HE Cy3/DsRed 
filter).  
For high-throughput data acquisition in co-culture experiments an automated wide 
field screening microscope (Olympus Biosystems IX81 inverted, Germany) were used in 
ViroQuant-CellNetworks RNAi Screening Facility, Bioquant, University of Heidelberg. 
4.3 Molecular Biology 
4.3.1 Pulverization of the tissues for RNA isolation 
After dissection, tissues were frozen in liquid nitrogen and kept on -80°C. Tissue was 
transferred into pre-cooled in liquid nitrogen bucket with metal ball, placed in Mikro-
Dismembrator S (Sartorius) and pulverized using 2500 rpm for 30 sec. Then powder was 
transferred back to tube in liquid nitrogen and 1 ml of Qiazol (Qiagen, Hilden, Germany) was 
added to bucket with residual tissue powder. Bucket was placed again to dismembrator and 
shacked for half a minute till Qiazol became a liquid back. Lysates were kept on -80°C till 
RNA isolation, but not longer than 1 month. 
4.3.2 RNA isolation and quantification of nucleic acids 
RNA was isolated from cell/tissue Qiazol lysates using RNeasy Micro or Mini Kit 
(Qiagen), respectively. Incubation of RNA on column with RNase-Free DNase Set (Qiagen) 
for 15 min was added to manufacture protocol. To determine concentration of RNA 1.5 μl 
were applied on blanked with H2O NanoDrop ND-1000 Spectrophotometer (Thermo Fisher 
Scientific, Darmstadt, Germany) and absorbance was measured at 260 nm. To determine 
purity of RNA samples 2 ratios were assessed 260/280 and 260/230 = ~2.0.  
4.3.3 cDNA synthesis and Quantitative Real-Time PCR 
For cDNA synthesis QuantiTect Reverse Transcription Kit (Qiagen) was used 
according to manufacture protocol using 100-1000 ng of RNA as starting material. Briefly 
100-1000 ng of RNA diluted with RNase-free water were incubated with 2 μl of gDNA 
wipeout buffer for 2 min. at 42°C in Thermomixer comfort MTP (Eppendorf), placed on ice 
and then mix solution (containing 1 μl of Quantiscript Reverse Transcriptase, 4 μl of 
Quantiscript RT Buffer and 1 μl of RT Primer Mix per sample) were added to sample. 
Samples were placed into Peqstar 2x gradient thermocycler (VWR Peqlab) for 30 min. at 
42°C following by 3 min. at 95°C. To perform quantitative real time PCR (qPCR) samples 
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were diluted 1 to 10 and 5 μl of diluted cDNA was used. For qPCR the Taqman Gene 
Expression Master Mix (4369016, Applied Biosystems) and specific Gene Expression 
Assays (Applied Biosystems) were used in StepOnePlus Real-Time PCR System (Applied 
Biosystems). mRNA levels relative to TBP expression were calculated by the delta Ct 
method. 
4.3.4 Gene Expression Profiling 
RNA was isolated from gWAT or cell population and provided to Genomics and 
proteomics core facility (GPCF, DKFZ, Heidelberg) in concentration 50ng/µl not less than 
500ng. Quality of RNA was assessed by Bioanalyzer in GPCF. Affymetrix GeneChip® 
Mouse Gene 2.0 ST Arrays, 4-5 chips per diet group per one time point were used. 
4.4 Biochemistry 
4.4.1 Enzyme-linked Immunosorbent Assay  
Insulin 
Insulin concentration in the blood serum was determined by Insulin (Mouse) ELISA Kit (80-
INSMS-E01-AL, ALPCO) accordingly manufacture protocol. Briefly, serum samples were 
thawed on ice and 5µl of samples/standards/controls 2 replicates per sample were pipetted 
on microplate. Then 75µl Working Strength Conjugate was applied into each well. Plate were 
covered and shacked at 700 rpm on RT for 2h. Then plate was washed 6 times with Working 
Strength Washing Buffer following by applying of 100µl of TMB substrate into each well. 
Plate were covered and shacked at 700 rpm on RT for 15 min, 100 µl of stop solution were 
added. The absorbance was measured on microplate reader on 450 nm. Insulin 
concentration was determined using Elisa analysis web-resource 
(http://www.elisaanalysis.com/).  
IGF-1 
IGF-1 concentration in the blood serum was determined by Insulin-like Growth Factor 1 
(Mouse) AssayMax ELISA Kit (EMI1001-1, AssayPro, USA) accordingly manufacture 
protocol. Briefly, serum samples were thawed on ice and diluted in 1:250 with 1x MiX Diluent 
in replicates. Standards were diluted accordingly to protocol starting from 10- 0.156 ng/ml 
through serial dilutions. Then 50µl of samples/standards per well were added to microplate, 
covered and incubated at RT for 2h. Then plate was washed 6 times with Washing buffer 
and 50µl of Mouse IGF-1 biotinylated antibody was added per well following by 30 min 
incubation at RT. After washing 50µl Streptavidin-Peroxidase Conjugate per well were added 
and plate was incubated at RT for 30min. After washing 50µl of Chromogen Substrate per 
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well were added and plate was incubated at RT for 12 min following by addition of 50µl of 
Stop solution. The absorbance was measured on microplate reader on 450 nm. IGF-1 
concentration was determined using Elisa analysis web-resource 
(http://www.elisaanalysis.com/). 
4.4.2 Serum Metabolite Assays  
Triglycerides  
To determine glycerol, total triglycerides and true (free) triglycerides 2 µl of serum in 
duplicates and commercial kit (T2449, Sigma) were used accordingly to manufacture 
protocol. Absorbance was measured on 550 nm using the Mithras Microplate Reader 
(Berthold). 
Cholesterol  
To determine cholesterol 2 µl of diluted 1:1 in 1xPBS serum in duplicates and 
commercial kit (CH200, Randox) were used. Briefly 100 µl of cholesterol reagent was added 
to the sample in 96-well plate and incubated on 37°C for 5 min following by absorbance 
detection on 505nm using the Mithras Microplate Reader (Berthold). 
Non-esterified fatty acid (NEFA) 
To determine NEFAs 2 µl of serum in duplicates and commercial kit (434-91795, 436-
91995, Wako) were used accordingly to manufacture protocol. Absorbance was measured 
on 550 nm using the Mithras Microplate Reader (Berthold). 
Ketone Bodies  
To determine 2 µl of serum in duplicates and commercial kit (415-73301, Wako) were 
used accordingly to manufacture protocol. Absorbance was measured on 405 nm using the 
Mithras Microplate Reader (Berthold). 
4.5 Computational Biology 
4.5.1 Gene expression analysis: 
Data RMA-normalization, visualization and quality controls were done via Affymetrix® 
Expression Console™ Software. Statistical analysis was performed via Chipster. Linear 
modelling (Smyth et al. 2005) was used for identifying interaction/main effect p values for 2 
factors (type of diet and duration of diet) applying Benjamini and Hochberg's p value 
adjustment. To investigate enriched gene sets Gene set enrichment analysis (GSEA) 
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software from Broad Institute was used accordingly to available tutorial. Gene ontology (GO) 
gene set (Consortium 2000) was used for enrichment analysis. To prepare Venn diagrams 
Venny 2.1.0 – BioinfoGP was used http://bioinfogp.cnb.csic.es/tools/venny/index.html 
4.5.2 Image processing 
Adipocyte lipid droplet area  
Adipocyte lipid droplet area was estimated automatically with constant settings using 
an ImageJ macro (http://rsbweb.nih.gov/ij). Briefly, Adipocytes were segmented as shown on 
Fig. 4.3 and area was measured. Adipocyte diameter and volume were estimated based on 
area using following formulas:  
 
Number of adipocytes per gram of WAT was calculated as following: 1) convert the 
volume from μm3 to a volume in picolitres (pl) (1 pl = 1000 μm3). 2) calculate the mass of a 
cell, where mass = volume x density and the density of adipose tissue can be assumed to be 
0.96 g ml-1, mean cell mass = mean cell volume x 0.96. 3) calculate the number of cells per 
mg of tissue as number of cells per mg tissue = 1/mean cell mass, then to estimate absolute 
number of adipocytes per depot=number of adipocytes per gram x gram of tissue. 
 
Figure 4.3: Illustration of adipocyte lipid droplet area measurement. A) Image of gWAT histology 
B) Lipid droplet areas recognized by automated algorithm. 
EdU-labeled nuclei count 
Count of EdU-labeled nuclei and all nuclei (labeled with DAPI) was performed 
automatically with constant settings using an ImageJ macro (http://rsbweb.nih.gov/ij). Briefly, 
nuclei were segmented, counted in both channels and then ratio of EdU-labeled nuclei to all 
nuclei in the field was calculated.  
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Figure 4.4: Illustration of EdU/DAPI-labeled nuclei recognition by automatic algorithm. 
4.6 Statistical analysis  
To asses significance of results statistics software GraphPad Prism (GraphPad 
Software, USA) version 5.04 was used. For one factor comparison in case of two groups the 
Mann–Whitney U test, in case three and more groups - one-way Anova with Tukey’s post-
hoc test was applied. For 2 factor analysis two-way ANOVA with post-hoc test by Bonferroni 
method was used. Statistical tests mentioned in the legend of figures. 
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5. APPENDIX 
Appendix figures  
 
Appendix Figure 1: Long-term effects of high-fat diet and sucrose/fructose in early onset obesity. 
40 two-week old female C57BL/6NCrl mice were acclimatized on control diet (CD) for one week and then 
fed with 4 different diets: CD with water, high-fat diet with water (HFD, 60% of fat), CD with 
(sucrose/fructose) S/F and HFD with S/F. Diets were applied for 15 weeks. For the first 5 weeks, low 
concentration of S/F (18.9/23.1 g/l) was applied to acclimatize mice to sweet drinks and for the remaining 
10 weeks concentration was increased (94.5/115.5 g/l). A) Food intake in kcalories (kcal) calculated per 
mouse per 24 hours, data represented as mean ± SD from 2 cages per group. B) Cumulative food intake 
for 8 weeks, data represented as mean ± SD from 2 cages per group, two-way Anova with Bonferroni 
post-hoc test was used to assess significance, *, comparison between indicated groups, pV< 0.05, #, § 
comparison with CD, pV< 0.05. C) Weekly whole body lean mass (by EchoMRI) D) Glucose tolerance  
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test (GTT) was performed after overnight fasting for 16 hours. E) Insulin tolerance test (ITT) was 
performed after 5 hours fasting. C-E data represented as mean ± SEM. 
 
 
Appendix Figure 2: Long-term effects of high-fat diet and sucrose/fructose in early onset 
obesity. 40 two-week old female C57BL/6NCrl mice were acclimatized on control diet (CD) for one 
week and then fed with 4 different diets: CD with water, high-fat diet with water (HFD, 60% of fat), CD 
with (sucrose/fructose) S/F and HFD with S/F. Diets were applied for 15 weeks. For the first 5 weeks, 
low concentration of S/F (18.9/23.1 g/l) was applied to acclimatize mice to sweet drinks and for the 
remaining 10 weeks concentration was increased (94.5/115.5 g/l). A) Weight of ingunal WAT 
(IngWAT). B) Weight of interscapular brown adipose tissue (isBAT) C) Weight of liver D) Weight of 
gastrocnemius (Gc) muscles. A-D data represented as mean ± SEM, each dot represents individual 
mouse, line is mean of the group, two-way Anova with Bonferroni post-hoc test was used to assess 
significance, *, pV< 0.05, ns- no statistically significant difference. 
 
 
Appendix Figure 3: Body weight and WAT accumulation after two days of high-fat diet. 42 two-
week old female C57BL/6NCrl mice were acclimatized on control diet (CD) for one week and then fed 
with high-fat (HFD) or CD for one week. A) Body mass weight. B) Perigonadal WAT (gWAT) weight in 
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day 2. F) inguinal WAT (IngWAT) weight in day 2. For A-C each dot represents individual mouse, line is 
mean of the group, Mann-Whitney t- test was used to assess significance. 
 
 
Appendix Figure 4: Validation of selected from expression profiles genes by qPCR. Each dot 
represents individual mouse, line is mean of the group, significance between groups were tested by one-
100 
 
way Anova with Tukey’s post-hoc test, *, comparison with CD, pV< 0.05, #, comparison with indicated 
group, pV< 0.05, ns, no statistically significant difference. 
 
 
Appendix Figure 5: C3H10T1/2 and 3T3-L1 cell lines as different feeder systems. Upper panel - 
cells were treated with mitomycin C (MitC) to prevent overgrowth of culture, middle panel - cells were 
differentiated without rosiglitazone (Rosi) and bottom panel- cells were differentiated with Rosi, scale 
bar, 100 µm. 
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Appendix tables  
Appendix table 1: The list of enriched gene sets after 2 and 7 days of HFD (vs. CD) (gWAT). 
Name of gene set day 2 day 7 
31 gene sets included exclusively in "HFD day2": ES FDR ES FDR 
REGULATION OF T CELL ACTIVATION 0.7 0.0000 0.5 0.161 
LIPID RAFT 0.7 0.0030 0.3 0.694 
INTERLEUKIN RECEPTOR ACTIVITY 0.7 0.0072 0.5 0.127 
LEUKOCYTE MIGRATION 0.7 0.0088 0.5 0.289 
T CELL DIFFERENTIATION 0.7 0.0106 0.5 0.196 
VASCULATURE DEVELOPMENT 0.5 0.0131 0.4 0.138 
G PROTEIN COUPLED RECEPTOR BINDING 0.5 0.0141 0.4 0.138 
ANGIOGENESIS 0.5 0.0178 0.4 0.167 
REGULATION OF LYMPHOCYTE ACTIVATION 0.6 0.0202 0.5 0.128 
LYMPHOCYTE DIFFERENTIATION 0.6 0.0212 0.4 0.243 
POSITIVE REGULATION OF T CELL ACTIVATION 0.6 0.0225 0.5 0.151 
ANATOMICAL STRUCTURE FORMATION 0.5 0.0229 0.4 0.245 
POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION 0.6 0.0320 0.5 0.128 
INTERLEUKIN BINDING 0.6 0.0342 0.4 0.243 
CHEMOKINE ACTIVITY 0.5 0.0343 0.5 0.143 
T CELL PROLIFERATION 0.6 0.0392 0.5 0.128 
GOLGI MEMBRANE 0.5 0.0458 #N/A #N/A 
CELL SURFACE 0.4 0.0489 #N/A #N/A 
PHAGOCYTOSIS 0.6 0.0517 0.5 0.386 
REGULATION OF T CELL PROLIFERATION 0.6 0.0682 0.5 0.128 
N ACYLTRANSFERASE ACTIVITY 0.6 0.0768 #N/A #N/A 
CATION HOMEOSTASIS 0.4 0.0755 0.3 0.292 
N ACETYLTRANSFERASE ACTIVITY 0.6 0.0743 #N/A #N/A 
INFLAMMATORY RESPONSE 0.4 0.0752 0.3 0.294 
CYTOKINE AND CHEMOKINE MEDIATED SIGNALING 
PATHWAY 0.6 0.0771 0.5 0.233 
CELL MIGRATION 0.4 0.0819 0.3 0.246 
CELLULAR CATION HOMEOSTASIS 0.4 0.0795 0.3 0.296 
RECEPTOR SIGNALING PROTEIN ACTIVITY 0.4 0.0850 0.2 0.736 
ION HOMEOSTASIS 0.4 0.0881 0.3 0.243 
RESPONSE TO VIRUS 0.5 0.0944 0.4 0.401 
TRANSMEMBRANE RECEPTOR PROTEIN KINASE 
ACTIVITY 0.4 0.0961 0.4 0.150 
38 common gene sets in "HFD day 2" and "HFD day 7":         
HEMATOPOIETIN INTERFERON CLASSD200 DOMAIN 
CYTOKINE RECEPTOR ACTIVITY 0.7 0.0000 0.5 0.027 
T CELL ACTIVATION 0.6 0.0000 0.5 0.068 
CELLULAR DEFENSE RESPONSE 0.6 0.0000 0.6 0.002 
IMMUNE RESPONSE 0.5 0.0007 0.4 0.007 
DEFENSE RESPONSE 0.5 0.0013 0.4 0.030 
IMMUNE SYSTEM PROCESS 0.4 0.0016 0.4 0.007 
LYMPHOCYTE ACTIVATION 0.6 0.0015 0.5 0.059 
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LEUKOCYTE ACTIVATION 0.5 0.0029 0.4 0.061 
EXTRACELLULAR MATRIX STRUCTURAL 
CONSTITUENT 0.7 0.0027 0.6 0.007 
CYTOKINE METABOLIC PROCESS 0.6 0.0031 0.6 0.003 
LOCOMOTORY BEHAVIOR 0.5 0.0029 0.5 0.016 
POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC 
PROCESS 0.7 0.0029 0.7 0.003 
POSITIVE REGULATION OF IMMUNE SYSTEM 
PROCESS 0.6 0.0067 0.5 0.039 
CELL ACTIVATION 0.5 0.0069 0.4 0.060 
REGULATION OF IMMUNE SYSTEM PROCESS 0.5 0.0070 0.4 0.061 
CYTOKINE BIOSYNTHETIC PROCESS 0.6 0.0069 0.6 0.003 
REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 0.6 0.0086 0.5 0.017 
BEHAVIOR 0.4 0.0112 0.5 0.006 
POSITIVE REGULATION OF TRANSLATION 0.5 0.0222 0.6 0.003 
CYTOKINE BINDING 0.5 0.0253 0.5 0.059 
CHEMOKINE RECEPTOR BINDING 0.6 0.0248 0.5 0.096 
AUXILIARY TRANSPORT PROTEIN ACTIVITY 0.6 0.0255 0.6 0.040 
REGULATION OF IMMUNE RESPONSE 0.5 0.0350 0.6 0.009 
RESPONSE TO EXTERNAL STIMULUS 0.4 0.0383 0.3 0.066 
RESPONSE TO OTHER ORGANISM 0.5 0.0385 0.4 0.059 
IMMUNE EFFECTOR PROCESS 0.5 0.0393 0.5 0.033 
CYTOKINE PRODUCTION 0.4 0.0390 0.5 0.007 
POSITIVE REGULATION OF IMMUNE RESPONSE 0.5 0.0460 0.6 0.018 
POSITIVE REGULATION OF CELLULAR PROTEIN 
METABOLIC PROCESS 0.4 0.0684 0.4 0.063 
POSITIVE REGULATION OF PROTEIN METABOLIC 
PROCESS 0.4 0.0674 0.4 0.061 
RESPONSE TO WOUNDING 0.4 0.0828 0.4 0.083 
TRANSMEMBRANE RECEPTOR ACTIVITY 0.3 0.0808 0.4 0.008 
LEUKOCYTE DIFFERENTIATION 0.5 0.0865 0.5 0.061 
HEMOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT 0.4 0.0930 0.4 0.086 
POSITIVE REGULATION OF MULTICELLULAR 
ORGANISMAL PROCESS 0.4 0.0940 0.5 0.049 
ADAPTIVE IMMUNE RESPONSE GO 0002460 0.5 0.0973 0.7 0.008 
ADAPTIVE IMMUNE RESPONSE 0.5 0.0976 0.6 0.005 
AXON GUIDANCE 0.5 0.0974 0.6 0.021 
88 gene sets included exclusively in "HFD day 7":         
M PHASE OF MITOTIC CELL CYCLE 0.2 0.9904 0.7 0.000 
SPINDLE 0.3 0.7050 0.8 0.000 
MITOSIS 0.2 0.9787 0.7 0.000 
CHROMOSOMEPERICENTRIC REGION 0.3 0.8029 0.8 0.000 
M PHASE #N/A #N/A 0.6 0.000 
MITOTIC CELL CYCLE 0.1 1.0000 0.6 0.000 
KINETOCHORE 0.3 0.9530 0.7 0.000 
CHROMOSOME SEGREGATION 0.3 0.7281 0.7 0.000 
SPINDLE MICROTUBULE #N/A #N/A 0.8 0.001 
CELL CYCLE PROCESS #N/A #N/A 0.5 0.001 
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REGULATION OF MITOSIS 0.3 0.8087 0.6 0.001 
SISTER CHROMATID SEGREGATION 0.2 1.0000 0.8 0.002 
MITOTIC SISTER CHROMATID SEGREGATION 0.1 0.9999 0.8 0.002 
CELL CYCLE PHASE #N/A #N/A 0.5 0.002 
SPINDLE POLE 0.3 0.9772 0.7 0.002 
PROTEINACEOUS EXTRACELLULAR MATRIX 0.4 0.1008 0.5 0.003 
MOTOR ACTIVITY #N/A #N/A 0.6 0.003 
CHROMOSOMAL PART #N/A #N/A 0.5 0.004 
MICROTUBULE CYTOSKELETON 0.2 0.9564 0.5 0.004 
CELL DIVISION 0.3 0.6736 0.7 0.004 
COLLAGEN 0.5 0.1234 0.7 0.005 
CYTOKINESIS 0.3 0.8995 0.7 0.006 
MICROTUBULE MOTOR ACTIVITY 0.3 0.9802 0.7 0.008 
CHROMOSOME #N/A #N/A 0.5 0.007 
RHODOPSIN LIKE RECEPTOR ACTIVITY 0.3 0.4875 0.5 0.007 
CONDENSED CHROMOSOME 0.2 1.0000 0.6 0.007 
EXTRACELLULAR MATRIX 0.4 0.1310 0.5 0.008 
G PROTEIN COUPLED RECEPTOR ACTIVITY 0.3 0.2623 0.4 0.015 
ESTABLISHMENT OF ORGANELLE LOCALIZATION 0.5 0.1534 0.7 0.016 
MICROTUBULE #N/A #N/A 0.6 0.017 
EXTRACELLULAR MATRIX PART 0.3 0.3107 0.5 0.017 
CELL CYCLE GO 0007049 #N/A #N/A 0.4 0.018 
PEPTIDE RECEPTOR ACTIVITY #N/A #N/A 0.5 0.017 
DNA PACKAGING #N/A #N/A 0.5 0.020 
CENTROSOME 0.2 1.0000 0.5 0.020 
MICROTUBULE BASED PROCESS 0.2 0.9877 0.5 0.022 
PROTEOGLYCAN METABOLIC PROCESS 0.4 0.4838 0.6 0.024 
NEUROPEPTIDE BINDING 0.4 0.5497 0.6 0.025 
MICROTUBULE CYTOSKELETON ORGANIZATION AND 
BIOGENESIS #N/A #N/A 0.5 0.025 
WOUND HEALING 0.4 0.2157 0.5 0.026 
CARBOHYDRATE BINDING 0.4 0.2337 0.5 0.027 
BRAIN DEVELOPMENT 0.4 0.2588 0.5 0.027 
PATTERN BINDING 0.4 0.1751 0.5 0.030 
HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL 
COMPOUNDS 0.4 0.1771 0.6 0.032 
BLOOD COAGULATION 0.4 0.3587 0.5 0.039 
INTEGRIN BINDING 0.4 0.4167 0.5 0.040 
NEUROPEPTIDE RECEPTOR ACTIVITY 0.3 0.6850 0.6 0.043 
G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING 
PATHWAY 0.3 0.1404 0.4 0.043 
MITOTIC CELL CYCLE CHECKPOINT #N/A #N/A 0.6 0.043 
PROTEIN HOMODIMERIZATION ACTIVITY 0.3 0.2580 0.4 0.048 
CYTOSKELETAL PART #N/A #N/A 0.4 0.048 
DEFENSE RESPONSE TO BACTERIUM 0.5 0.1272 0.6 0.049 
PEPTIDE BINDING 0.2 0.7887 0.4 0.052 
COAGULATION 0.3 0.3531 0.5 0.052 
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REGULATION OF BODY FLUID LEVELS 0.2 0.7892 0.5 0.057 
G PROTEIN SIGNALING COUPLED TO CAMP 
NUCLEOTIDE SECOND MESSENGER 0.4 0.2547 0.4 0.059 
PROTEASE INHIBITOR ACTIVITY 0.4 0.1342 0.5 0.059 
POSITIVE REGULATION OF CELL PROLIFERATION 0.3 0.2736 0.4 0.059 
REGULATION OF RESPONSE TO STIMULUS 0.4 0.2635 0.4 0.059 
EXTRACELLULAR REGION 0.3 0.1503 0.3 0.063 
MICROTUBULE ORGANIZING CENTER #N/A #N/A 0.4 0.063 
REGULATION OF BLOOD PRESSURE 0.4 0.5309 0.6 0.063 
HEMOSTASIS 0.3 0.5299 0.5 0.062 
EXTRACELLULAR REGION PART 0.3 0.2619 0.3 0.063 
AMINE RECEPTOR ACTIVITY 0.2 1.0000 0.5 0.063 
REGULATION OF PROTEIN SECRETION 0.3 0.7478 0.6 0.063 
CHROMOSOME ORGANIZATION AND BIOGENESIS 0.2 0.9246 0.4 0.064 
CHROMATIN BINDING #N/A #N/A 0.5 0.067 
CELL PROLIFERATION GO 0008283 0.2 0.3858 0.3 0.068 
G PROTEIN SIGNALING ADENYLATE CYCLASE 
ACTIVATING PATHWAY 0.4 0.3232 0.5 0.068 
IMMUNE SYSTEM DEVELOPMENT 0.4 0.1006 0.4 0.070 
FATTY ACID OXIDATION 0.3 0.7183 0.6 0.070 
ORGANELLE LOCALIZATION 0.4 0.2907 0.5 0.070 
POLYSACCHARIDE BINDING 0.4 0.3227 0.5 0.076 
HORMONE ACTIVITY 0.4 0.1579 0.5 0.079 
REGULATION OF CELL PROLIFERATION 0.3 0.3982 0.3 0.079 
RECEPTOR BINDING 0.3 0.1952 0.3 0.079 
RESPONSE TO BACTERIUM 0.4 0.1948 0.5 0.082 
POSITIVE REGULATION OF RESPONSE TO STIMULUS 0.4 0.1371 0.5 0.092 
CAMP MEDIATED SIGNALING 0.3 0.3583 0.4 0.095 
SENSORY PERCEPTION OF CHEMICAL STIMULUS 0.3 0.8191 0.6 0.095 
NEGATIVE REGULATION OF CATALYTIC ACTIVITY 0.3 0.3691 0.4 0.096 
PROTEIN DIMERIZATION ACTIVITY 0.3 0.3571 0.3 0.099 
JAK STAT CASCADE 0.4 0.3564 0.5 0.099 
CELL RECOGNITION 0.4 0.6019 0.5 0.099 
GLYCOSAMINOGLYCAN BINDING 0.4 0.2218 0.5 0.100 
ADENYLATE CYCLASE ACTIVATION 0.5 0.2858 0.5 0.099 
SECOND MESSENGER MEDIATED SIGNALING 0.3 0.1999 0.4 0.099 
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Appendix table 2: The list of enriched gene sets after 2 and 7 days of CD (vs. HFD) (gWAT). 
Name of gene set Day 2 Day 7 
28 gene sets included exclusively in "day2": ES FDR ES FDR 
CONTRACTILE FIBER PART -0.8 0.0000 -0.3 0.9157 
CONTRACTILE FIBER -0.8 0.0000 -0.3 0.9414 
STRUCTURAL CONSTITUENT OF MUSCLE -0.7 0.0000 #N/A #N/A 
MYOFIBRIL -0.8 0.0002 -0.2 0.9961 
NUCLEOTIDE METABOLIC PROCESS -0.6 0.0018 -0.5 0.1697 
NUCLEOBASENUCLEOSIDE AND NUCLEOTIDE 
METABOLIC PROCESS -0.6 0.0100 -0.4 0.3225 
PROTEIN AMINO ACID O LINKED GLYCOSYLATION -0.7 0.0181 -0.6 0.1217 
CARBOHYDRATE METABOLIC PROCESS -0.4 0.0327 -0.4 0.1125 
AEROBIC RESPIRATION -0.7 0.0324 -0.6 0.1043 
CARBOHYDRATE CATABOLIC PROCESS -0.6 0.0340 -0.3 0.6722 
CELLULAR CARBOHYDRATE CATABOLIC PROCESS -0.6 0.0430 -0.4 0.6659 
VOLTAGE GATED CALCIUM CHANNEL ACTIVITY -0.6 0.0502 -0.3 0.8825 
VOLTAGE GATED CALCIUM CHANNEL COMPLEX -0.7 0.0528 -0.4 0.6916 
PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE 
GROUP AS ACCEPTOR -0.6 0.0535 -0.6 0.1193 
RESPONSE TO ORGANIC SUBSTANCE -0.6 0.0559 -0.5 0.1378 
REGULATION OF HEART CONTRACTION -0.6 0.0560 #N/A #N/A 
REGULATION OF CATABOLIC PROCESS -0.6 0.0652 #N/A #N/A 
GENERATION OF PRECURSOR METABOLITES AND 
ENERGY -0.4 0.0704 -0.4 0.1625 
MYOSIN COMPLEX -0.6 0.0707 -0.4 0.7789 
OXIDOREDUCTASE ACTIVITY GO 0016616 -0.5 0.0704 -0.4 0.1204 
CELLULAR CATABOLIC PROCESS -0.4 0.0703 -0.4 0.1008 
CELLULAR POLYSACCHARIDE METABOLIC PROCESS -0.6 0.0705 -0.5 0.4540 
CELLULAR CARBOHYDRATE METABOLIC PROCESS -0.4 0.0704 -0.3 0.2442 
RIBOSOME -0.5 0.0704 -0.5 0.1529 
CARBOHYDRATE KINASE ACTIVITY -0.6 0.0744 -0.5 0.2686 
THIOLESTER HYDROLASE ACTIVITY -0.6 0.0764 -0.3 0.8844 
RESPONSE TO TEMPERATURE STIMULUS -0.6 0.0758 -0.6 0.1112 
CATABOLIC PROCESS -0.4 0.0765 -0.4 0.1316 
40 common gene sets in "day2" and "day7":         
MITOCHONDRION -0.6 0.0000 -0.5 0.0000 
MITOCHONDRIAL PART -0.6 0.0000 -0.6 0.0000 
MITOCHONDRIAL INNER MEMBRANE -0.7 0.0000 -0.6 0.0000 
ORGANELLE INNER MEMBRANE -0.7 0.0000 -0.6 0.0003 
MITOCHONDRIAL ENVELOPE -0.6 0.0000 -0.6 0.0002 
COENZYME METABOLIC PROCESS -0.7 0.0000 -0.7 0.0009 
COFACTOR METABOLIC PROCESS -0.7 0.0000 -0.6 0.0003 
MITOCHONDRIAL MEMBRANE -0.6 0.0000 -0.6 0.0002 
MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX I -0.9 0.0000 -0.7 0.0035 
RESPIRATORY CHAIN COMPLEX I -0.9 0.0000 -0.7 0.0061 
NADH DEHYDROGENASE COMPLEX -0.9 0.0000 -0.7 0.0038 
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OXIDOREDUCTASE ACTIVITY ACTING ON NADH OR 
NADPH -0.8 0.0000 -0.6 0.0900 
MITOCHONDRIAL MATRIX -0.7 0.0000 -0.6 0.0004 
MITOCHONDRIAL LUMEN -0.7 0.0000 -0.6 0.0004 
COFACTOR BIOSYNTHETIC PROCESS -0.8 0.0000 -0.7 0.0024 
MITOCHONDRIAL RESPIRATORY CHAIN -0.8 0.0000 -0.7 0.0004 
ORGANELLAR RIBOSOME -0.8 0.0004 -0.7 0.0012 
MITOCHONDRIAL RIBOSOME -0.8 0.0005 -0.7 0.0008 
ORGANELLE ENVELOPE -0.5 0.0006 -0.5 0.0062 
MITOCHONDRIAL MEMBRANE PART -0.6 0.0005 -0.6 0.0021 
ENVELOPE -0.5 0.0006 -0.5 0.0088 
RIBOSOMAL SUBUNIT -0.8 0.0009 -0.8 0.0017 
OXIDOREDUCTASE ACTIVITY -0.5 0.0014 -0.4 0.0035 
ENERGY DERIVATION BY OXIDATION OF ORGANIC 
COMPOUNDS -0.6 0.0014 -0.5 0.0949 
PROTEASOME COMPLEX -0.7 0.0019 -0.8 0.0002 
CARBOHYDRATE TRANSMEMBRANE TRANSPORTER 
ACTIVITY -0.7 0.0024 -0.7 0.0116 
OXIDOREDUCTASE ACTIVITY ACTING ON CH OH 
GROUP OF DONORS -0.5 0.0058 -0.5 0.0621 
CARBOHYDRATE TRANSPORT -0.7 0.0067 -0.7 0.0103 
STRUCTURAL CONSTITUENT OF RIBOSOME -0.5 0.0069 -0.6 0.0020 
CELLULAR RESPIRATION -0.7 0.0071 -0.6 0.0367 
LIPID BIOSYNTHETIC PROCESS -0.5 0.0070 -0.5 0.0011 
HYDROGEN ION TRANSMEMBRANE TRANSPORTER 
ACTIVITY -0.6 0.0103 -0.6 0.0646 
STEROID BIOSYNTHETIC PROCESS -0.6 0.0226 -0.7 0.0119 
ALCOHOL METABOLIC PROCESS -0.5 0.0250 -0.5 0.0560 
GLUCOSE METABOLIC PROCESS -0.6 0.0392 -0.5 0.0821 
ELECTRON CARRIER ACTIVITY -0.5 0.0399 -0.5 0.0212 
RESPONSE TO OXIDATIVE STRESS -0.5 0.0501 -0.6 0.0034 
RNA POLYMERASE ACTIVITY -0.6 0.0651 -0.7 0.0235 
LIPID METABOLIC PROCESS -0.4 0.0692 -0.4 0.0293 
ORGANELLE MEMBRANE -0.4 0.0713 -0.4 0.0412 
29 gene sets included exclusively in "day7":         
PHOSPHATASE REGULATOR ACTIVITY -0.5 0.2739 -0.7 0.0074 
NUCLEOTIDYLTRANSFERASE ACTIVITY -0.5 0.1495 -0.5 0.0115 
PEROXISOME ORGANIZATION AND BIOGENESIS -0.5 0.2233 -0.7 0.0293 
TRANSLATION FACTOR ACTIVITY NUCLEIC ACID 
BINDING -0.3 0.7380 -0.5 0.0300 
TRANSLATION REGULATOR ACTIVITY -0.3 0.8007 -0.5 0.0359 
SECONDARY METABOLIC PROCESS -0.4 0.4168 -0.6 0.0478 
OXIDOREDUCTASE ACTIVITY ACTING ON THE 
ALDEHYDE OR OXO GROUP OF DONORS -0.5 0.1635 -0.6 0.0484 
TRANSLATIONAL INITIATION -0.2 0.9972 -0.5 0.0499 
TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR 
ARYLOTHER THAN METHYLGROUPS -0.5 0.2876 -0.6 0.0549 
CELLULAR PROTEIN COMPLEX ASSEMBLY -0.5 0.1386 -0.6 0.0588 
OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH 
GROUP OF DONORS -0.5 0.2733 -0.6 0.0590 
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PROTEIN N TERMINUS BINDING -0.3 0.8801 -0.5 0.0618 
LIGASE ACTIVITY -0.4 0.2869 -0.4 0.0686 
VITAMIN METABOLIC PROCESS -0.5 0.2308 -0.6 0.0750 
BIOSYNTHETIC PROCESS -0.3 0.1962 -0.4 0.0752 
NITROGEN COMPOUND CATABOLIC PROCESS -0.5 0.1898 -0.6 0.0762 
TRNA METABOLIC PROCESS -0.4 0.6818 -0.6 0.0763 
PHOSPHOLIPID BIOSYNTHETIC PROCESS -0.4 0.4141 -0.5 0.0766 
MONOVALENT INORGANIC CATION TRANSMEMBRANE 
TRANSPORTER ACTIVITY -0.5 0.1335 -0.5 0.0941 
RNA POLYMERASE COMPLEX -0.3 0.9945 -0.6 0.0941 
CELLULAR BIOSYNTHETIC PROCESS -0.3 0.2632 -0.4 0.0945 
PHOSPHOLIPID METABOLIC PROCESS -0.4 0.3275 -0.4 0.0954 
PEROXISOME -0.4 0.4598 -0.5 0.0955 
GOLGI VESICLE TRANSPORT -0.2 1.0000 -0.5 0.0957 
NUCLEAR DNA DIRECTED RNA POLYMERASE 
COMPLEX -0.3 0.9894 -0.6 0.0962 
MICROBODY -0.4 0.4254 -0.5 0.0965 
INTRACELLULAR TRANSPORT -0.3 0.6275 -0.4 0.0969 
TRANSLATION INITIATION FACTOR ACTIVITY -0.3 0.9774 -0.5 0.0978 
ER TO GOLGI VESICLE MEDIATED TRANSPORT -0.4 0.8114 -0.6 0.0994 
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Appendix table 3: The list of enriched gene sets after 7 days of HFD vs. CD and HPD (gWAT). 
Name of gene set HFD vs. CD HFD vs. HPD 
32 gene sets included exclusively in "HFD vs. CD": ES FDR ES FDR 
KINESIN COMPLEX 0.8 0.0013 0.6 0.1756 
BRAIN DEVELOPMENT 0.5 0.0074 0.3 0.5564 
CYTOSKELETON ORGANIZATION AND BIOGENESIS 0.4 0.0084 0.4 0.2090 
ACTIN CYTOSKELETON ORGANIZATION AND 
BIOGENESIS 0.5 0.0085 0.3 0.3341 
CARBOHYDRATE BINDING 0.5 0.0171 0.5 0.1272 
ACTIN POLYMERIZATION AND OR 
DEPOLYMERIZATION 0.7 0.0186 0.3 0.7999 
CYTOSKELETON 0.4 0.0277 0.4 0.1527 
POSITIVE REGULATION OF CELL CYCLE 0.7 0.0319 0.5 0.3561 
POSITIVE REGULATION OF IMMUNE RESPONSE 0.6 0.0325 0.5 0.1621 
PHOSPHOLIPASE C ACTIVATION 0.7 0.0327 0.7 0.1017 
TISSUE DEVELOPMENT 0.4 0.0327 0.3 0.3786 
LEADING EDGE 0.5 0.0370 0.5 0.1834 
POSITIVE REGULATION OF IMMUNE SYSTEM 
PROCESS 0.5 0.0371 0.4 0.2539 
ACTIN FILAMENT BASED PROCESS 0.4 0.0416 0.3 0.3608 
MESODERM DEVELOPMENT 0.6 0.0444 0.5 0.3905 
MICROTUBULE BASED PROCESS 0.5 0.0544 0.4 0.1782 
CELL PROJECTION BIOGENESIS 0.6 0.0546 0.5 0.2203 
CELL MIGRATION 0.4 0.0561 0.3 0.4381 
CHROMOSOME ORGANIZATION AND BIOGENESIS 0.4 0.0590 0.4 0.2072 
SUGAR BINDING 0.6 0.0594 0.5 0.1028 
PROTEIN HETERODIMERIZATION ACTIVITY 0.5 0.0646 0.3 0.4966 
PHOSPHOLIPASE C ACTIVITY 0.6 0.0672 0.3 0.8952 
SULFURIC ESTER HYDROLASE ACTIVITY 0.7 0.0768 0.7 0.1435 
COLLAGEN BINDING 0.7 0.0796 0.6 0.2169 
PROTEIN DIMERIZATION ACTIVITY 0.4 0.0888 0.3 0.4386 
ENDOPLASMIC RETICULUM LUMEN 0.7 0.0893 0.6 0.3592 
REGULATION OF IMMUNE RESPONSE 0.5 0.0914 0.4 0.3253 
RUFFLE 0.5 0.0919 0.4 0.3295 
BASOLATERAL PLASMA MEMBRANE 0.5 0.0922 0.4 0.2983 
POSITIVE REGULATION OF MULTICELLULAR 
ORGANISMAL PROCESS 0.5 0.0931 0.4 0.2362 
ACTIN FILAMENT POLYMERIZATION 0.7 0.0932 0.5 0.6057 
LAMELLIPODIUM 0.6 0.0954 0.5 0.2046 
38 common gene sets in "HFD vs. CD" and "HFD vs. 
HPD":         
SPINDLE 0.8 0 0.8 0.0000 
MITOSIS 0.7 0 0.7 0.0000 
M PHASE OF MITOTIC CELL CYCLE 0.7 0 0.7 0.0000 
M PHASE 0.6 0 0.6 0.0000 
MITOTIC CELL CYCLE 0.6 0 0.6 0.0000 
CELL CYCLE PROCESS 0.5 0 0.5 0.0000 
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MICROTUBULE CYTOSKELETON 0.5 0 0.5 0.0008 
CHROMOSOMEPERICENTRIC REGION 0.7 0 0.8 0.0000 
CELL CYCLE PHASE 0.5 0 0.5 0.0001 
CHROMOSOME SEGREGATION 0.7 0.00011 0.7 0.0001 
SPINDLE MICROTUBULE 0.8 0.00032 0.8 0.0014 
DNA PACKAGING 0.7 0.00062 0.6 0.0034 
REGULATION OF MITOSIS 0.6 0.00068 0.7 0.0001 
CHROMOSOME 0.5 0.00115 0.6 0.0001 
CELL CYCLE GO 0007049 0.5 0.00122 0.5 0.0022 
SISTER CHROMATID SEGREGATION 0.8 0.00135 0.8 0.0010 
SPINDLE ORGANIZATION AND BIOGENESIS 0.8 0.00174 0.8 0.0302 
MICROTUBULE MOTOR ACTIVITY 0.8 0.00176 0.7 0.0062 
CELLULAR DEFENSE RESPONSE 0.6 0.00177 0.6 0.0248 
SPINDLE POLE 0.7 0.00185 0.8 0.0017 
CHROMOSOMAL PART 0.5 0.00188 0.6 0.0001 
MICROTUBULE CYTOSKELETON ORGANIZATION 
AND BIOGENESIS 0.6 0.00208 0.6 0.0470 
MITOTIC SISTER CHROMATID SEGREGATION 0.8 0.00209 0.8 0.0009 
CYTOSKELETAL PART 0.5 0.00219 0.4 0.0219 
CONDENSED CHROMOSOME 0.6 0.00259 0.7 0.0013 
KINETOCHORE 0.7 0.0046 0.7 0.0009 
MICROTUBULE ORGANIZING CENTER 0.5 0.00476 0.5 0.0387 
MOTOR ACTIVITY 0.6 0.0048 0.6 0.0201 
CHROMOSOME CONDENSATION 0.8 0.00481 0.9 0.0021 
CENTROSOME 0.5 0.00507 0.5 0.0233 
CELL CYCLE CHECKPOINT GO 0000075 0.6 0.01118 0.6 0.0017 
ESTABLISHMENT OF ORGANELLE LOCALIZATION 0.7 0.01128 0.6 0.0598 
MICROTUBULE 0.6 0.01331 0.6 0.0032 
MITOTIC CELL CYCLE CHECKPOINT 0.6 0.03233 0.7 0.0180 
IMMUNE SYSTEM PROCESS 0.4 0.03302 0.4 0.0347 
IMMUNE RESPONSE 0.4 0.03639 0.4 0.0478 
CELL DIVISION 0.6 0.03949 0.6 0.0466 
CYTOKINESIS 0.6 0.05571 0.7 0.0213 
17 gene sets included exclusively in "HFD vs. HPD":         
HYDROLASE ACTIVITY HYDROLYZING O 
GLYCOSYL COMPOUNDS 0.5 0.12331 0.6 0.0073 
EXTRACELLULAR MATRIX 0.4 0.15901 0.5 0.0184 
PROTEINACEOUS EXTRACELLULAR MATRIX 0.4 0.10742 0.5 0.0198 
HEMATOPOIETIN INTERFERON CLASSD200 
DOMAIN CYTOKINE RECEPTOR ACTIVITY 0.5 0.17973 0.6 0.0204 
EXTRACELLULAR MATRIX STRUCTURAL 
CONSTITUENT 0.5 0.15472 0.6 0.0207 
HYDROLASE ACTIVITY ACTING ON GLYCOSYL 
BONDS 0.4 0.46074 0.6 0.0270 
PROTEASE INHIBITOR ACTIVITY 0.5 0.23144 0.6 0.0339 
DEFENSE RESPONSE 0.3 0.19153 0.4 0.0522 
COLLAGEN 0.5 0.17333 0.6 0.0675 
CELL SUBSTRATE ADHESION 0.5 0.1959 0.5 0.0678 
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DNA INTEGRITY CHECKPOINT 0.5 0.19197 0.6 0.0699 
POSITIVE REGULATION OF CYTOKINE 
BIOSYNTHETIC PROCESS 0.5 0.26635 0.6 0.0705 
INTEGRIN BINDING 0.5 0.15876 0.6 0.0786 
INTERLEUKIN RECEPTOR ACTIVITY 0.5 0.23326 0.6 0.0817 
REGULATION OF CELL CYCLE 0.4 0.12463 0.4 0.0850 
INTERFERON GAMMA PRODUCTION 0.5 0.31058 0.7 0.0976 
INTERFERON GAMMA BIOSYNTHETIC PROCESS 0.5 0.33754 0.7 0.0985 
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Appendix table 4: The list of enriched gene sets after 7 days of HFD-R vs. CD and HPD (gWAT). 
Name of gene set HFD-R vs. CD HFD-R vs. HPD 
18 gene sets included exclusively in "HFD R vs. 
CD": ES FDR ES FDR 
BRAIN DEVELOPMENT 0.6 0.0012 0.5 0.1687 
AXON GUIDANCE 0.7 0.0051 0.5 0.2154 
REGULATION OF MUSCLE CONTRACTION 0.7 0.0068 0.6 0.1875 
CELL MATRIX JUNCTION 0.7 0.0128 0.6 0.1575 
MORPHOGENESIS OF AN EPITHELIUM 0.7 0.0188 0.4 0.6587 
BASOLATERAL PLASMA MEMBRANE 0.6 0.0307 0.5 0.2806 
HEMATOPOIETIN INTERFERON CLASSD200 
DOMAIN CYTOKINE RECEPTOR BINDING 0.7 0.0313 
#N/
A #N/A 
CYTOSKELETON ORGANIZATION AND 
BIOGENESIS 0.4 0.0498 0.3 0.2904 
CELL SUBSTRATE ADHERENS JUNCTION 0.6 0.0504 0.6 0.2143 
MICROTUBULE BASED PROCESS 0.5 0.0588 0.4 0.2806 
SOLUTE SODIUM SYMPORTER ACTIVITY 0.7 0.0596 0.5 0.6263 
NUCLEAR UBIQUITIN LIGASE COMPLEX 0.7 0.0673 0.5 0.4757 
PROTEIN HOMODIMERIZATION ACTIVITY 0.4 0.0711 0.4 0.2049 
MYELOID CELL DIFFERENTIATION 0.5 0.0718 0.5 0.2000 
SMOOTH MUSCLE CONTRACTION GO 0006939 0.7 0.0743 0.5 0.4720 
CYTOSKELETAL PROTEIN BINDING 0.4 0.0833 0.3 0.3277 
ENDOTHELIAL CELL PROLIFERATION 0.7 0.0837 0.5 0.4882 
MYOBLAST DIFFERENTIATION 0.6 0.0849 0.5 0.3099 
44 common gene sets in "HFD R vs. CD" and "HFD R vs. 
HPD":       
SPINDLE 0.8 0.0000 0.8 0.0000 
M PHASE 0.6 0.0000 0.6 0.0000 
MITOSIS 0.6 0.0000 0.7 0.0000 
M PHASE OF MITOTIC CELL CYCLE 0.6 0.0000 0.7 0.0000 
MITOTIC CELL CYCLE 0.6 0.0000 0.6 0.0000 
CHROMOSOMEPERICENTRIC REGION 0.8 0.0000 0.8 0.0000 
CELL CYCLE PROCESS 0.5 0.0000 0.6 0.0000 
CONTRACTILE FIBER 0.8 0.0000 0.6 0.0139 
CHROMOSOME SEGREGATION 0.7 0.0000 0.8 0.0000 
STRUCTURAL CONSTITUENT OF MUSCLE 0.7 0.0000 0.7 0.0011 
CELL CYCLE PHASE 0.5 0.0000 0.5 0.0001 
SPINDLE MICROTUBULE 0.8 0.0001 0.9 0.0001 
KINETOCHORE 0.7 0.0001 0.8 0.0001 
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MYOFIBRIL 0.8 0.0001 0.7 0.0315 
SARCOMERE 0.9 0.0001 0.8 0.0012 
CONTRACTILE FIBER PART 0.8 0.0002 0.7 0.0091 
CHROMOSOME 0.5 0.0002 0.6 0.0000 
CHROMOSOMAL PART 0.6 0.0002 0.6 0.0001 
MICROTUBULE 0.7 0.0003 0.7 0.0003 
MICROTUBULE CYTOSKELETON 0.5 0.0006 0.5 0.0001 
MICROTUBULE MOTOR ACTIVITY 0.8 0.0007 0.7 0.0083 
ESTABLISHMENT OF ORGANELLE 
LOCALIZATION 0.8 0.0007 0.7 0.0094 
CELL CYCLE GO 0007049 0.5 0.0007 0.5 0.0003 
CHROMOSOME CONDENSATION 0.9 0.0007 0.9 0.0010 
KINESIN COMPLEX 0.8 0.0009 0.7 0.0660 
SISTER CHROMATID SEGREGATION 0.8 0.0010 0.8 0.0002 
MITOTIC SISTER CHROMATID SEGREGATION 0.8 0.0010 0.8 0.0002 
CONDENSED CHROMOSOME 0.7 0.0010 0.7 0.0002 
ORGANELLE LOCALIZATION 0.7 0.0013 0.6 0.0109 
CYTOSKELETAL PART 0.5 0.0019 0.5 0.0006 
SPINDLE POLE 0.7 0.0030 0.7 0.0038 
CHROMOSOME ORGANIZATION AND 
BIOGENESIS 0.5 0.0051 0.5 0.0376 
DNA PACKAGING 0.6 0.0051 0.6 0.0241 
SPINDLE ORGANIZATION AND BIOGENESIS 0.8 0.0067 0.8 0.0063 
MOTOR ACTIVITY 0.6 0.0074 0.6 0.0391 
CYTOKINESIS 0.7 0.0121 0.8 0.0001 
CELL DIVISION 0.7 0.0122 0.8 0.0002 
CENTROSOME 0.5 0.0163 0.6 0.0012 
REGULATION OF MITOSIS 0.6 0.0187 0.7 0.0002 
CYTOSKELETON 0.4 0.0214 0.4 0.0532 
MICROTUBULE CYTOSKELETON 
ORGANIZATION AND BIOGENESIS 0.6 0.0220 0.5 0.0680 
NEGATIVE REGULATION OF CELL 
DIFFERENTIATION 0.6 0.0437 0.6 0.0757 
MICROTUBULE ORGANIZING CENTER 0.5 0.0465 0.6 0.0013 
STRIATED MUSCLE CONTRACTION GO 0006941 0.7 0.0651 0.8 0.0081 
19 gene sets included exclusively in "HFD R vs. 
HPD":         
HEMATOPOIETIN INTERFERON CLASSD200 
DOMAIN CYTOKINE RECEPTOR ACTIVITY 0.5 0.2339 0.6 0.0092 
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CELL CYCLE CHECKPOINT GO 0000075 0.5 0.1901 0.6 0.0132 
NEGATIVE REGULATION OF HYDROLASE 
ACTIVITY 0.6 0.2029 0.8 0.0161 
REGULATION OF CELL CYCLE 0.4 0.1069 0.4 0.0201 
DNA REPLICATION 0.4 0.2083 0.5 0.0338 
DAMAGED DNA BINDING 0.3 0.8636 0.7 0.0345 
HYDROLASE ACTIVITY ACTING ON GLYCOSYL 
BONDS 0.3 0.5780 0.5 0.0489 
EXTRACELLULAR MATRIX 0.4 0.1330 0.5 0.0501 
MITOTIC CELL CYCLE CHECKPOINT 0.6 0.1688 0.6 0.0610 
REGULATION OF MITOTIC CELL CYCLE 0.5 0.3115 0.6 0.0613 
HYDROLASE ACTIVITY HYDROLYZING O 
GLYCOSYL COMPOUNDS 0.4 0.3458 0.6 0.0631 
MUSCLE DEVELOPMENT 0.4 0.2429 0.5 0.0634 
ACTIN FILAMENT 0.6 0.1095 0.6 0.0638 
PROTEINACEOUS EXTRACELLULAR MATRIX 0.4 0.1508 0.5 0.0677 
NUCLEAR CHROMOSOME 0.4 0.3095 0.5 0.0685 
REGULATION OF LIPID METABOLIC PROCESS 0.4 0.6910 0.7 0.0744 
LIPID TRANSPORTER ACTIVITY 0.4 0.4514 0.6 0.0769 
INTEGRIN BINDING 0.5 0.1878 0.6 0.0805 
FATTY ACID OXIDATION 0.5 0.3119 0.6 0.0959 
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Appendix Figure 5: The list of genes differentially expressed upon 2 and 7 days of HFD vs. CD (gWAT). 
Transcript 
ID 
Gene Symbol Accession 
pV 
(Interaction) 
pV 
(MainDiet) 
FC 
(log) 
d2 
pV d2 
FC 
(log) 
d7 
pV d7 
17265268  Cxcl16   chemokine (C-X-C motif) ligand 16  0.0596 0.2738 0.22 0.33261 0.94 0.002585 
17233993  Egr2   early growth response 2  0.0596 0.9609 0.02 0.96453 0.79 0.003397 
17378741  Nnat   neuronatin  0.9930 0.0000 2.18 0.00018 2.49 4.00E-06 
17346150  Lrg1   leucine-rich alpha-2-glycoprotein 1  0.3291 0.0196 0.71 0.03424 1.65 0.002585 
17535208  Fmr1   fragile X mental retardation syndrome 1  0.2007 0.0000 0.89 0.00218 1.50 0.000172 
17395091  Pmepa1  
 prostate transmembrane protein, androgen 
induced 1  0.9975 0.0000 1.37 0.00058 1.35 0.007351 
17520364  Plod2  
 procollagen lysine, 2-oxoglutarate 5-dioxygenase 
2  0.9930 0.0471 0.63 0.09751 1.14 0.011407 
17463781  Emp1   epithelial membrane protein 1  0.9930 0.0000 0.93 0.00093 1.09 0.001549 
17325206  Adcy5   adenylate cyclase 5  0.9930 0.0100 0.61 0.03894 0.92 0.01295 
17462451  Slc6a13  
 solute carrier family 6 (neurotransmitter 
transporter, GABA), member 13  0.9930 0.0064 0.61 0.03868 0.91 0.009303 
17486110  Peg3   paternally expressed 3  0.9930 0.0046 0.70 0.01291 0.86 0.03022 
17232162  Vnn1   vanin 1  0.9948 0.0098 1.02 0.0457 0.84 0.10852 
17346125  Plin4   perilipin 4  0.9975 0.0008 0.81 0.02517 0.78 0.010939 
17283549  Ifi27l2a   interferon, alpha-inducible protein 27 like 2A  0.9930 0.0003 0.98 0.01865 0.78 0.010939 
17325540  Gpr156   G protein-coupled receptor 156  0.9930 0.0029 0.63 0.03682 0.77 0.010939 
17482943  Il4ra   interleukin 4 receptor, alpha  0.9930 0.0029 0.59 0.0506 0.76 0.005672 
17305034  Sncg   synuclein, gamma  0.9956 0.0282 0.64 0.13742 0.75 0.025765 
17497421  Bnip3   BCL2 0.9975 0.0177 0.74 0.07724 0.71 0.070535 
17289196  Lhfpl2   lipoma HMGIC fusion partner-like 2  0.9956 0.0049 0.59 0.0457 0.67 0.02013 
17425631  Svep1  
 sushi, von Willebrand factor type A, EGF and 
pentraxin domain containing 1  0.9930 0.0001 0.77 0.01377 0.65 0.007417 
17227077  Prelp   proline arginine-rich end leucine-rich repeat  0.9966 0.0031 0.59 0.03651 0.63 0.025441 
17438832  Slc4a4  
 solute carrier family 4 (anion exchanger), member 
4  0.9975 0.0228 0.59 0.09187 0.62 0.068107 
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17509976  Slc25a42   solute carrier family 25, member 42  0.9956 0.0039 0.65 0.01301 0.58 0.105568 
17341080  Thbs2   thrombospondin 2  0.9930 0.0092 0.72 0.0983 0.51 0.082842 
17527917 
 
B930092H01Rik   RIKEN cDNA B930092H01 gene  0.9930 0.0395 0.59 0.18892 0.45 0.141935 
17430861  Sesn2   sestrin 2  0.9930 0.0292 0.64 0.09219 0.42 0.283575 
17329361  Kng2   kininogen 2  0.2057 0.0010 -1.02 0.03496 0.08 0.840027 
17516124  Olfr878   olfactory receptor 878  0.8036 0.0172 -0.64 0.09219 -0.02 0.973016 
17387624  Olfr1019   olfactory receptor 1019  0.5417 0.0471 0.91 0.23859 -0.29 0.478422 
17242376  Pfkl   phosphofructokinase, liver, B-type  0.9930 0.0004 -0.60 0.01169 -0.35 0.149665 
17350671  Gm5507   predicted gene 5507  0.9930 0.0007 -0.60 0.02923 -0.43 0.059008 
17427860  Acot11   acyl-CoA thioesterase 11  0.8957 0.0009 -1.19 0.0045 -0.44 0.432976 
17251441  Slc25a35   solute carrier family 25, member 35  0.9930 0.0039 -0.58 0.04212 -0.46 0.095174 
17409753  Agl  
 amylo-1,6-glucosidase, 4-alpha-
glucanotransferase  0.9930 0.0046 -0.58 0.05969 -0.47 0.065319 
17324835  Tfrc   transferrin receptor  0.9930 0.0122 -0.72 0.0983 -0.47 0.140277 
17279277  Aspg   asparaginase homolog (S. cerevisiae)  0.9956 0.0177 -0.60 0.0716 -0.51 0.132116 
17496408  Aldoa   aldolase A, fructose-bisphosphate  0.9930 0.0014 -0.66 0.01301 -0.55 0.071672 
17328829  Slc25a1  
 solute carrier family 25 (mitochondrial carrier, 
citrate transporter), member 1  0.9930 0.0004 -0.69 0.01971 -0.58 0.017797 
17273200  Pcyt2   phosphate cytidylyltransferase 2, ethanolamine  0.9960 0.0135 -0.53 0.13613 -0.59 0.012851 
17447310  Lrpap1  
 low density lipoprotein receptor-related protein 
associated protein 1  0.9930 0.0378 -0.35 0.18584 -0.60 0.010695 
17266335  Traf4   TNF receptor associated factor 4  0.9960 0.0105 -0.68 0.0457 -0.60 0.105568 
17318983  Tst   thiosulfate sulfurtransferase, mitochondrial  0.9930 0.0188 -0.37 0.09009 -0.61 0.014042 
17253461  Tlcd1   TLC domain containing 1  0.9940 0.0438 -0.50 0.23953 -0.61 0.014189 
17505252  Cyb5b   cytochrome b5 type B  0.9930 0.0193 -0.47 0.15623 -0.61 0.009569 
17371847  Pdk1   pyruvate dehydrogenase kinase, isoenzyme 1  0.9985 0.0012 -0.62 0.02603 -0.61 0.022871 
17433040  Pgd   phosphogluconate dehydrogenase  0.9966 0.0006 -0.66 0.03022 -0.62 0.009569 
17427746  Prkaa2  
 protein kinase, AMP-activated, alpha 2 catalytic 
subunit  0.9956 0.0098 -0.54 0.0429 -0.62 0.047859 
17526861  Dlat  
 dihydrolipoamide S-acetyltransferase (E2 
component of pyruvate dehydrogenase complex)  0.9960 0.0006 -0.57 0.01985 -0.62 0.010939 
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17319554  Pmm1   phosphomannomutase 1  0.9930 0.0429 -0.43 0.14248 -0.62 0.028678 
17453124  Psph   phosphoserine phosphatase  0.9966 0.0253 -0.56 0.10793 -0.62 0.055638 
17335540  Pim1   proviral integration site 1  0.9930 0.0000 -0.91 0.00103 -0.62 0.01793 
17383832  Gm13610   predicted gene 13610  0.9977 0.0055 -0.61 0.07612 -0.63 0.017609 
17220018  Cnst   consortin, connexin sorting protein  0.9930 0.0025 -0.54 0.02923 -0.64 0.018987 
17467556  Rpia   ribose 5-phosphate isomerase A  0.9930 0.0431 -0.44 0.05522 -0.65 0.05515 
17219156 
 
3110045C21Rik   RIKEN cDNA 3110045C21 gene  0.9966 0.0040 -0.69 0.04242 -0.65 0.040242 
17391861 
 
1700037H04Rik   RIKEN cDNA 1700037H04 gene  0.9956 0.0068 -0.58 0.04242 -0.66 0.034099 
17356216  Pcx   pyruvate carboxylase  0.9930 0.0373 -0.39 0.13207 -0.66 0.014016 
17493432  Thrsp   thyroid hormone responsive  0.9930 0.0000 -0.86 0.00132 -0.66 0.020034 
17388756  Pdhx   pyruvate dehydrogenase complex, component X  0.9930 0.0083 -0.53 0.09943 -0.68 0.007417 
17268010  Acsf2   acyl-CoA synthetase family member 2  0.9930 0.0228 -0.46 0.15126 -0.68 0.008739 
17505851  Nudt7  
 nudix (nucleoside diphosphate linked moiety X)-
type motif 7  0.9960 0.0204 -0.62 0.11498 -0.68 0.031761 
17485357  Dhcr7   7-dehydrocholesterol reductase  0.9930 0.0485 -0.56 0.17467 -0.71 0.034099 
17535434  Nsdhl   NAD(P) dependent steroid dehydrogenase-like  0.9960 0.0057 -0.64 0.06055 -0.71 0.017609 
17281843  Dhrs7   dehydrogenase 0.9959 0.0015 -0.65 0.03372 -0.71 0.010959 
17303400  Pdhb   pyruvate dehydrogenase (lipoamide) beta  0.9974 0.0000 -0.71 0.00525 -0.74 0.003957 
17359689  Scd2   stearoyl-Coenzyme A desaturase 2  0.9930 0.0004 -1.00 0.03022 -0.76 0.006219 
17518007  Pkm   pyruvate kinase, muscle  0.9956 0.0000 -0.72 0.00487 -0.78 0.001713 
17400048  Rorc   RAR-related orphan receptor gamma  0.9930 0.0228 -0.63 0.11639 -0.78 0.02151 
17307588  Fdft1   farnesyl diphosphate farnesyl transferase 1  0.9930 0.0047 -0.56 0.03894 -0.78 0.009984 
17418519  Oscp1   organic solute carrier partner 1  0.9956 0.0007 -0.87 0.00754 -0.79 0.035351 
17231229  Hsd11b1   hydroxysteroid 11-beta dehydrogenase 1  0.9930 0.0122 -0.64 0.06513 -0.79 0.022871 
17501041  Casp3   caspase 3  0.9930 0.0101 -0.57 0.10205 -0.80 0.005672 
17428209 
 
9630013D21Rik   RIKEN cDNA 9630013D21 gene  0.9930 0.0376 -0.55 0.20247 -0.82 0.007029 
17254395  Acaca   acetyl-Coenzyme A carboxylase alpha  0.9975 0.0000 -0.85 0.00487 -0.83 0.002942 
17351473  Slmo1   slowmo homolog 1 (Drosophila)  0.9930 0.0008 -0.62 0.01219 -0.83 0.007332 
117 
 
17468018  Hk2   hexokinase 2  0.9930 0.0211 -0.65 0.09009 -0.83 0.02468 
17475498  Cyp2f2  
 cytochrome P450, family 2, subfamily f, 
polypeptide 2  0.9960 0.0207 -0.75 0.18584 -0.84 0.005517 
17442187  Tmem120b   transmembrane protein 120B  0.9930 0.0147 -0.56 0.10802 -0.84 0.005949 
17326567  Gbe1   glucan (1,4-alpha-), branching enzyme 1  0.9966 0.0002 -0.81 0.01007 -0.84 0.005672 
17529398  Me1   malic enzyme 1, NADP(+)-dependent, cytosolic  0.9930 0.0000 -0.96 0.00215 -0.85 0.001713 
17284037  Mpc1   mitochondrial pyruvate carrier 1  0.9930 0.0029 -0.62 0.04124 -0.86 0.005423 
17370897  Gpd2  
 glycerol phosphate dehydrogenase 2, 
mitochondrial  0.9960 0.0027 -0.79 0.01469 -0.86 0.028633 
17443185  Mlxipl   MLX interacting protein-like  0.9930 0.0146 -0.65 0.08166 -0.86 0.014409 
17483007  Sbk1   SH3-binding kinase 1  0.9960 0.0042 -0.80 0.07724 -0.88 0.005124 
17362595  Fads2   fatty acid desaturase 2  0.9930 0.0011 -0.59 0.03894 -0.89 0.001713 
17298183  Tkt   transketolase  0.9971 0.0000 -0.93 0.00254 -0.90 0.005691 
17525955  Sc5d  
 sterol-C5-desaturase (fungal ERG3, delta-5-
desaturase) homolog (S. cerevisae)  0.9930 0.0098 -0.70 0.11155 -0.90 0.004499 
17333079  Mpc1   mitochondrial pyruvate carrier 1  0.9930 0.0114 -0.69 0.04619 -0.91 0.020232 
17285056  Idi1   isopentenyl-diphosphate delta isomerase  0.9930 0.0039 -0.70 0.04105 -0.91 0.008739 
17281721  Pygl   liver glycogen phosphorylase  0.9930 0.0000 -1.08 0.01007 -0.93 0.001713 
17501098  Cldn22   claudin 22  0.9966 0.0137 -1.02 0.08188 -0.94 0.05551 
17361299 
 
2010003K11Rik   RIKEN cDNA 2010003K11 gene  0.9930 0.0034 -0.72 0.0457 -0.94 0.005672 
17396056  Fabp5   fatty acid binding protein 5, epidermal  0.9930 0.0301 -0.53 0.2211 -0.94 0.001549 
17330463  Gm19522   predicted gene, 19522  0.9930 0.0218 -0.73 0.17153 -0.95 0.005014 
17279317 
 
A530016L24Rik   RIKEN cDNA A530016L24 gene  0.9930 0.0445 -0.56 0.20221 -0.96 0.005112 
17531650  Pth1r   parathyroid hormone 1 receptor  0.9930 0.0005 -0.79 0.03894 -0.97 0.000667 
17221360  Lactb2   lactamase, beta 2  0.9930 0.0020 -0.70 0.07612 -0.99 0.000612 
17454382  Adap1   ArfGAP with dual PH domains 1  0.9938 0.0211 -0.84 0.12061 -1.01 0.015417 
17340967  Acat2   acetyl-Coenzyme A acetyltransferase 2  0.9930 0.0188 -0.76 0.0716 -1.02 0.018987 
17547610  Fasn   fatty acid synthase  0.9966 0.0015 -0.97 0.03496 -1.02 0.007539 
17483133  Fam57b   family with sequence similarity 57, member B  0.9989 0.0001 -1.03 0.01157 -1.02 0.002168 
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17548238  Gm3601   predicted gene 3601  0.9930 0.0366 -0.57 0.15126 -1.06 0.004188 
17435584  Insig1   insulin induced gene 1  0.9930 0.0092 -0.74 0.11915 -1.06 0.001713 
17442719  Aacs   acetoacetyl-CoA synthetase  0.9930 0.0038 -0.85 0.0457 -1.07 0.005672 
17472497  Gys2   glycogen synthase 2  0.9930 0.0004 -1.26 0.03022 -1.08 0.002168 
17265096  Slc2a4  
 solute carrier family 2 (facilitated glucose 
transporter), member 4  0.9930 0.0007 -0.71 0.03022 -1.08 0.001549 
17548717  Gm3601   predicted gene 3601  0.9930 0.0235 -0.60 0.12005 -1.08 0.003771 
17442046  Hvcn1   hydrogen voltage-gated channel 1  0.9930 0.0297 -0.76 0.18644 -1.13 0.003425 
17269521  Acly   ATP citrate lyase  0.9930 0.0000 -1.40 0.00093 -1.17 0.002585 
17252912  Tlcd2   TLC domain containing 2  0.9930 0.0206 -0.89 0.13804 -1.19 0.005672 
17399474  Pmvk   phosphomevalonate kinase  0.9930 0.0001 -1.07 0.00651 -1.21 0.001713 
17406708  Tmem79   transmembrane protein 79  0.9930 0.0071 -0.95 0.04212 -1.25 0.010939 
17406908  Fdps   farnesyl diphosphate synthetase  0.9930 0.0025 -1.08 0.03475 -1.29 0.007021 
17355443  Lipg   lipase, endothelial  0.9930 0.0092 -0.90 0.0457 -1.30 0.008352 
17439037  Parm1   prostate androgen-regulated mucin-like protein 1  0.9930 0.0006 -0.90 0.01985 -1.31 0.001549 
17513681  Mvd   mevalonate (diphospho) decarboxylase  0.9930 0.0107 -0.87 0.07724 -1.31 0.005014 
17525894  Sorl1  
 sortilin-related receptor, LDLR class A repeats-
containing  0.9930 0.0016 -1.01 0.04212 -1.31 0.001762 
17402558  Elovl6  
 ELOVL family member 6, elongation of long chain 
fatty acids (yeast)  0.9930 0.0000 -1.51 0.00093 -1.37 0.000535 
17414747  Orm2   orosomucoid 2  0.9956 0.0098 -1.19 0.1048 -1.39 0.005112 
17500543  Ppp1r3b  
 protein phosphatase 1, regulatory (inhibitor) 
subunit 3B  0.9960 0.0050 -1.57 0.00651 -1.40 0.109325 
17445308  Cyp51   cytochrome P450, family 51  0.9930 0.0016 -0.92 0.03354 -1.44 0.00167 
17515335  Gm6484   predicted gene 6484  0.9966 0.0207 -1.35 0.06708 -1.47 0.051943 
17234552  Lss   lanosterol synthase  0.9930 0.0010 -1.16 0.03354 -1.49 0.001713 
17440826  Acacb   acetyl-Coenzyme A carboxylase beta  0.9930 0.0015 -0.98 0.03424 -1.49 0.001549 
17378359  Acss2   acyl-CoA synthetase short-chain family member 2  0.9985 0.0000 -1.51 0.0041 -1.50 0.001713 
17357981  Prune2   prune homolog 2 (Drosophila)  0.9930 0.0453 -0.86 0.2487 -1.51 0.001549 
17256388  Ttc25   tetratricopeptide repeat domain 25  0.9956 0.0000 -1.43 0.00093 -1.53 0.00167 
17218965  Adcy10   adenylate cyclase 10  0.9930 0.0010 -1.33 0.01865 -1.63 0.004499 
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17421875  Slc2a5  
 solute carrier family 2 (facilitated glucose 
transporter), member 5  0.9930 0.0000 -2.51 7.90E-05 -2.09 0.000667 
17524117  Hephl1   hephaestin-like 1  0.9930 0.0068 -1.54 0.09704 -2.28 0.001137 
17359678  Scd3   stearoyl-coenzyme A desaturase 3  0.9956 0.0863 -0.61 0.0429 -0.75 0.157693 
17480675  P4ha3  
 procollagen-proline, 2-oxoglutarate 4-dioxygenase 
(proline 4-hydroxylase), alpha polypeptide III  0.2007 0.6577 0.29 0.59665 1.69 0.007627 
17302031  Siah3   seven in absentia homolog 3 (Drosophila)  0.2007 0.6530 0.21 0.53991 1.27 0.009303 
17439535  Bmp3   bone morphogenetic protein 3  0.7553 0.0601 0.56 0.02923 1.25 0.010939 
17491193  Saa3   serum amyloid A 3  0.8186 0.6614 0.29 0.72299 1.18 0.010939 
17512809  Hp   haptoglobin  0.9930 0.0539 0.75 0.08166 1.15 0.033421 
17263073  Gm12248   predicted gene 12248  0.7884 0.6185 0.27 0.63335 1.08 0.020172 
17268210  Ngfr  
 nerve growth factor receptor (TNFR superfamily, 
member 16)  0.9930 0.0826 0.68 0.24235 0.95 0.021848 
17538018  Nrk   Nik related kinase  0.9904 0.1088 0.38 0.13207 0.80 0.02013 
17230918  Cenpf   centromere protein F  0.9930 0.7578 0.20 0.80339 0.80 0.028162 
17491285  Ptpn5   protein tyrosine phosphatase, non-receptor type 5  0.7553 0.6718 0.18 0.65031 0.78 0.034099 
17428017  Zyg11a   zyg-11 family member A, cell cycle regulator  0.9930 0.6413 0.24 0.71718 0.76 0.026692 
17397932  Sucnr1   succinate receptor 1  0.9930 0.0559 0.58 0.26685 0.76 0.009303 
17456934  Mest   mesoderm specific transcript  0.2007 0.8522 0.08 0.88287 0.76 0.002942 
17284919  Akr1c14   aldo-keto reductase family 1, member C14  0.9930 0.4896 0.31 0.63111 0.75 0.018719 
17228234  Npl   N-acetylneuraminate pyruvate lyase  0.9417 0.5187 0.24 0.54818 0.74 0.040242 
17402797  Cenpe   centromere protein E  0.9930 0.7442 0.18 0.79443 0.72 0.02635 
17482000  Spon1   spondin 1, (f-spondin) extracellular matrix protein  0.9930 0.3082 0.33 0.3886 0.72 0.040242 
17381630  Pfkfb3   6-phosphofructo-2-kinase 0.9930 0.2137 0.44 0.38363 0.70 0.04681 
17462351  Il17ra   interleukin 17 receptor A  0.4769 0.7400 0.12 0.75974 0.69 0.016704 
17467232  Gprin3   GPRIN family member 3  0.9930 0.1467 0.42 0.36119 0.66 0.020786 
17515478  Bmper   BMP-binding endothelial regulator  0.9930 0.0586 0.36 0.27317 0.64 0.005672 
17404859  Trpc3  
 transient receptor potential cation channel, 
subfamily C, member 3  0.9930 0.1206 0.41 0.2367 0.64 0.044802 
17430645  Nkain1  Na+/K+ transporting ATPase interacting 1  0.9930 0.1478 0.39 0.26848 0.64 0.047859 
17358838  Kif20b   kinesin family member 20B  0.9930 0.9112 0.09 0.92723 0.62 0.047859 
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17449795  4932430I15Rik   RIKEN cDNA 4932430I15 gene  0.2555 0.9289 -0.05 0.92538 0.61 0.034099 
17211305  Pi15   peptidase inhibitor 15  0.9930 0.2722 0.34 0.51511 0.60 0.010979 
17294738  Vcan   versican  0.9553 0.2521 0.25 0.51101 0.60 0.004492 
17323192  Snai2   snail homolog 2 (Drosophila)  0.7884 0.2284 0.23 0.46658 0.60 0.005227 
17271751  Gm11711   predicted gene 11711  0.9930 0.1743 0.39 0.376 0.59 0.036331 
17374488  Thbs1   thrombospondin 1  0.3884 0.7094 0.11 0.76346 0.58 0.011683 
17481550  Olfml1   olfactomedin-like 1  0.9930 0.2278 -0.30 0.359 -0.59 0.038812 
17280062  Lpin1   lipin 1  0.9930 0.8346 -0.12 0.86709 -0.59 0.02961 
17255210  Tob1   transducer of ErbB-2.1  0.9930 0.0847 -0.36 0.25027 -0.59 0.021501 
17435946  Abhd1   abhydrolase domain containing 1  0.9930 0.2994 -0.29 0.46674 -0.59 0.02961 
17259383  Slc25a10  
 solute carrier family 25 (mitochondrial carrier, 
dicarboxylate transporter), member 10  0.9930 0.4581 -0.27 0.61392 -0.59 0.028162 
17509629  Sc4mol   sterol-C4-methyl oxidase-like  0.9930 0.1297 -0.41 0.31711 -0.61 0.035058 
17410251  Enpep   glutamyl aminopeptidase  0.9930 0.2472 -0.33 0.46397 -0.62 0.015151 
17426981  Plin2   perilipin 2  0.9930 0.1081 -0.39 0.31003 -0.65 0.014042 
17368349  Fam69b   family with sequence similarity 69, member B  0.9930 0.0557 -0.50 0.13751 -0.67 0.048555 
17388371  Mapk8ip1  
 mitogen-activated protein kinase 8 interacting 
protein 1  0.9930 0.0591 -0.44 0.20247 -0.67 0.018621 
17232763  Ddo   D-aspartate oxidase  0.9930 0.0906 -0.45 0.20826 -0.68 0.036544 
17363429  Aldh1a7   aldehyde dehydrogenase family 1, subfamily A7  0.9930 0.1374 -0.53 0.35544 -0.69 0.035196 
17294664  Polr3g  
 polymerase (RNA) III (DNA directed) polypeptide 
G  0.9930 0.1911 -0.38 0.35687 -0.70 0.025441 
17386569  Chn1   chimerin (chimaerin) 1  0.8123 0.3910 -0.24 0.47587 -0.70 0.018621 
17503650  Nkd1   naked cuticle 1 homolog (Drosophila)  0.9930 0.3901 -0.27 0.42445 -0.70 0.042994 
17401480  Dennd2d   DENN 0.9553 0.4223 -0.26 0.55409 -0.71 0.016801 
17355189  Spire1   spire homolog 1 (Drosophila)  0.9930 0.0698 -0.45 0.24329 -0.71 0.012426 
17502233  Slc27a1  
 solute carrier family 27 (fatty acid transporter), 
member 1  0.9930 0.0826 -0.37 0.2648 -0.72 0.007417 
17503094  Podnl1   podocan-like 1  0.2555 0.9395 -0.04 0.93351 -0.76 0.015884 
17417146  Pdzk1ip1   PDZK1 interacting protein 1  0.9930 0.7658 -0.23 0.8364 -0.77 0.011332 
17453714  Sh2b2   SH2B adaptor protein 2  0.9930 0.1194 -0.41 0.38363 -0.78 0.002856 
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17229466  Hsd17b7   hydroxysteroid (17-beta) dehydrogenase 7  0.9930 0.1264 -0.52 0.38448 -0.79 0.007332 
17256537  Mlx   MAX-like protein X  0.9930 0.0512 -0.54 0.17153 -0.79 0.02013 
17493461  Aqp11   aquaporin 11  0.9289 0.5904 -0.24 0.62291 -0.82 0.03022 
17319050  Mfng  
 MFNG O-fucosylpeptide 3-beta-N-
acetylglucosaminyltransferase  0.9930 0.3538 -0.33 0.46993 -0.83 0.017579 
17311512  Mal2   mal, T cell differentiation protein 2  0.9930 0.4704 -0.51 0.63111 -0.88 0.032011 
17378848  Snhg11   small nucleolar RNA host gene 11  0.9930 0.2525 -0.52 0.46658 -0.91 0.012426 
17281084  Egln3   EGL nine homolog 3 (C. elegans)  0.9930 0.2007 -0.44 0.44467 -0.92 0.003771 
17368171  Bmyc   brain expressed myelocytomatosis oncogene  0.9930 0.1288 -0.45 0.22718 -0.93 0.012675 
17282158  Rdh11   retinol dehydrogenase 11  0.3884 0.0882 -0.37 0.2487 -0.97 0.002168 
17300147  Traj53   T cell receptor alpha joining 53  0.8123 0.4776 -0.32 0.52068 -1.02 0.02013 
17404073  Fabp5   fatty acid binding protein 5, epidermal  0.9930 0.1513 -0.58 0.27477 -1.03 0.02182 
17522504  Als2cl   ALS2 C-terminal like  0.4769 0.1468 -0.38 0.14585 -1.04 0.007961 
17509944  Ncan   neurocan  0.9930 0.1422 -0.76 0.28995 -1.07 0.042777 
17245481  Rassf3   Ras association (RalGDS 0.2555 0.0534 -0.40 0.17146 -1.08 0.001713 
17311807  Sqle   squalene epoxidase  0.9930 0.1850 -0.64 0.37558 -1.11 0.01516 
17300247  Trav9d-3   T cell receptor alpha variable 9D-3  0.1821 0.9441 0.06 0.93994 -1.13 0.008774 
17472271  Slc15a5   solute carrier family 15, member 5  0.8141 0.4223 -0.39 0.45695 -1.19 0.018631 
17361996  Ppp2r5b  
 protein phosphatase 2, regulatory subunit B (B56), 
beta isoform  0.9930 0.0528 -0.75 0.22956 -1.37 0.002168 
17300163  Traj44   T cell receptor alpha joining 44  0.8202 0.3532 -0.58 0.53879 -1.60 0.002168 
17487805  Atp1a3   ATPase, Na+ 0.4931 0.5716 -0.48 0.71437 -1.98 0.000427 
17414738  Orm3   orosomucoid 3  0.9471 0.0801 -1.01 0.28436 -2.10 0.001549 
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Appendix table 6: List of genes differentially expressed upon 7 days of HFD vs. CD from 
second profiling (gWAT) 
Transcript 
ID 
Gene 
Symbol Accession 
FC 
(log) pV 
17378741  Nnat   neuronatin  1.91 0.03595 
17421875  Slc2a5  
 solute carrier family 2 (facilitated glucose 
transporter), member 5  -1.81 0.01972 
17487805  Atp1a3   ATPase, Na+ -1.43 0.02484 
17414738  Orm3   orosomucoid 3  -1.38 0.04011 
17359918  Elovl3  
 elongation of very long chain fatty acids 
(FEN1 -1.37 0.04011 
17395091  Pmepa1  
 prostate transmembrane protein, androgen 
induced 1  1.29 0.01629 
17535208  Fmr1   fragile X mental retardation syndrome 1  1.26 0.01629 
17256388  Ttc25   tetratricopeptide repeat domain 25  -1.25 0.01629 
17440826  Acacb   acetyl-Coenzyme A carboxylase beta  -1.23 0.00429 
17218965  Adcy10   adenylate cyclase 10  -1.14 0.03595 
17548559  Emp1   epithelial membrane protein 1  1.10 0.04011 
17366746  Mir669k   microRNA 669k  -1.03 0.02605 
17402558  Elovl6  
 ELOVL family member 6, elongation of long 
chain fatty acids (yeast)  -1.01 0.03595 
17400048  Rorc   RAR-related orphan receptor gamma  -1.01 0.01938 
17355443  Lipg   lipase, endothelial  -0.99 0.04342 
17439037  Parm1  
 prostate androgen-regulated mucin-like 
protein 1  -0.97 0.04011 
17463781  Emp1   epithelial membrane protein 1  0.95 0.01629 
17231229  Hsd11b1   hydroxysteroid 11-beta dehydrogenase 1  -0.95 0.01685 
17513681  Mvd   mevalonate (diphospho) decarboxylase  -0.95 0.03811 
17483133  Fam57b   family with sequence similarity 57, member B  -0.94 0.01938 
17340967  Acat2   acetyl-Coenzyme A acetyltransferase 2  -0.94 0.01972 
17351473  Slmo1   slowmo homolog 1 (Drosophila)  -0.93 0.04375 
17531650  Pth1r   parathyroid hormone 1 receptor  -0.90 0.01972 
17282158  Rdh11   retinol dehydrogenase 11  -0.90 0.03775 
17482943  Il4ra   interleukin 4 receptor, alpha  0.85 0.04011 
17522504  Als2cl   ALS2 C-terminal like  -0.85 0.01629 
17443185  Mlxipl   MLX interacting protein-like  -0.84 0.01629 
17265096  Slc2a4  
 solute carrier family 2 (facilitated glucose 
transporter), member 4  -0.83 0.01938 
17442046  Hvcn1   hydrogen voltage-gated channel 1  -0.83 0.04011 
17527934  Kif23   kinesin family member 23  0.80 0.04923 
17335540  Pim1   proviral integration site 1  -0.80 0.01629 
17469627  Oxtr   oxytocin receptor  -0.79 0.03775 
17502233  Slc27a1  
 solute carrier family 27 (fatty acid 
transporter), member 1  -0.78 0.04011 
17470119  Ret   ret proto-oncogene  0.78 0.03595 
17442719  Aacs   acetoacetyl-CoA synthetase  -0.77 0.01938 
17245481  Rassf3   Ras association (RalGDS -0.77 0.04078 
17325206  Adcy5   adenylate cyclase 5  0.77 0.04787 
17397907  Gm9696  
 arylacetamide deacetylase-like 2 
pseudogene  -0.77 0.04923 
17370897  Gpd2  
 glycerol phosphate dehydrogenase 2, 
mitochondrial  -0.75 0.01938 
17333079  Mpc1   mitochondrial pyruvate carrier 1  -0.74 0.0173 
17217914  Aspm  
 asp (abnormal spindle)-like, microcephaly 
associated (Drosophila)  0.73 0.04375 
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17479575  Prc1   protein regulator of cytokinesis 1  0.73 0.04923 
17229433  Nuf2  
 NUF2, NDC80 kinetochore complex 
component, homolog (S. cerevisiae)  0.72 0.03811 
17399474  Pmvk   phosphomevalonate kinase  -0.71 0.04078 
17433145  Rbp7   retinol binding protein 7, cellular  0.71 0.04923 
17268909  Top2a   topoisomerase (DNA) II alpha  0.71 0.04553 
17234436  Chchd10  
 coiled-coil-helix-coiled-coil-helix domain 
containing 10  -0.70 0.01972 
17397932  Sucnr1   succinate receptor 1  0.70 0.04078 
17236811  Lum   lumican  0.68 0.0286 
17523494  Kif15   kinesin family member 15  0.68 0.02605 
17508025  Ckap2   cytoskeleton associated protein 2  0.68 0.04011 
17498750  Cd209g   CD209g antigen  0.66 0.03979 
17269521  Acly   ATP citrate lyase  -0.66 0.04011 
17526881  Dixdc1   DIX domain containing 1  -0.65 0.02582 
17371847  Pdk1  
 pyruvate dehydrogenase kinase, isoenzyme 
1  -0.64 0.02484 
17285867  Hist1h2ab   histone cluster 1, H2ab  0.64 0.04011 
17531671  Tmie   transmembrane inner ear  -0.63 0.04553 
17388756  Pdhx  
 pyruvate dehydrogenase complex, 
component X  -0.63 0.01938 
17268010  Acsf2   acyl-CoA synthetase family member 2  -0.62 0.03811 
17505851  Nudt7  
 nudix (nucleoside diphosphate linked moiety 
X)-type motif 7  -0.62 0.03348 
17442187 
 
Tmem120b   transmembrane protein 120B  -0.62 0.0337 
17252609  P2rx5  
 purinergic receptor P2X, ligand-gated ion 
channel, 5  -0.61 0.03811 
17456934  Mest   mesoderm specific transcript  0.60 0.04011 
17217789  Kif14   kinesin family member 14  0.59 0.02697 
17232763  Ddo   D-aspartate oxidase  -0.59 0.03811 
17519910  Ttk   Ttk protein kinase  0.58 0.04078 
 
Appendix table 7: List of genes differentially expressed upon 7 days of HFD vs. HFD-R from 
second profiling (gWAT) 
Transcript 
ID Gene Symbol Accession 
FC 
(log) pV 
17477979  Dbp   D site albumin promoter binding protein  1.99 0.0002 
17515335  Gm6484   predicted gene 6484  -1.46 0.0076 
17303625  Nr1d2  
 nuclear receptor subfamily 1, group D, 
member 2  1.41 0.0028 
17524117  Hephl1   hephaestin-like 1  -1.39 0.0175 
17500543  Ppp1r3b  
 protein phosphatase 1, regulatory 
(inhibitor) subunit 3B  -1.33 0.0118 
17433328  Per3   period circadian clock 3  1.32 0.0007 
17268884  Nr1d1  
 nuclear receptor subfamily 1, group D, 
member 1  1.30 0.0129 
17310400 
 
1700047G03Rik   RIKEN cDNA 1700047G03 gene  -1.27 0.0024 
17481960  Arntl  
 aryl hydrocarbon receptor nuclear 
translocator-like  -1.23 0.0006 
17375701  Slc27a2  
 solute carrier family 27 (fatty acid 
transporter), member 2  1.12 0.046 
17309832  C6   complement component 6  -1.12 0.0129 
17300183  Trav14d-3-dv8  
 T cell receptor alpha variable 14D-3-
DV8  -1.11 0.0329 
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17285846  Hist1h4m   histone cluster 1, H4m  -1.09 0.0028 
17491193  Saa3   serum amyloid A 3  -1.06 0.0136 
17469627  Oxtr   oxytocin receptor  -1.05 0.0024 
17467209  Fam13a  
 family with sequence similarity 13, 
member A  1.04 0.0027 
17352710  Cables1   CDK5 and Abl enzyme substrate 1  -1.00 0.0425 
17278261  Serpina3b  
 serine (or cysteine) peptidase inhibitor, 
clade A, member 3B  -0.99 0.0306 
17400862  Hmgcs2  
 3-hydroxy-3-methylglutaryl-Coenzyme A 
synthase 2  0.99 0.0444 
17313376  Tef   thyrotroph embryonic factor  0.99 0.0024 
17212087  Npas2   neuronal PAS domain protein 2  -0.91 0.004 
17300163  Traj44   T cell receptor alpha joining 44  -0.90 0.0432 
17533282  Mid1ip1  
 Mid1 interacting protein 1 (gastrulation 
specific G12-like (zebrafish))  -0.90 0.0074 
17520416  Paqr9  
 progestin and adipoQ receptor family 
member IX  -0.89 0.0007 
17291019  Hist1h4m   histone cluster 1, H4m  -0.87 0.0307 
17482230  Acsm5  
 acyl-CoA synthetase medium-chain 
family member 5  0.87 0.0106 
17254065  Ccl8   chemokine (C-C motif) ligand 8  -0.86 0.0186 
17502233  Slc27a1  
 solute carrier family 27 (fatty acid 
transporter), member 1  0.83 0.0024 
17363086  Dtx4   deltex 4 homolog (Drosophila)  -0.83 0.0024 
17472760  Bhlhe41  
 basic helix-loop-helix family, member 
e41  0.82 0.0136 
17211405  Gsta3   glutathione S-transferase, alpha 3  -0.81 0.0214 
17459074  BB365896   expressed sequence BB365896  0.81 0.0203 
17408015  Hist2h3c2   histone cluster 2, H3c2  -0.81 0.0136 
17300247  Trav9d-3   T cell receptor alpha variable 9D-3  -0.81 0.0399 
17548559  Emp1   epithelial membrane protein 1  -0.80 0.0158 
17241954  Gstt2   glutathione S-transferase, theta 2  0.78 0.0028 
17543315  Asb12  
 ankyrin repeat and SOCS box-
containing 12  -0.77 0.0425 
17409816  D3Bwg0562e  
 DNA segment, Chr 3, Brigham & 
Women's Genetics 0562 expressed  -0.77 0.0419 
17373521  Chst1  
 carbohydrate (keratan sulfate Gal-6) 
sulfotransferase 1  0.76 0.0006 
17311807  Sqle   squalene epoxidase  -0.76 0.0182 
17283742  Syne3  
 spectrin repeat containing, nuclear 
envelope family member 3  0.75 0.0029 
17249853  Gm12236   predicted gene 12236  -0.75 0.0109 
17441490  Fbxo21   F-box protein 21  0.74 0.0058 
17361996  Ppp2r5b  
 protein phosphatase 2, regulatory 
subunit B (B56), beta isoform  -0.73 0.0214 
17426097  Mup3   major urinary protein 3  -0.73 0.0136 
17292634  Nfil3   nuclear factor, interleukin 3, regulated  -0.72 0.0071 
17321474  Gm5620   tubulin, alpha 1B pseudogene  -0.71 0.0237 
17500548  Gm20359   predicted gene, 20359  -0.71 0.0229 
17449562  Rassf6   Ras association (RalGDS 0.70 0.0158 
17222825  Nabp1   nucleic acid binding protein 1  -0.69 0.0251 
17446793  Slc5a6  
 solute carrier family 5 (sodium-
dependent vitamin transporter), member 
6  0.69 0.0136 
17535208  Fmr1   fragile X mental retardation syndrome 1  -0.68 0.0054 
17409284  Celsr2  
 cadherin, EGF LAG seven-pass G-type 
receptor 2 (flamingo homolog, 0.68 0.0024 
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Drosophila)  
17265365  Inca1  
 inhibitor of CDK, cyclin A1 interacting 
protein 1  0.68 0.0175 
17310172  Ranbp3l   RAN binding protein 3-like  0.67 0.0129 
17507374  Irs2   insulin receptor substrate 2  0.67 0.0205 
17220475  Dusp10   dual specificity phosphatase 10  -0.67 0.0048 
17364150  Pank1   pantothenate kinase 1  0.67 0.008 
17218361 
 
A930039A15Rik   RIKEN cDNA A930039A15 gene  0.67 0.0324 
17471107  Plekhg6  
 pleckstrin homology domain containing, 
family G (with RhoGef domain) member 
6  0.66 0.0199 
17230725  Marc1  
 mitochondrial amidoxime reducing 
component 1  -0.66 0.0182 
17464654  Pdk4  
 pyruvate dehydrogenase kinase, 
isoenzyme 4  0.66 0.0417 
17230408  Adck3   aarF domain containing kinase 3  0.66 0.0158 
17331720  Adamts5  
 a disintegrin-like and metallopeptidase 
(reprolysin type) with thrombospondin 
type 1 motif, 5 (aggrecanase-2)  -0.65 0.0027 
17372621  Slc43a1   solute carrier family 43, member 1  0.65 0.0099 
17340657  Gm9992   predicted gene 9992  0.64 0.0205 
17290173  Hmgcs1  
 3-hydroxy-3-methylglutaryl-Coenzyme A 
synthase 1  -0.64 0.0016 
17407934  Gm129   predicted gene 129  0.63 0.0158 
17544878  Morc4   microrchidia 4  -0.62 0.0027 
17333198  Gm16168   predicted gene 16168  0.61 0.0476 
17515315  Ldlr   low density lipoprotein receptor  -0.61 0.0346 
17484587  Cyp2e1  
 cytochrome P450, family 2, subfamily e, 
polypeptide 1  0.61 0.0151 
17498502  Ccnd1   cyclin D1  -0.61 0.0137 
17456545  Lep   leptin  -0.60 0.0251 
17519364  Fam214a  
 family with sequence similarity 214, 
member A  0.60 0.0431 
17507175  Cd209e   CD209e antigen  -0.59 0.0205 
17495821  Cdr2   cerebellar degeneration-related 2  -0.59 0.0076 
17290242  Net1   neuroepithelial cell transforming gene 1  0.59 0.0158 
17326183  Gm6936   predicted gene 6936  -0.59 0.0352 
17315860  Slc1a3  
 solute carrier family 1 (glial high affinity 
glutamate transporter), member 3  0.59 0.0175 
17537861  Arxes2  
 adipocyte-related X-chromosome 
expressed sequence 2  0.58 0.0212 
17401480  Dennd2d   DENN/MADD domain containing 2D 0.58 0.0307 
17518378  Dennd4a  DENN/MADD domain containing 4A -0.58 0.0136 
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